Professor Ric Day

Professor Ric Day

Professor

AM, MB BS (Hons) Syd, MD UNSW, FRACP

Medicine & Health
School of Clinical Medicine

Prof Day AM (MBBS, FRACP, MD) is internationally and nationally recognised for his research, leadership and advocacy in support of quality use of medicines (QUM). He has been deeply involved in Australia’s National Medicines Policy and the QUM component culminating in his Chairmanship of the Pharmaceutical Health and Rational Use of Medicines Committee (PHARM) for the Federal Government in 1999-2008. PHARM provided strategic advice about QUM and supported the creation of the National Prescribing Service (NPS MedicinesWise). This work has informed his approach to advocacy and health policy and interventions. His research focuses on QUM and methods of enhancing the safe use of medicines using eHealth systems and decision support tools He has published over 600 peer reviewed papers: NEJM (4), BMJ (8), Lancet (5), Arch Intern Med (3), PLoS Med (2), Ann Intern Med (1), PNAS (1), & J Am Med Inform Assoc (9), & leading rheumatology (Ann Rheum Dis (6)) and clinical pharmacology journals (Clin Pharmacol Ther (7) and Brit J Clin Pharmacol (38). He has been cited over 22,600 times. He has published > 30 papers on gout. He collaborates widely in his research. His current collaborations have lead to significant work investigating the potential of eHealth tools to increase medication safety but he has other significant areas of research. Day collaborates especially with Prof J. Westbrook,  (Health Systems and eHealth and Medication Safety Research all at Macquarie University, Sydney) and Prof Melissa Baysari and Profs. C.Maher, J.Latimer, C.Lin & colleagues (University of Sydney -Large RCTs in primary care in musculoskeletal conditions) and Professor Anthony Rodgers (George Institute for Global Health – innovative clinical trial research designs in musculoskeletal disorders). Rigorous evaluation of electronic medication systems including implementation, effectiveness in reducing medication errors, decision support and alerts and new types of errors have led to highly cited publications (>26 papers). Day’s 5 year NH&MRC Partnership Grant (1094708) investigating the potential of eHealth tools to assist patients with gout adhere to their medications, of generic importance for chronic illnesses, builds on this work. Day’s innovative work extending the patient populations that can take metformin safely and benefit from its life saving cardiac protective properties, for example in people with type II diabetes and chronic kidney disease (CKD), non-diabetic obese women, people with cardiac failure and people with hepatic function impairment has been enhanced by national collaborations and is highly cited (e.g Graham et al, Clin Pharmacokin 2011; cited > 400 times).

Prof Day is a committed undergraduate & post-graduate teacher & research mentor (two awards) focussing on Quality Use of Medicines (QUM) & translation of evidence into practice. In the last 5 years, Day’s Honours (5), Independent Learning Program medical students (10), PhDs (13), MSc (3), Advanced trainees (3) and Post-Docs (5) have made 97 presentations nationally & internationally.

Prof Day has received many awards, including Member of the Order of Australia AM, 2000 relating mostly to his focus upon QUM. He received the AMA Distinguished Service Award in 2009, became an Inaugural Life Member of the NPS in 2011 and made Fellow of Australasian Society of Clinical & Experimental Pharmacologists and Toxicologists (ASCEPT) in 2022. Prof Day was also the first non-US President of the Drug Information Association (DIA). Further, Prof Day is a practicing Rheumatologist and Clinical Pharmacologist and is an active educator and contributor to national resources such as the Australian Medicines Handbook (he was an inaugural Director) and Therapeutic Guidelines. Prof Day’s involvement with the pharmaceutical enterprise is extensive. He has held several positions including member of Medicines Australia Code of Conduct Committee since 1995; President of the national association of pharmacologists and toxicologists, ASCEPT 1995, Director of Medical Benefits Fund Australia, now BUPA, in 1998-2002, Co-chair of Medication Safety Taskforce for the Australian Safety and Quality Council (2001-3), Chair NPS R&D committee (2008-10), Ministerial Appointee of the Australian Health Informatics Committee 2003-5, Co-chair of National Electronic Medication Management reference group for the National e-Health Transition Authority and currently, Chair of Medication Expert Advisory Committee to the NSW Ministry of Health, Member NSW Early Phase Clinical Trials Committee, Member NSW Chief Scientist’s Cannabis Expert Advisory Committee, Chair NSW Cannabis Prescribers Committee, all for NSW Ministry of Health and Chair Research Advisory Committee of the National Institute of Complementary Medicine (NICM) Research Committee, University of Western Sydney 2014-17. Prof Day’s knowledge of, and connections to, the pharmaceutical industry are enhanced by his role as the senior academic advisor for Australia’s leading post-graduate degree in Drug Development – Masters of Pharmaceutical Medicine program that he cofounded at UNSW in the Faculty of Medicine.

Phone
+61 2 8382 2331
Location
St Vincent's Clinical School, UNSW Medicine, UNSW Sydney Department of Clinical Pharmacology & Toxicology Therapeutics Centre, Level 2 Xavier Building St Vincent's Hospital Sydney Darlinghurst NSW 2010
  • Book Chapters | 2019
    Pile KD; Graham GG; Mahler SM; Day RO, 2019, 'Disease-Modifying Anti-rheumatic Drugs', in Nijkamp and Parnham’s Principles of Immunopharmacology: Fourth revised and extended edition, Springer International Publishing, pp. 709 - 750, http://dx.doi.org/10.1007/978-3-030-10811-3_34
    Book Chapters | 2018
    Baysari M; Chan J; Carland J; Stocker S; Moran M; Day R, 2018, 'Usability of Reports Generated by a Computerised Dose Prediction Software', in Connecting the System to Enhance the Practitioner and Consumer Experience in Healthcare, IOS Press, Netherlands, pp. 27 - 32, http://dx.doi.org/10.3233/978-1-61499-890-7-27
    Book Chapters | 2016
    Day R; graham GG, 2016, 'Coxibs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1 - 7, http://dx.doi.org/10.1007/978-3-0348-0620-6_22-1
    Book Chapters | 2016
    Day R; pile KD; graham GG; katelaris C, 2016, 'Antimalarial Drugs', in Compendium of Inflammatory Diseases, Springer Basel, Basel, pp. 97 - 101, http://dx.doi.org/10.1007/978-3-7643-8550-7
    Book Chapters | 2016
    Graham GG; Roberts MS; Day RO; Rainsford KD, 2016, 'Pharmacokinetics and metabolism of the salicylates', in Aspirin and Related Drugs, pp. 97 - 155
    Book Chapters | 2013
    Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/
    Book Chapters | 2013
    Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs', in Encyclopedia of Inflammatory Diseases, edn. 6, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/
    Book Chapters | 2013
    Day RO; Williams KM; Graham GG, 2013, 'Urate-lowering therapy: Uricosurics', in Dalbeth N; Peresa-Ruiz F; Schlesinger N (ed.), Gout, Future Medicine Ltd, pp. 174 - 188, http://dx.doi.org/10.2217/ebo.13.104
    Book Chapters | 2013
    Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/
    Book Chapters | 2011
    Baysari MT; Westbrook J; Day RO, 2011, 'Medication decision-making on hospital ward-rounds', in Moen A; Andersen SK; Aarts J; Hurlen P (ed.), Studies in Health Technology and Informatics, IOS Press, Amsterdam, pp. 935 - 939, http://dx.doi.org/10.3233/978-1-60750-806-9-935
    Book Chapters | 2011
    Pile K; Graham GG; Mahler SM; Day RO, 2011, 'Disease modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 585 - 619, http://books.google.com.au/books?id=X0deXiGtcCAC&printsec=frontcover#v=onepage&q&f=false
    Book Chapters | 2005
    Bachmeier CJ; Brooks PM; Day RO; Graham GG; Littlejohn GO; Morand E; Pile K; Williams KM, 2005, 'Disease-modifying anti-rheumatic drugs (DMARD)', in Nijkamp FJ; Parnham MJ (ed.), Principles of Immunopharmacology (2nd Ed), edn. 2nd, Birkhauser Verlag, Basel, pp. 511 - 544
    Book Chapters | 2003
    Day RO, 2003, 'Therapy of osteoarthritis', in Scott D; Cope A (ed.), The Year in Rheumatic Disorders 2003, edn. First, Clinical Publishibg Services Ltd, Oxford, United Kingdom, pp. 23 - 34
    Book Chapters | 2000
    Day RO; Quinn DE; Williams KK; Handel ML; Brooks PM, 2000, 'Connective tissue and bone disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702
    Book Chapters | 2000
    Day RO; Quinn DI; March LM; Graham GG; Williams KM, 2000, 'Rheumatoid arthritis. New Frontiers in pathogenesis and treatment', in NSAIDs and analgesics, edn. Original, Oxford University Press, Oxford, England, pp. 307 - 328
    Book Chapters | 2000
    Day RO, 2000, 'Rheumatic Disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702
    Book Chapters | 1999
    Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1999, 'Disease-modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 379 - 403
    Book Chapters | 1999
    Brady S; Day RO; Graham GG, 1999, 'Are Intra-Articular steroids as effective?', in Challenges in Rheumatoid Arthritis, edn. Original, Blackwell Science, Oxford, UK, pp. 174 - 189
    Book Chapters | 1998
    Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1998, 'Disease Modifying antirheumatic drugs', in Textbook of Immunopharmacology, edn. 3, Burkhauser, Basel, Switzerland, pp. 183 - 190, http://dx.doi.org/10.1097/00002281-199705000-00003
    Book Chapters | 1998
    Brooks PM; Day RO, 1998, 'Arthritis', in Drug Therapy in old age, edn. Original, Wiley & Sons, Chichester UK, pp. 387 - 400
    Book Chapters | 1998
    Brooks PM; Savdie E; Day RO, 1998, 'Antirheumatic drugs and renal disease', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 28 - 29
    Book Chapters | 1998
    Day RO, 1998, 'Formulary and Guide to Prescribing (second edition)', in Formulary Guide to Prescribing (2nd Ed), edn. Original, St. Vincent's Hospital, Sydney, Australia, pp. 1 - 445
    Book Chapters | 1998
    Day RO, 1998, 'SARDS', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 8.1 - 8.10
    Book Chapters | 1998
    Graham GG; Milligan MK; Day RO; Williams KM; Ziegler JB, 1998, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in Rainsford KD; Powanda MC (ed.), Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, pp. 77 - 92, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081416000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Book Chapters | 1998
    Yeomans N; Brooks PM; Day RO, 1998, 'Non steroidal anti-inflammatory drugs and peptic ulceration', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 27 - 28
    Book Chapters | 1997
    Day RO, 1997, 'Sulfasalazine.', in In: `The Textbook of Rheumatology`, Edition 5., edn. Original, pp. 741 - 746
    Book Chapters | 1997
    Graham GG; Milligan MK; Day RO; Williams KM; Zeig , 1997, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in In: `Safety and efficacy of non-prescription (OTC) analgesics, edn. Original, Kluwer Academic Publishers, Great Britain, pp. 77 - 92
    Book Chapters | 1997
    Quinn DE; Day RO, 1997, 'Guide to Clinically More Important Drug Interactions.', in Drug Safety, edn. Original, Adis International Limited, Auckland, New Zealand, pp. 1665 - 1700
  • Journal articles | 2023
    Brett J; Bahceci D; Lipworth W; Liknaitzky P; Day RO; Rodgers A, 2023, 'Can old drugs learn new tricks? Achieving registration and public subsidy listing for off-patent medicines with novel therapeutic applications', Internal Medicine Journal, 53, pp. 1284 - 1287, http://dx.doi.org/10.1111/imj.16159
    Journal articles | 2023
    Carland JE; Stacy AE; Schaffer AL; Day RO; Brett J; Reuter SE; Stocker SL, 2023, 'Blood, dose recommendation reports and phone calls: Experiences of a therapeutic drug monitoring advisory service for vancomycin', British Journal of Clinical Pharmacology, 89, pp. 1896 - 1902, http://dx.doi.org/10.1111/bcp.15668
    Journal articles | 2023
    Chin PKL; Charles K; Murnion B; McGuire TM; Hilmer SN; Martin J; Reith D; Joyce D; Lucas C; Holford N; Day R; Schneider J; Doogue M; Han CH; Herd S; Harrison C; O'Mara D, 2023, 'Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.15814
    Journal articles | 2023
    Chowdhury G; Carland JE; Kumar S; Olsen N; Graham G; Kumarasinghe G; Hayward CS; Greenfield JR; Macdonald P; Day RO; Stocker SL, 2023, 'The safe use of metformin in heart failure patients both with and without T2DM: A cross-sectional and longitudinal study', British Journal of Clinical Pharmacology, 89, pp. 2603 - 2613, http://dx.doi.org/10.1111/bcp.15737
    Journal articles | 2023
    Ferreira GE; Abdel-Shaheed C; Underwood M; Finnerup NB; Day RO; McLachlan A; Eldabe S; Zadro JR; Maher CG, 2023, 'Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews', BMJ, 380, pp. e072415, http://dx.doi.org/10.1136/bmj-2022-072415
    Journal articles | 2023
    Kirubakaran R; Uster DW; Hennig S; Carland JE; Day RO; Wicha SG; Stocker SL, 2023, 'Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients', British Journal of Clinical Pharmacology, 89, pp. 1162 - 1175, http://dx.doi.org/10.1111/bcp.15566
    Journal articles | 2023
    Milder TY; Stocker SL; Baysari MT; Day RO; Greenfield JR, 2023, '‘We are somehow fixated on this being a diabetes drug’: a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.16203
    Journal articles | 2023
    Spragg JCJ; Michael TJF; Aslani P; Coleshill MJ; Chan JS; Day RO; Stocker SL, 2023, 'Optimizing adherence to allopurinol for gout: patients' perspectives', British Journal of Clinical Pharmacology, 89, pp. 1978 - 1991, http://dx.doi.org/10.1111/bcp.15657
    Journal articles | 2023
    Stefani M; Musgrave K; Sevastos J; Penny M; Day RO; Roberts DM, 2023, 'Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low-flux filters, and the potential impact of dosing software', Nephrology, 28, pp. 534 - 539, http://dx.doi.org/10.1111/nep.14198
    Journal articles | 2023
    Stojanova J; Day RO; Suthers G, 2023, 'Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at-risk patients', Medical Journal of Australia, 218, pp. 441 - 444, http://dx.doi.org/10.5694/mja2.51937
    Journal articles | 2023
    Sullivan JK; Fahey PP; Agho KE; Hurley SP; Feng Z; Day RO; Lim D, 2023, 'Valproic acid as a radio-sensitizer in glioma: A systematic review and meta-analysis.', Neurooncol Pract, 10, pp. 13 - 23, http://dx.doi.org/10.1093/nop/npac078
    Journal articles | 2023
    Wewege MA; Bagg MK; Jones MD; Ferraro MC; Cashin AG; Rizzo RRN; Leake HB; Hagstrom AD; Sharma S; McLachlan AJ; Maher CG; Day R; Wand BM; O'Connell NE; Nikolakopolou A; Schabrun S; Gustin SM; McAuley JH, 2023, 'Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis', BMJ, 380, pp. e072962, http://dx.doi.org/10.1136/bmj-2022-072962
    Journal articles | 2023
    Wise S; Smith E; Carlos L; Coleshill M; Day RO; Melocco T; Carland JE, 2023, 'Who is asking? Requests for antimicrobial prescribing advice received by hospital pharmacists', Journal of Pharmacy Practice and Research, 53, pp. 39 - 43, http://dx.doi.org/10.1002/jppr.1841
    Journal articles | 2022
    Abdel Shaheed C; Awal W; Zhang G; Gilbert SE; Gallacher D; McLachlan A; Day RO; Ferreira GE; Jones CMP; Ahedi H; Tamrakar M; Blyth FM; Stanaway F; Maher CG, 2022, 'Efficacy, safety, and dose-dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta-analysis', Medical Journal of Australia, 216, pp. 305 - 311, http://dx.doi.org/10.5694/mja2.51392
    Journal articles | 2022
    Abdel Shaheed C; Beardsley J; Day RO; McLachlan AJ, 2022, 'Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: Mechanisms and relevance to infection', British Journal of Clinical Pharmacology, 88, pp. 3114 - 3131, http://dx.doi.org/10.1111/bcp.15281
    Journal articles | 2022
    Baysari MT; Dort BAV; Zheng WY; Li L; Hilmer S; Westbrook J; Day R, 2022, 'Prescribers’ reported acceptance and use of drug-drug interaction alerts: An Australian survey', Health Informatics Journal, 28, http://dx.doi.org/10.1177/14604582221100678
    Journal articles | 2022
    Baysari MT; Van Dort BA; Stanceski K; Hargreaves A; Zheng WY; Moran M; Day R; Li L; Westbrook J; Hilmer S, 2022, 'Is evidence of effectiveness a driver for clinical decision support selection? A qualitative descriptive study of senior hospital staff', International Journal for Quality in Health Care, 35, http://dx.doi.org/10.1093/intqhc/mzad004
    Journal articles | 2022
    Chaudhri K; Kearney M; Di Tanna GL; Gnanenthiran SR; Day RO; Rodgers A; Atkins ER, 2022, 'Does splitting a tablet obtain an accurate dose? A systematic review and meta- analysis', Journal of Pharmacy Practice and Research, 52, pp. 411 - 421, http://dx.doi.org/10.1002/jppr.1843
    Journal articles | 2022
    Coleshill MJ; Day RO; Tam K; Kouhkamari M; Caillet V; Aung E; Kannangara DRW; Cronin P; Rodgers A; Stocker SL, 2022, 'Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions', British Journal of Clinical Pharmacology, 88, pp. 4894 - 4901, http://dx.doi.org/10.1111/bcp.15435
    Journal articles | 2022
    Jones CMP; Lin CWC; Day RO; Koes BW; Latimer J; Maher CG; McLachlan A; Billot L, 2022, 'OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain—a statistical analysis plan', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06028-y
    Journal articles | 2022
    Kamel B; Abuhelwa AY; Foster D; Duong JK; Graham GG; Williams KM; Pile KD; Day RO, 2022, 'Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout', British Journal of Clinical Pharmacology, 88, pp. 5359 - 5368, http://dx.doi.org/10.1111/bcp.15462
    Journal articles | 2022
    Kirubakaran R; Hennig S; Maslen B; Day RO; Carland JE; Stocker SL, 2022, 'Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients', British Journal of Clinical Pharmacology, 88, pp. 1751 - 1772, http://dx.doi.org/10.1111/bcp.15091
    Journal articles | 2022
    Li L; Baker J; Rathnayake K; Kotwal S; Westbrook JI; Day R; Endre Z, 2022, 'Medication use and hospital-acquired acute kidney injury: an electronic health record-based study', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.15938
    Journal articles | 2022
    Mashuri YA; Wulandari LPL; Khan M; Ferdiana A; Probandari A; Wibawa T; Batura N; Liverani M; Day R; Jan S; Schierhout G; Wahyono D; Yulianto ; Kaldor J; Guy R; Law M; Yeung S; Wiseman V, 2022, 'The response to COVID-19 among drug retail outlets in Indonesia: A cross-sectional survey of knowledge, attitudes, and practices', The Lancet Regional Health - Western Pacific, 22, pp. 100420, http://dx.doi.org/10.1016/j.lanwpc.2022.100420
    Journal articles | 2022
    Milder T; Stocker S; Baysari M; Day R; Greenfield J, 2022, 'Prescribing of SGLT2 Inhibitors in Clinical Practice: A Qualitative Study of Cardiologists', Heart, Lung and Circulation, 31, pp. S96 - S97, http://dx.doi.org/10.1016/j.hlc.2022.06.117
    Journal articles | 2022
    Nguyen AD; Lind KE; Day RO; Ross D; Raban MZ; Georgiou A; Westbrook JI, 2022, 'Measuring quality of gout management in residential aged care facilities', Rheumatology Advances in Practice, 6, http://dx.doi.org/10.1093/rap/rkac091
    Journal articles | 2022
    Pearce A; Terrill B; Alffenaar JW; Patanwala AE; Kummerfeld S; Day R; Young MA; Stocker SL, 2022, 'Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals', Internal Medicine Journal, 52, pp. 1135 - 1143, http://dx.doi.org/10.1111/imj.15719
    Journal articles | 2022
    Radovanovic M; Day RO; Jones GDR; Galettis P; Norris RLG, 2022, 'LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring', Journal of Mass Spectrometry and Advances in the Clinical Lab, 26, pp. 48 - 59, http://dx.doi.org/10.1016/j.jmsacl.2022.11.001
    Journal articles | 2022
    Radovanovic M; Jones G; Day RO; Galettis P; Norris RLG, 2022, 'Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry', Journal of Mass Spectrometry and Advances in the Clinical Lab, 24, pp. 57 - 64, http://dx.doi.org/10.1016/j.jmsacl.2022.04.002
    Journal articles | 2022
    Rizzo RRN; Ferraro MC; Wewege MA; Cashin AG; Leake HB; O'Hagan ET; Jones MD; Gustin SM; McLachlan AJ; Day R; McAuley JH, 2022, 'Targeting neurotrophic factors for low back pain and sciatica: A systematic review and meta-analysis', Rheumatology (United Kingdom), 61, pp. 2243 - 2254, http://dx.doi.org/10.1093/rheumatology/keab785
    Journal articles | 2022
    Sandaradura I; Alffenaar JW; Cotta MO; Daveson K; Day RO; Van Hal S; Lau C; Marriott DJE; Penm J; Roberts JA; Tabah A; Williams P; Imani S, 2022, 'Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementation', British Journal of Clinical Pharmacology, 88, pp. 669 - 679, http://dx.doi.org/10.1111/bcp.14995
    Journal articles | 2022
    Thorlund JB; Simic M; Pihl K; Berthelsen DB; Day R; Koes B; Juhl CB, 2022, 'Similar Effects of Exercise Therapy, Nonsteroidal Anti-inflammatory Drugs, and Opioids for Knee Osteoarthritis Pain: A Systematic Review with Network Meta-analysis', Journal of Orthopaedic and Sports Physical Therapy, 52, pp. 207 - 216, http://dx.doi.org/10.2519/jospt.2022.10490
    Journal articles | 2022
    Tiwary M; Milder TY; Stocker SL; Day RO; Greenfield JR, 2022, 'Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction', Internal Medicine Journal, 52, pp. 1666 - 1676, http://dx.doi.org/10.1111/imj.15727
    Journal articles | 2022
    Westbrook JI; Li L; Raban MZ; Mumford V; Badgery-Parker T; Gates P; Fitzpatrick E; Merchant A; Woods A; Baysari M; McCullagh C; Day R; Gazarian M; Dickinson M; Seaman K; Dalla-Pozza L; Ambler G; Barclay P; Gardo A; O’Brien T; Barbaric D; White L, 2022, 'Short- and long-term effects of an electronic medication management system on paediatric prescribing errors', npj Digital Medicine, 5, http://dx.doi.org/10.1038/s41746-022-00739-x
    Journal articles | 2022
    Wise S; Coleshill MJ; Taylor N; Le M; Debono D; Day RO; Melocco T; Baysari MT; Laba TL; Carland JE, 2022, 'Australian hospital outpatient pharmacies: service adaptations during the 2020 national coronavirus disease 2019 lockdown', Journal of Pharmacy Practice and Research, 52, pp. 326 - 328, http://dx.doi.org/10.1002/jppr.1810
    Journal articles | 2022
    Wong DD; van Zuylen WJ; Novos T; Stocker S; Reuter SE; Au J; Foster CSP; Day RO; Horvath AR; Endre Z; Rawlinson WD, 2022, 'Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis', Microbiology Spectrum, 10, http://dx.doi.org/10.1128/spectrum.02684-21
    Journal articles | 2022
    Wulandari LPL; Khan M; Probandari A; Batura N; Ferdiana A; Mashuri YA; Wibawa T; Daraninggar D; Dewi BK; Day R; Jan S; Schierhout G; Yeung S; Wiseman V; Liverani M, 2022, '"We face the same risk as the other health workers": Perceptions and experiences of community pharmacists in Indonesia during the COVID-19 pandemic.', PLOS Glob Public Health, 2, pp. e0000606, http://dx.doi.org/10.1371/journal.pgph.0000606
    Journal articles | 2022
    Yager RC; Taylor N; Stocker SL; Day RO; Baysari MT; Carland JE, 2022, 'Would they accept it? An interview study to identify barriers and facilitators to user acceptance of a prescribing advice service', BMC Health Services Research, 22, pp. 514, http://dx.doi.org/10.1186/s12913-022-07927-1
    Journal articles | 2021
    Abdel Shaheed C; Ferreira GE; Dmitritchenko A; McLachlan AJ; Day RO; Saragiotto B; Lin C; Langendyk V; Stanaway F; Latimer J; Kamper S; McLachlan H; Ahedi H; Maher CG, 2021, 'The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews', Medical Journal of Australia, 214, pp. 324 - 331, http://dx.doi.org/10.5694/mja2.50992
    Journal articles | 2021
    Baysari MT; Moran M; Del Gigante J; Day RO, 2021, 'Indications-based prescribing: A challenge for hospital prescribers', British Journal of Clinical Pharmacology, 87, pp. 730 - 731, http://dx.doi.org/10.1111/bcp.14532
    Journal articles | 2021
    Braithwaite HE; Darley DR; Brett J; Day RO; Carland JE, 2021, 'Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review', Transplantation Reviews, 35, http://dx.doi.org/10.1016/j.trre.2021.100610
    Journal articles | 2021
    Carland JE; Elhage T; Baysari MT; Stocker SL; Marriott DJE; Taylor N; Day RO, 2021, 'Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose-recommendation software', British Journal of Clinical Pharmacology, 87, pp. 1215 - 1233, http://dx.doi.org/10.1111/bcp.14496
    Journal articles | 2021
    Carland JE; Stocker SL; Baysari MT; Li C; Själin J; Moran MA; Tang S; Sandaradura I; Elhage T; Gilbey T; Williams KM; Marriott DJE; Day RO, 2021, 'Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices', British Journal of Clinical Pharmacology, 87, pp. 4221 - 4229, http://dx.doi.org/10.1111/bcp.14834
    Journal articles | 2021
    Cashin AG; Folly T; Bagg MK; Wewege MA; Jones MD; Ferraro MC; Leake HB; Rizzo RRN; Schabrun SM; Gustin SM; Day R; Williams CM; McAuley JH, 2021, 'Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: Systematic review and meta-analysis', The BMJ, 374, pp. n1446, http://dx.doi.org/10.1136/bmj.n1446
    Journal articles | 2021
    Chan DKY; Day R, 2021, 'Precision medicine and clinical relevance in older people', Aging Medicine, 4, pp. 292 - 293, http://dx.doi.org/10.1002/agm2.12178
    Journal articles | 2021
    Chye A; Lin CWC; Hancock MJ; Harris I; Latimer J; Maher CG; McLachlan AJ; Mathieson S; Koes B; Day RO; Billot L; Jan S; Angell B, 2021, 'Healthcare expenditure and its predictors in a cohort of Australians living with sciatica', European Spine Journal, 30, pp. 878 - 885, http://dx.doi.org/10.1007/s00586-020-06605-2
    Journal articles | 2021
    Coleshill MJ; Aung E; Carland JE; Faasse K; Stocker S; Day RO, 2021, 'Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy?', Therapeutic Innovation and Regulatory Science, 55, pp. 138 - 141, http://dx.doi.org/10.1007/s43441-020-00198-0
    Journal articles | 2021
    Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; Gamboa S; Day RO, 2021, 'Expanding the role of Australian community dietitians in gout management', International Journal of Rheumatic Diseases, 24, pp. 1402 - 1408, http://dx.doi.org/10.1111/1756-185X.14224
    Journal articles | 2021
    Cunio CB; Uster DW; Carland JE; Buscher H; Liu Z; Brett J; Stefani M; Jones GRD; Day RO; Wicha SG; Stocker SL, 2021, 'Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients', Clinical Microbiology and Infection, 27, pp. 783.e7 - 783.e14, http://dx.doi.org/10.1016/j.cmi.2020.07.005
    Journal articles | 2021
    Day RO; Williams KM; Scott KF, 2021, 'Honorary Professor Garry Graham', Inflammopharmacology, 29, pp. 1255 - 1259, http://dx.doi.org/10.1007/s10787-021-00872-1
    Journal articles | 2021
    Ferdiana A; Liverani M; Khan M; Wulandari LPL; Mashuri YA; Batura N; Wibawa T; Yeung S; Day R; Jan S; Wiseman V; Probandari A, 2021, 'Community pharmacies, drug stores, and antibiotic dispensing in Indonesia: a qualitative study', BMC Public Health, 21, http://dx.doi.org/10.1186/s12889-021-11885-4
    Journal articles | 2021
    Ferraro MC; Bagg MK; Wewege MA; Cashin AG; Leake HB; Rizzo RRN; Jones MD; Gustin SM; Day R; Loo CK; McAuley JH, 2021, 'Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis', Systematic Reviews, 10, pp. 62, http://dx.doi.org/10.1186/s13643-021-01599-4
    Journal articles | 2021
    Ghinea N; Critchley C; Morrell B; Kerridge I; Campbell T; Day R; Gazarian M; Isaacs D; Liauw W; Olver I; Pace J; Pearson S; Salkeld G; Lipworth W, 2021, 'A survey of Australian public attitudes towards funding of high cost cancer medicines', Health Policy, 125, pp. 327 - 334, http://dx.doi.org/10.1016/j.healthpol.2020.12.002
    Journal articles | 2021
    Hoang BH; Do PG; Le LD; Bui TTH; Bui TN; Nguyen QM; To DH; Nguyen AD; Dinh MM; Goldhaber SZ; Day R; Nguyen HL, 2021, 'Safety, Efficacy of an Accelerated Regimen of Low-Dose Recombinant Tissue-Type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism', Clinical and Applied Thrombosis/Hemostasis, 27, http://dx.doi.org/10.1177/10760296211037920
    Journal articles | 2021
    Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I, 2021, 'Correction to: An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy (European Journal of Clinical Microbiology & Infectious Diseases, (2018), 37, 11, (2171-2175), 10.1007/s10096-018-3357-9)', European Journal of Clinical Microbiology and Infectious Diseases, 40, pp. 1789, http://dx.doi.org/10.1007/s10096-021-04291-6
    Journal articles | 2021
    Kirubakaran R; Stocker SL; Carlos L; Day RO; Carland JE, 2021, 'Tacrolimus Therapy in Adult Heart Transplant Recipients: Evaluation of a Bayesian Forecasting Software', Therapeutic Drug Monitoring, 43, pp. 736 - 746, http://dx.doi.org/10.1097/FTD.0000000000000909
    Journal articles | 2021
    Ludlow K; Westbrook J; Jorgensen M; Lind KE; Baysari MT; Gray LC; Day RO; Ratcliffe J; Lord SR; Georgiou A; Braithwaite J; Raban MZ; Close J; Beattie E; Zheng WY; Debono D; Nguyen A; Siette J; Seaman K; Miao M; Root J; Roffe D; O'Toole L; Carrasco M; Thompson A; Shaikh J; Wong J; Stanton C; Haddock R, 2021, 'Co-designing a dashboard of predictive analytics and decision support to drive care quality and client outcomes in aged care: A mixed-method study protocol', BMJ Open, 11, pp. e048657, http://dx.doi.org/10.1136/bmjopen-2021-048657
    Journal articles | 2021
    MacHado GC; Abdel-Shaheed C; Underwood M; Day RO, 2021, 'Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain', The BMJ, 372, pp. n104, http://dx.doi.org/10.1136/bmj.n104
    Journal articles | 2021
    Milder T; Stocker S; Baysari M; Day RO; Greenfield J, 2021, 'Prescribing of SGLT2 Inhibitors in Primary Care: A Qualitative Study of Primary Care Physicians and Endocrinologists', DIABETES, 70, http://dx.doi.org/10.2337/db21-779-P
    Journal articles | 2021
    Milder TY; Stocker SL; Baysari M; Day RO; Greenfield JR, 2021, 'Prescribing of SGLT2 inhibitors in primary care: A qualitative study of General Practitioners and Endocrinologists', Diabetes Research and Clinical Practice, 180, pp. 109036, http://dx.doi.org/10.1016/j.diabres.2021.109036
    Journal articles | 2021
    Nathan N; Nguyen AD; Stocker S; Laba TL; Baysari MT; Day RO, 2021, 'Out-of-pocket spending among a cohort of Australians living with gout', International Journal of Rheumatic Diseases, 24, pp. 327 - 334, http://dx.doi.org/10.1111/1756-185X.13979
    Journal articles | 2021
    Premachandra KH; Day RO; Roberts DM, 2021, 'Managing hyperuricemia and gout in chronic kidney disease: A clinical conundrum', Current Opinion in Nephrology and Hypertension, 30, pp. 245 - 251, http://dx.doi.org/10.1097/MNH.0000000000000691
    Journal articles | 2021
    Roydhouse SA; Carland JE; Debono DS; Baysari MT; Reuter SE; Staciwa AJ; Sandhu APK; Day RO; Stocker SL, 2021, 'Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions', British Journal of Clinical Pharmacology, 87, pp. 4273 - 4282, http://dx.doi.org/10.1111/bcp.14844
    Journal articles | 2021
    Ryan AC; Carland JE; McLeay RC; Lau C; Marriott DJE; Day RO; Stocker SL, 2021, 'Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing', British Journal of Clinical Pharmacology, 87, pp. 1422 - 1431, http://dx.doi.org/10.1111/bcp.14542
    Journal articles | 2021
    Sandaradura I; Marriott DJE; Day RO; Norris RLG; Pang E; Stocker SL; Reuter SE, 2021, 'Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy', European Journal of Clinical Microbiology and Infectious Diseases, 40, pp. 1521 - 1528, http://dx.doi.org/10.1007/s10096-021-04201-w
    Journal articles | 2021
    Sandaradura I; Wojciechowski J; Marriott DJE; Day RO; Stocker S; Reuter SE, 2021, 'Model-optimized fluconazole dose selection for critically ill patients improves early pharmacodynamic target attainment without the need for therapeutic drug monitoring', Antimicrobial Agents and Chemotherapy, 65, http://dx.doi.org/10.1128/AAC.02019-20
    Journal articles | 2021
    Simic M; Harmer AR; Agaliotis M; Nairn L; Bridgett L; March L; Votrubec M; Edmonds J; Woodward M; Day R; Fransen M, 2021, 'Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study', Arthritis Research and Therapy, 23, http://dx.doi.org/10.1186/s13075-021-02540-9
    Journal articles | 2021
    Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J, 2021, 'Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis', Clinical Pharmacology and Therapeutics, 109, pp. 212 - 221, http://dx.doi.org/10.1002/cpt.2113
    Journal articles | 2021
    Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG, 2021, 'A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study', Clinical Pharmacology and Therapeutics, 109, pp. 175 - 183, http://dx.doi.org/10.1002/cpt.2065
    Journal articles | 2021
    Westbrook JI; Li L; Raban MZ; Woods A; Koyama AK; Baysari MT; Day RO; McCullagh C; Prgomet M; Mumford V; Dalla-Pozza L; Gazarian M; Gates PJ; Lichtner V; Barclay P; Gardo A; Wiggins M; White L, 2021, 'Associations between double-checking and medication administration errors: A direct observational study of paediatric inpatients', BMJ Quality and Safety, 30, pp. 320 - 330, http://dx.doi.org/10.1136/bmjqs-2020-011473
    Journal articles | 2021
    Wulandari LPL; Khan M; Liverani M; Ferdiana A; Mashuri YA; Probandari A; Wibawa T; Batura N; Schierhout G; Kaldor J; Guy R; Law M; Day R; Hanefeld J; Parathon H; Jan S; Yeung S; Wiseman V, 2021, 'Prevalence and determinants of inappropriate antibiotic dispensing at private drug retail outlets in urban and rural areas of Indonesia: A mixed methods study', BMJ Global Health, 6, pp. e004993 - e004993, http://dx.doi.org/10.1136/bmjgh-2021-004993
    Journal articles | 2021
    Yeh MC; Wu BJ; Li Y; Elahy M; Prado-Lourenco L; Sockler J; Lau H; Day RO; Khachigian LM, 2021, 'BT2 suppresses human monocytic-endothelial cell adhesion, bone erosion and inflammation', Journal of Inflammation Research, 14, pp. 1019 - 1028, http://dx.doi.org/10.2147/JIR.S296676
    Journal articles | 2021
    Zheng WY; van Dort B; Marcilly R; Day R; Burke R; Shakib S; Ku Y; Reid-Anderson H; Baysari M, 2021, 'A tool for evaluating medication alerting systems: Development and initial assessment', JMIR Medical Informatics, 9, http://dx.doi.org/10.2196/24022
    Journal articles | 2021
    te West N; Day R; Graham G; Wright M; White C; Popovic G; Moore KH, 2021, 'Serum concentrations of estriol vary widely after application of vaginal oestriol cream', British Journal of Clinical Pharmacology, 87, pp. 2354 - 2360, http://dx.doi.org/10.1111/bcp.14635
    Journal articles | 2020
    Abdel Shaheed C; Maher CG; Buchbinder R; Ng B; Enke O; Guzowski R; McLachlan AJ; Day RO; Richards B; Latimer J; Lin CWC, 2020, 'Efficacy and harms of orally, intramuscularly or intravenously administered glucocorticoids for sciatica: A systematic review and meta-analysis', European Journal of Pain (United Kingdom), 24, pp. 518 - 535, http://dx.doi.org/10.1002/ejp.1505
    Journal articles | 2020
    Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833
    Journal articles | 2020
    Baysari MT; Zheng WY; Tariq A; Heywood M; Scott G; Li L; Van Dort BA; Rathnayake K; Day R; Westbrook JI, 2020, 'An experimental investigation of the impact of alert frequency and relevance on alert dwell time', International Journal of Medical Informatics, 133, http://dx.doi.org/10.1016/j.ijmedinf.2019.104027
    Journal articles | 2020
    Brett J; Anthony C; Day R, 2020, 'Off-label quetiapine prescribing in general hospital inpatients', Journal of Pharmacy Practice and Research, http://dx.doi.org/10.1002/jppr.1608
    Journal articles | 2020
    Buchbinder R; Bourne A; Latimer J; Harris I; Whittle SL; Richards B; Taylor WJ; Clavisi O; Green S; Hinman RS; March L; Day R; Ferreira ML; Billot L; Maher CG, 2020, 'Early development of the Australia and New Zealand Musculoskeletal Clinical Trials Network', Internal Medicine Journal, 50, pp. 17 - 23, http://dx.doi.org/10.1111/imj.14191
    Journal articles | 2020
    Chaudhri K; Stocker SL; Williams KM; McLeay RC; Marriott DJE; Di Tanna GL; Day RO; Carland JE, 2020, 'Voriconazole: An audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package', Journal of Antimicrobial Chemotherapy, 75, pp. 1981 - 1984, http://dx.doi.org/10.1093/jac/dkaa098
    Journal articles | 2020
    Coulshed A; Nguyen AD; Stocker SL; Day RO, 2020, 'Australian patient perspectives on the impact of gout', International Journal of Rheumatic Diseases, 23, pp. 1372 - 1378, http://dx.doi.org/10.1111/1756-185X.13934
    Journal articles | 2020
    Day R; Nguyen A; Graham G; Aung E; Coleshill M; Stocker S, 2020, 'Better outcomes for patients with gout', Inflammopharmacology, 28, pp. 1395 - 1400, http://dx.doi.org/10.1007/s10787-020-00694-7
    Journal articles | 2020
    Day RO; Coleshill MJ; Stocker SL; Nguyen AD; Robinson P; Aung E, 2020, 'Predictors of success in gout treatment', Journal of Rheumatology, 47, pp. 313 - 315, http://dx.doi.org/10.3899/jrheum.191150
    Journal articles | 2020
    Ghinea N; Wiersma M; Kerridge I; Olver I; Pearson S; Day R; Liauw W; Lipworth W, 2020, '“Some sort of fantasy land”: A qualitative investigation of appropriate prescribing in cancer care', Journal of Evaluation in Clinical Practice, 26, pp. 747 - 754, http://dx.doi.org/10.1111/jep.13278
    Journal articles | 2020
    Kamel B; Graham GG; Stocker SL; Liu Z; Williams KM; Carland JE; Pile KD; Day RO, 2020, 'A pharmacokinetic-pharmacodynamic study of a single dose of febuxostat in healthy subjects', British Journal of Clinical Pharmacology, 86, pp. 2486 - 2496, http://dx.doi.org/10.1111/bcp.14357
    Journal articles | 2020
    Kirubakaran R; Stocker SL; Hennig S; Day RO; Carland JE, 2020, 'Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review', Clinical Pharmacokinetics, 59, pp. 1357 - 1392, http://dx.doi.org/10.1007/s40262-020-00922-x
    Journal articles | 2020
    Liu C; Abdel Shaheed C; McLachlan AJ; Latimer J; Li Q; Buchbinder R; Day RO; Maher CG; Richards B; Oliveira JS; Lin CWC, 2020, 'OASIS-a randomised, placebo-controlled trial of oral glucocorticoids for leg pain in patients with acute sciatica: trial protocol', BMJ open, 10, pp. e040559, http://dx.doi.org/10.1136/bmjopen-2020-040559
    Journal articles | 2020
    Lowenstein D; Zheng WY; Burke R; Kenny E; Sandhu A; Makeham M; Westbrook J; Day RO; Baysari MT, 2020, 'Do user preferences align with human factors assessment scores of drug–drug interaction alerts?', Health Informatics Journal, 26, pp. 563 - 575, http://dx.doi.org/10.1177/1460458219840210
    Journal articles | 2020
    Machado GC; Ghinea N; Rogan E; Day RO; Maher CG, 2020, 'Emergency department care for low back pain: Should we adopt recommendations from primary care guidelines?', EMA - Emergency Medicine Australasia, 32, pp. 890 - 892, http://dx.doi.org/10.1111/1742-6723.13593
    Journal articles | 2020
    Milder TY; Day RO; Stocker SL; Greenfield JR, 2020, 'Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetes', Internal Medicine Journal, 50, pp. 645 - 646, http://dx.doi.org/10.1111/imj.14819
    Journal articles | 2020
    Milder TY; Stocker SL; Day RO; Greenfield JR, 2020, 'Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease', Drug Safety, 43, pp. 1211 - 1221, http://dx.doi.org/10.1007/s40264-020-01010-6
    Journal articles | 2020
    Nguyen AD; Lind KE; Day RO; Georgiou A; Westbrook JI, 2020, 'A profile of health status and demographics of aged care facility residents with gout', Australasian Journal on Ageing, 39, pp. e153 - e161, http://dx.doi.org/10.1111/ajag.12716
    Journal articles | 2020
    Raban MZ; Lind KE; Day RO; Gray L; Georgiou A; Westbrook JI, 2020, 'Trends, determinants and differences in antibiotic use in 68 residential aged care homes in Australia, 2014-2017: a longitudinal analysis of electronic health record data', BMC Health Services Research, 20, pp. 883, http://dx.doi.org/10.1186/s12913-020-05723-3
    Journal articles | 2020
    Sarkies MN; Francis-Auton E; Long JC; Partington A; Pomare C; Nguyen HM; Wu W; Westbrook J; Day RO; Levesque JF; Mitchell R; Rapport F; Cutler H; Tran Y; Clay-Williams R; Watson DE; Arnolda G; Hibbert PD; Lystad R; Mumford V; Leipnik G; Sutherland K; Hardwick R; Braithwaite J, 2020, 'Implementing large-system, value-based healthcare initiatives: A realist study protocol for seven natural experiments', BMJ Open, 10, pp. e044049 - e044049, http://dx.doi.org/10.1136/bmjopen-2020-044049
    Journal articles | 2020
    Shingde RV; Reuter SE; Graham GG; Carland JE; Williams KM; Day RO; Stocker SL, 2020, 'Assessing the accuracy of two bayesian forecasting programs in estimating vancomycin drug exposure', Journal of Antimicrobial Chemotherapy, 75, pp. 3293 - 3302, http://dx.doi.org/10.1093/jac/dkaa320
    Journal articles | 2020
    Simic M; Harmer AR; Agaliotis M; Nairn L; Bridgett L; March L; Votrubec M; Edmonds J; Woodward M; Day R; Fransen M, 2020, 'Clinical Risk Factors Associated with Radiographic Osteoarthritis Progression Among People with Knee Pain: A Longitudinal Study', , http://dx.doi.org/10.21203/rs.3.rs-67862/v1
    Journal articles | 2020
    Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO, 2020, 'The safety and pharmacokinetics of metformin in patients with chronic liver disease', Alimentary Pharmacology and Therapeutics, 51, pp. 565 - 575, http://dx.doi.org/10.1111/apt.15635
    Journal articles | 2020
    Van Dort BA; Baysari MT; Carland JE; Stocker SL; Braithwaite HE; Fernon AR; Day RO, 2020, 'Education to improve vancomycin use: the perspectives of educators and education recipients', Internal Medicine Journal, 50, pp. 565 - 572, http://dx.doi.org/10.1111/imj.14408
    Journal articles | 2020
    Wewege MA; Bagg MK; Jones MD; McAuley JH; Cashin AG; Day RO; Ferraro MC; Folly T; Gustin SM; Hagstrom AD; Leake HB; Loo CK; McLachlan AJ; O’Hagan ET; Rizzo RRN; Schabrun SM, 2020, 'Analgesic medicines for adults with low back pain: protocol for a systematic review and network meta-analysis', Systematic Reviews, 9, pp. 255, http://dx.doi.org/10.1186/s13643-020-01506-3
    Journal articles | 2020
    Xu A; Baysari MT; Stocker SL; Leow LJ; Day RO; Carland JE, 2020, 'Researchers' views on, and experiences with, the requirement to obtain informed consent in research involving human participants: A qualitative study', BMC Medical Ethics, 21, pp. 93, http://dx.doi.org/10.1186/s12910-020-00538-7
    Journal articles | 2020
    Zheng WY; Van Dort B; Marcilly R; Day R; Burke R; Shakib S; Ku Y; Reid-Anderson H; Baysari M, 2020, 'A Tool for Evaluating Medication Alerting Systems: Development and Initial Assessment (Preprint)', , http://dx.doi.org/10.2196/preprints.24022
    Journal articles | 2020
    te West NID; Day RO; Hiley B; White C; Wright M; Moore KH, 2020, 'Estriol serum levels in new and chronic users of vaginal estriol cream: A prospective observational study', Neurourology and Urodynamics, 39, pp. 1137 - 1144, http://dx.doi.org/10.1002/nau.24331
    Journal articles | 2019
    Abdel Shaheed C; Carland JE; Graham GG; Stocker SL; Smith G; Hicks M; Williams KM; Furlong T; Macdonald P; Greenfield JR; Smith FC; Chowdhury G; Day RO, 2019, 'Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis', British Journal of Clinical Pharmacology, 85, pp. 2772 - 2783, http://dx.doi.org/10.1111/bcp.14107
    Journal articles | 2019
    Baysari M; Del Gigante J; Moran M; Lehnbom E; Day R, 2019, 'Mandatory Medication Indications in Electronic Systems a he Prescriber Perspective', Stud Health Technol Inform, 265, pp. 95 - 100, http://dx.doi.org/10.3233/SHTI190145
    Journal articles | 2019
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R, 2019, 'Optimising computerised decision support to transform medication safety and reduce prescriber burden: Study protocol for a mixed-methods evaluation of drug-drug interaction alerts', BMJ Open, 9, pp. e026034, http://dx.doi.org/10.1136/bmjopen-2018-026034
    Journal articles | 2019
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG, 2019, 'Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting', Clinical Microbiology and Infection, 25, pp. 1286.e1 - 1286.e7, http://dx.doi.org/10.1016/j.cmi.2019.02.029
    Journal articles | 2019
    Chaudhri K; Kearney M; Day RO; Rodgers A; Atkins E, 2019, 'Effect of dose administration AIDS on adherence to self-administered medications: A systematic review protocol', BMJ Open, 9, pp. e030536, http://dx.doi.org/10.1136/bmjopen-2019-030536
    Journal articles | 2019
    Chaudhri K; Kearney M; Di Tanna GL; Day RO; Rodgers A; Atkins ER, 2019, 'Does splitting a tablet obtain the accurate dose?: A systematic review protocol', Medicine, 98, pp. e17189, http://dx.doi.org/10.1097/MD.0000000000017189
    Journal articles | 2019
    Coleshill MJ; Aung E; Nguyen AD; Stocker SL; Baysari MT; Kamel B; Schulz M; McLachlan AJ; Day RO, 2019, 'Improving adherence to urate-lowering therapy in people living with gout', International Journal of Rheumatic Diseases, 22, pp. 542 - 544, http://dx.doi.org/10.1111/1756-185X.13566
    Journal articles | 2019
    Darley DR; Carlos L; Hennig S; Liu Z; Day R; Glanville AR, 2019, 'Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection', European Journal of Clinical Pharmacology, 75, pp. 879 - 888, http://dx.doi.org/10.1007/s00228-019-02658-5
    Journal articles | 2019
    Day RO; Cohen M; Coleshill MJ; Ghinea N; Lipworth W; Maher CG; Latimer J; Lin CWC; McLachlan AJ, 2019, 'Is it ethical to prescribe paracetamol for acute low back pain and osteoarthritis?', The Lancet Rheumatology, 1, pp. e140 - e142, http://dx.doi.org/10.1016/S2665-9913(19)30041-4
    Journal articles | 2019
    Day RO; Lau W; Stocker SL; Aung E; Coleshill MJ; Schulz M; Bechara J; Carland JE; Graham GG; Williams KM; McLachlan AJ, 2019, 'Management of gout in older people', Journal of Pharmacy Practice and Research, 49, pp. 90 - 97, http://dx.doi.org/10.1002/jppr.1511
    Journal articles | 2019
    Kamel B; Williams KM; Graham GG; Norris RLG; Stocker SL; Carland JE; Pile KD; Day RO, 2019, 'Determination of febuxostat in human plasma by high performance liquid chromatography (HPLC) with fluorescence-detection', Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1126-1127, http://dx.doi.org/10.1016/j.jchromb.2019.121764
    Journal articles | 2019
    Leopoldino AO; MacHado GC; Ferreira PH; Pinheiro MB; Day R; McLachlan AJ; Hunter DJ; Ferreira ML, 2019, 'Paracetamol versus placebo for knee and hip osteoarthritis', Cochrane Database of Systematic Reviews, 2019, http://dx.doi.org/10.1002/14651858.CD013273
    Journal articles | 2019
    Li JW; Badve SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5
    Journal articles | 2019
    Milder TY; Stocker SL; Samocha-Bonet D; Day RO; Greenfield JR, 2019, 'Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease', European Journal of Clinical Pharmacology, 75, pp. 1481 - 1490, http://dx.doi.org/10.1007/s00228-019-02732-y
    Journal articles | 2019
    Milder TY; Stocker SL; Shaheed CA; McGrath-Cadell L; Samocha-Bonet D; Greenfield JR; Day RO, 2019, 'Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis', JOURNAL OF CLINICAL MEDICINE, 8, http://dx.doi.org/10.3390/jcm8010045
    Journal articles | 2019
    Shingde RV; Graham GG; Reuter SE; Carland JE; Day RO; Stocker SL, 2019, 'Comparison of the Area Under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients With Normal Renal Function.', Ther Drug Monit, 41, pp. 726 - 731, http://dx.doi.org/10.1097/FTD.0000000000000690
    Journal articles | 2019
    Shingde RV; Graham GG; Reuter SE; Carland JE; Day RO; Stocker SL, 2019, 'Comparison of the Area under the Curve for Vancomycin Estimated Using Compartmental and Noncompartmental Methods in Adult Patients with Normal Renal Function', Therapeutic Drug Monitoring, 41, pp. 726 - 731, http://dx.doi.org/10.1097/FTD.0000000000000690
    Journal articles | 2019
    Sindone J; Day R; Stefani M; Joseph J, 2019, 'Perioperative Management of Antiplatelets in Elective Surgery at a Tertiary Hospital', Heart, Lung and Circulation, 28, pp. S370 - S370, http://dx.doi.org/10.1016/j.hlc.2019.06.553
    Journal articles | 2019
    Tay E; Sotiriou A; Graham GG; Wilhelm K; Snowden L; Day RO, 2019, 'Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidance', THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 9, http://dx.doi.org/10.1177/2045125319836889
    Journal articles | 2019
    Tay EMY; Preisz P; Day RO, 2019, 'Role and impact of brain computed tomography in the management of drug overdoses and guideline recommendations', EMA - Emergency Medicine Australasia, 31, pp. 1053 - 1058, http://dx.doi.org/10.1111/1742-6723.13316
    Journal articles | 2018
    Baysari MT; Lowenstein D; Zheng WY; Day RO, 2018, 'Reliability, ease of use and usefulness of I-MeDeSA for evaluating drug-drug interaction alerts in an Australian context', BMC Medical Informatics and Decision Making, 18, http://dx.doi.org/10.1186/s12911-018-0666-y
    Journal articles | 2018
    Carland JE; Smith FC; Day RO, 2018, 'Lactic Acidosis, Metformin Use, and Dose-Response Association', JAMA Internal Medicine, 178, pp. 1428 - 1429, http://dx.doi.org/10.1001/jamainternmed.2018.4448
    Journal articles | 2018
    Chan JOS; Baysari MT; Carland JE; Sandaradura I; Moran M; Day RO, 2018, 'Barriers and facilitators of appropriate vancomycin use: prescribing context is key', European Journal of Clinical Pharmacology, 74, pp. 1523 - 1529, http://dx.doi.org/10.1007/s00228-018-2525-2
    Journal articles | 2018
    Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; McLachlan AJ; Day RO, 2018, 'Exploring current and potential roles of Australian community pharmacists in gout management: A qualitative study', BMC Family Practice, 19, http://dx.doi.org/10.1186/s12875-018-0744-3
    Journal articles | 2018
    Graham GG; Stocker SL; Kannangara DRW; Day RO, 2018, 'Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout', Current Rheumatology Reports, 20, http://dx.doi.org/10.1007/s11926-018-0760-2
    Journal articles | 2018
    Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I, 2018, 'An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy', European Journal of Clinical Microbiology and Infectious Diseases, 37, pp. 2171 - 2175, http://dx.doi.org/10.1007/s10096-018-3357-9
    Journal articles | 2018
    Indraratna PL; Virk S; Gurram D; Day RO, 2018, 'Use of colchicine in pregnancy: A systematic review and meta-analysis', Rheumatology (United Kingdom), 57, pp. 382 - 387, http://dx.doi.org/10.1093/rheumatology/kex353
    Journal articles | 2018
    Kumar SS; McManus H; Radovich T; Greenfield JR; Viardot A; Williams KM; Cronin P; Day RO, 2018, 'Interrogation of a longitudinal, national pharmacy claims dataset to explore factors that predict the need for add-on therapy in older and socioeconomically disadvantaged Australians with type 2 diabetes mellitus patients (T2DM)', European Journal of Clinical Pharmacology, 74, pp. 1327 - 1332, http://dx.doi.org/10.1007/s00228-018-2506-5
    Journal articles | 2018
    Lin CWC; Li Q; Williams CM; Maher CG; Day RO; Hancock MJ; Latimer J; Mclachlan AJ; Jan S, 2018, 'The economic burden of guideline-recommended first line care for acute low back pain', European Spine Journal, 27, pp. 109 - 116, http://dx.doi.org/10.1007/s00586-016-4781-0
    Journal articles | 2018
    Ma CKK; Danta M; Day R; Ma DDF, 2018, 'Dealing with the spiralling price of medicines: issues and solutions', Internal Medicine Journal, 48, pp. 16 - 24, http://dx.doi.org/10.1111/imj.13652
    Journal articles | 2018
    Maali Y; Perez-Concha O; Coiera E; Roffe D; Day RO; Gallego B, 2018, 'Predicting 7-day, 30-day and 60-day all-cause unplanned readmission: a case study of a Sydney hospital', BMC medical informatics and decision making, 18, pp. 1 - 11, http://dx.doi.org/10.1186/s12911-017-0580-8
    Journal articles | 2018
    Meslin SMM; Zheng WY; Day RO; Tay EMY; Baysari MT, 2018, 'Evaluation of Clinical Relevance of Drug-Drug Interaction Alerts Prior to Implementation', Applied Clinical Informatics, 9, pp. 849 - 855, http://dx.doi.org/10.1055/s-0038-1676039
    Journal articles | 2018
    Nguyen AD; Frensham LJ; Baysari MT; Carland JE; Day RO, 2018, 'Patients' use of mobile health applications: What general practitioners think', Family Practice, 36, pp. 214 - 218, http://dx.doi.org/10.1093/fampra/cmy052
    Journal articles | 2018
    Nguyen AD; Frensham LJ; Wong MXC; Meslin SMM; Martin P; Lau AY; Baysari MT; Day RO, 2018, 'Patient testing of a mobile health app and review of educational materials designed for gout patient self-management (Preprint)', , http://dx.doi.org/10.2196/preprints.9811
    Journal articles | 2018
    Nguyen AD; Frensham LJ; Wong MXC; Meslin SMM; Martin P; Lau AYS; Baysari MT; Day RO, 2018, 'mHealth app patient testing and review of educational materials designed for self-Management of gout patients: Descriptive qualitative studies', Journal of Medical Internet Research, 20, http://dx.doi.org/10.2196/mhealth.9811
    Journal articles | 2018
    Zheng WY; Richardson LC; Li L; Day RO; Westbrook JI; Baysari MT, 2018, 'Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis', European Journal of Clinical Pharmacology, 74, pp. 15 - 27, http://dx.doi.org/10.1007/s00228-017-2357-5
    Journal articles | 2017
    Baysari MT; Gigante JD; Moran M; Sandaradura I; Li L; Richardson KL; Sandhu A; Lehnbom EC; Westbrook JI; Day RO, 2017, 'Redesign of computerized decision support to improve antimicrobial prescribing', Applied Clinical Informatics, 8, pp. 949 - 963, http://dx.doi.org/10.4338/ACI2017040069
    Journal articles | 2017
    Baysari MT; Tariq A; Day RO; Westbrook JI, 2017, 'Alert override as a habitual behavior - A new perspective on a persistent problem', Journal of the American Medical Informatics Association, 24, pp. 409 - 412, http://dx.doi.org/10.1093/jamia/ocw072
    Journal articles | 2017
    Braithwaite J; Westbrook J; Coiera E; Runciman WB; Day R; Hillman K; Herkes J, 2017, 'A systems science perspective on the capacity for change in public hospitals', Israel Journal of Health Policy Research, 6, http://dx.doi.org/10.1186/s13584-017-0143-6
    Journal articles | 2017
    Day RO; Frensham LJ; Nguyen AD; Baysari MT; Aung E; Lau AYS; Zwar N; Reath J; Laba T; Li L; McLachlan A; Runciman WB; Buchbinder R; Clay-Williams R; Coiera E; Braithwaite J; McNeil HP; Hunter DJ; Pile KJ; Portek I; Williams KM; Westbrook JI, 2017, 'Effectiveness of an electronic patient-centred self-management tool for gout sufferers: A cluster randomised controlled trail protocol', BMJ Open, 7, http://dx.doi.org/10.1136/bmjopen-2017-017281
    Journal articles | 2017
    Day RO; Kannangara DRW; Stocker SL; Carland JE; Williams KM; Graham GG, 2017, 'Allopurinol: insights from studies of dose–response relationships', Expert Opinion on Drug Metabolism and Toxicology, 13, pp. 449 - 462, http://dx.doi.org/10.1080/17425255.2017.1269745
    Journal articles | 2017
    Day RO; Snowden L; McLachlan AJ, 2017, 'Life-threatening drug interactions: what the physician needs to know', Internal Medicine Journal, 47, pp. 501 - 512, http://dx.doi.org/10.1111/imj.13404
    Journal articles | 2017
    Day RO, 2017, 'Introduction to the Special Section: Phase I Clinical Trials', Therapeutic Innovation and Regulatory Science, 51, pp. 274 - 275, http://dx.doi.org/10.1177/2168479017706513
    Journal articles | 2017
    Day RO, 2017, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration (vol 68, pg 990, 2016)', AMERICAN JOURNAL OF KIDNEY DISEASES, 69, pp. 870 - 870, http://dx.doi.org/10.1053/j.ajkd.2017.03.016
    Journal articles | 2017
    Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2017, 'A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function', European Journal of Clinical Pharmacology, 73, pp. 981 - 990, http://dx.doi.org/10.1007/s00228-017-2251-1
    Journal articles | 2017
    Ghinea N; Lipworth W; Day R; Hill A; Dore GJ; Danta M, 2017, 'Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries', The Lancet, 389, pp. 1268 - 1272, http://dx.doi.org/10.1016/S0140-6736(16)32051-7
    Journal articles | 2017
    Jones G; Panova E; Day R, 2017, 'Guideline development for the management of gout: Role of combination therapy with a focus on lesinurad', Drug Design, Development and Therapy, 11, pp. 3077 - 3081, http://dx.doi.org/10.2147/DDDT.S97959
    Journal articles | 2017
    Kamel B; Graham GG; Williams KM; Pile KD; Day RO, 2017, 'Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat', Clinical Pharmacokinetics, 56, pp. 459 - 475, http://dx.doi.org/10.1007/s40262-016-0466-4
    Journal articles | 2017
    Kannangara DRW; Graham GG; Wright DFB; Stocker SL; Portek I; Pile KD; Barclay ML; Williams KM; Stamp LK; Day RO, 2017, 'Individualising the dose of allopurinol in patients with gout', British Journal of Clinical Pharmacology, 83, pp. 2015 - 2026, http://dx.doi.org/10.1111/bcp.13307
    Journal articles | 2017
    Leung S; Zheng WY; Sandhu A; Day R; Li L; Baysari M, 2017, 'Feedback and training to improve use of an electronic prescribing system: A randomised controlled trial', Studies in Health Technology and Informatics, 239, pp. 63 - 69, http://dx.doi.org/10.3233/978-1-61499-783-2-63
    Journal articles | 2017
    Lyell D; Magrabi F; Raban MZ; Pont LG; Baysari MT; Day RO; Coiera E, 2017, 'Automation bias in electronic prescribing', BMC Medical Informatics and Decision Making, 17, http://dx.doi.org/10.1186/s12911-017-0425-5
    Journal articles | 2017
    Machado GC; Maher CG; Ferreira PH; Day RO; Pinheiro MB; Ferreira ML, 2017, 'Non-steroidal anti-inflammatory drugs for spinal pain: A systematic review and meta-analysis', Annals of the Rheumatic Diseases, 76, pp. 1269 - 1278, http://dx.doi.org/10.1136/annrheumdis-2016-210597
    Journal articles | 2017
    Mathieson S; Maher CG; McLachlan AJ; Latimer J; Koes BW; Hancock MJ; Harris I; Day RO; Billot L; Pik J; Jan S; Lin CWC, 2017, 'Trial of pregabalin for acute and chronic sciatica', New England Journal of Medicine, 376, pp. 1111 - 1120, http://dx.doi.org/10.1056/NEJMoa1614292
    Journal articles | 2017
    Ramanathan SA; Hibbert PD; Maher CG; Day RO; Hindmarsh DM; Hooper TD; Hannaford NA; Runciman WB, 2017, 'CareTrack', Spine, 42, pp. E802 - E809, http://dx.doi.org/10.1097/BRS.0000000000001972
    Journal articles | 2017
    Shaheed CA; Mathieson S; Day RO; Maher CG; McLACHLAN AJ; McLACHLAN H; Lin CWC, 2017, 'What is the evidence for opioid analgesia for low back pain?', Medicine Today, 18, pp. 24 - 27
    Journal articles | 2017
    Walter SR; Day RO; Gallego B; Westbrook JI, 2017, 'The impact of serious adverse drug reactions: a population‐based study of a decade of hospital admissions in New South Wales, Australia', British journal of clinical pharmacology, 83, pp. 416 - 426, http://dx.doi.org/10.1111/bcp.13124
    Journal articles | 2017
    Wiles LK; Hibbert PD; Stephens JH; Coiera E; Westbrook J; Braithwaite J; Day RO; Hillman KM; Runciman WB, 2017, 'STANDING Collaboration: A study protocol for developing clinical standards', BMJ Open, 7, http://dx.doi.org/10.1136/bmjopen-2016-014048
    Journal articles | 2017
    2017, 'Erratum: Guideline development for the management of gout: role of combination therapy with a focus on lesinurad [Corrigendum].', Drug Des Devel Ther, 11, pp. 3589 - 3590, http://dx.doi.org/10.2147/DDDT.S158965
    Journal articles | 2016
    Baysari MT; Jackson N; Ramasamy S; Santiago P; Xiong J; Westbrook J; Omari A; Day RO, 2016, 'Exploring sub-optimal use of an electronic risk assessment tool for venous thromboembolism', Applied Ergonomics, 55, pp. 63 - 69, http://dx.doi.org/10.1016/j.apergo.2016.01.003
    Journal articles | 2016
    Baysari MT; Lehnbom EC; Li L; Hargreaves A; Day RO; Westbrook JI, 2016, 'The effectiveness of information technology to improve antimicrobial prescribing in hospitals: A systematic review and meta-analysis', International Journal of Medical Informatics, 92, pp. 15 - 34, http://dx.doi.org/10.1016/j.ijmedinf.2016.04.008
    Journal articles | 2016
    Butterfield RJ; Barratt MJ; Ezard N; Day RO, 2016, 'Drug checking to improve monitoring of new psychoactive substances in Australia Drug checking may need to play a part in future public health interventions', MEDICAL JOURNAL OF AUSTRALIA, 204, pp. 144 - +, http://dx.doi.org/10.5694/mja15.01058
    Journal articles | 2016
    Cai X; Perez-Concha O; Coiera E; Martin-Sanchez F; Day R; Roffe D; Gallego B, 2016, 'Real-time prediction of mortality, readmission, and length of stay using electronic health record data', Journal of the American Medical Informatics Association, 23, pp. 553 - 561, http://dx.doi.org/10.1093/jamia/ocv110
    Journal articles | 2016
    Day R; Hung SI; Chung WH, 2016, 'Allopurinol dose relative to renal function and risk of hypersensitivity reactions', Annals of the Rheumatic Diseases, 75, pp. e21, http://dx.doi.org/10.1136/annrheumdis-2015-209109
    Journal articles | 2016
    Day RO; Kamel B; Kannangara DRW; Williams KM; Graham GG, 2016, 'Xanthine oxidoreductase and its inhibitors: Relevance for gout', Clinical Science, 130, pp. 2167 - 2180, http://dx.doi.org/10.1042/CS20160010
    Journal articles | 2016
    Day RO; Snowden L, 2016, 'Where to find information about drugs', Australian Prescriber, 39, pp. 88 - 95, http://dx.doi.org/10.18773/austprescr.2016.023
    Journal articles | 2016
    De Lautour H; Taylor WJ; Adebajo A; Alten R; Burgos-Vargas R; Chapman P; Cimmino MA; Da Rocha Castelar Pinheiro G; Day R; Harrold LR; Helliwell P; Janssen M; Kerr G; Kavanaugh A; Khanna D; Khanna PP; Lin C; Louthrenoo W; McCarthy G; Vazquez-Mellado J; Mikuls TR; Neogi T; Ogdie A; Perez-Ruiz F; Schlesinger N; Ralph Schumacher H; Scirè CA; Singh JA; Sivera F; Slot O; Stamp LK; Tausche AK; Terkeltaub R; Uhlig T; Van De Laar M; White D; Yamanaka H; Zeng X; Dalbeth N, 2016, 'Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises', Arthritis Care and Research, 68, pp. 667 - 672, http://dx.doi.org/10.1002/acr.22741
    Journal articles | 2016
    Fernon A; Nguyen A; Baysari M; Day R, 2016, 'A user-centred approach to designing an etool for gout management', Studies in Health Technology and Informatics, 227, pp. 28 - 33, http://dx.doi.org/10.3233/978-1-61499-666-8-28
    Journal articles | 2016
    Kannangara DRW; Graham GG; Williams KM; Day RO, 2016, 'Effect of xanthine oxidase inhibitors on the renal clearance of uric acid and creatinine', Clinical Rheumatology, 35, pp. 2375 - 2376, http://dx.doi.org/10.1007/s10067-015-3165-x
    Journal articles | 2016
    Kannangara DRW; Phipps-Green AJ; Dalbeth N; Stamp LK; Williams KM; Graham GG; Day RO; Merriman TR, 2016, 'Hyperuricaemia: Contributions of urate transporter ABCG2 and the fractional renal clearance of urate', Annals of the Rheumatic Diseases, 75, pp. 1363 - 1366, http://dx.doi.org/10.1136/annrheumdis-2015-208111
    Journal articles | 2016
    Lin CWC; McLachlan AJ; Latimer J; Day RO; Billot L; Koes BW; Maher CG, 2016, 'OPAL: A randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocol', BMJ Open, 6, http://dx.doi.org/10.1136/bmjopen-2016-011278
    Journal articles | 2016
    Martin JH; Henry D; Gray J; Day R; Bochner F; Ferro A; Pirmohamed M; Mörike K; Schwab M, 2016, 'Achieving the World Health Organization's vision for clinical pharmacology', British journal of clinical pharmacology, 81, pp. 223 - 227, http://dx.doi.org/10.1111/bcp.12803
    Journal articles | 2016
    Martinello M; Schteinman A; Alavi M; Williams K; Dore GJ; Day R; Matthews GV, 2016, 'The impact of ribavirin plasma concentration on the efficacy of the interferon-sparing regimen, sofosbuvir and ribavirin', ANTIVIRAL THERAPY, 21, pp. 127 - 132, http://dx.doi.org/10.3851/IMP2984
    Journal articles | 2016
    Mathieson S; Billot L; Maher CG; McLachlan AJ; Latimer J; Koes BW; Hancock MJ; Harris I; Day RO; Pik J; Jan S; Lin CWC, 2016, 'PRECISE - pregabalin in addition to usual care: Statistical analysis plan', Trials, 17, http://dx.doi.org/10.1186/s13063-016-1174-y
    Journal articles | 2016
    Moon J; Kumar SS; Graham GG; Baysari MT; Williams KM; Chen W; Viardot A; Greenfield JR; Day RO, 2016, 'Trends in metformin utilisation and dose appropriateness in Australia', European Journal of Clinical Pharmacology, 72, pp. 1489 - 1496, http://dx.doi.org/10.1007/s00228-016-2117-y
    Journal articles | 2016
    Nguyen AD; Baysari MT; Kannangara DRW; Tariq A; Lau AYS; Westbrook JI; Day RO, 2016, 'Mobile applications to enhance self-management of gout', International Journal of Medical Informatics, 94, pp. 67 - 74, http://dx.doi.org/10.1016/j.ijmedinf.2016.06.021
    Journal articles | 2016
    Ní Chróinín D; Neto HM; Xiao D; Sandhu A; Brazel C; Farnham N; Perram J; Roach TS; Sutherland E; Day R; Beveridge A, 2016, 'Potentially inappropriate medications (PIMs) in older hospital in-patients: Prevalence, contribution to hospital admission and documentation of rationale for continuation', Australasian Journal on Ageing, 35, pp. 262 - 265, http://dx.doi.org/10.1111/ajag.12312
    Journal articles | 2016
    Rasheed H; McKinney C; Stamp LK; Dalbeth N; Topless RK; Day R; Kannangara D; Williams K; Smith M; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; Lu L; Stahl EA; Choi HK; So A; Merriman TR, 2016, 'The toll-like receptor 4 (TLR4) variant rs2149356 and risk of gout in European and polynesian sample sets', PLoS ONE, 11, http://dx.doi.org/10.1371/journal.pone.0147939
    Journal articles | 2016
    Richardson LC; Lehnbom EC; Baysari MT; Walter SR; Day RO; Westbrook JI, 2016, 'A time and motion study of junior doctor work patterns on the weekend: a potential contributor to the weekend effect?', Internal Medicine Journal, 46, pp. 819 - 825, http://dx.doi.org/10.1111/imj.13120
    Journal articles | 2016
    Santucci W; Day RO; Baysari MT, 2016, 'Evaluation of hospital-wide computerised decision support in an intensive care unit: An observational study', Anaesthesia and Intensive Care, 44, pp. 507 - 512, http://dx.doi.org/10.1177/0310057x1604400403
    Journal articles | 2016
    Shaheed CA; Maher CG; Williams KA; Day R; McLachlan AJ, 2016, 'Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain a systematic review and meta-analysis', JAMA Internal Medicine, 176, pp. 958 - 968, http://dx.doi.org/10.1001/jamainternmed.2016.1251
    Journal articles | 2016
    Smith FC; Kumar SS; Furlong TJ; Gangaram SV; Greenfield JR; Stocker SL; Graham GG; Williams KM; Day RO, 2016, 'Pharmacokinetics of Metformin in Patients Receiving Regular Hemodiafiltration', American Journal of Kidney Diseases, 68, pp. 990 - 992, http://dx.doi.org/10.1053/j.ajkd.2016.08.017
    Journal articles | 2016
    Stamp LK; Day RO; Yun J, 2016, 'Allopurinol hypersensitivity: Investigating the cause and minimizing the risk', Nature Reviews Rheumatology, 12, pp. 235 - 242, http://dx.doi.org/10.1038/nrrheum.2015.132
    Journal articles | 2016
    Tay EMY; Graham RI; Day RO, 2016, 'Severe GHB withdrawal delirium managed with dexmedetomidine', Medical Journal of Australia, 205, pp. 251 - 252.e1, http://dx.doi.org/10.5694/MJA16.00269
    Journal articles | 2016
    Vaccher S; Kannangara DRW; Baysari MT; Reath J; Zwar N; Williams KM; Day RO, 2016, 'Barriers to care in gout: From prescriber to patient', Journal of Rheumatology, 43, pp. 144 - 149, http://dx.doi.org/10.3899/jrheum.150607
    Journal articles | 2016
    Westbrook JI; Li L; Raban MZ; Baysari MT; Mumford V; Prgomet M; Georgiou A; Kim T; Lake R; McCullagh C; Dalla-Pozza L; Karnon J; O'Brien TA; Ambler G; Day R; Cowell CT; Gazarian M; Worthington R; Lehmann CU; White L; Barbaric D; Gardo A; Kelly M; Kennedy P, 2016, 'Stepped-wedge cluster randomised controlled trial to assess the effectiveness of an electronic medication management system to reduce medication errors, adverse drug events and average length of stay at two paediatric hospitals: A study protocol', BMJ Open, 6, http://dx.doi.org/10.1136/bmjopen-2016-011811
    Journal articles | 2016
    day RO, 2016, 'Ganciclovir - Hypoglycaemia', WHO SIGNAL, pp. 15 - 18
    Journal articles | 2015
    Chung WH; Chang WC; Stocker SL; Juo CG; Graham GG; Lee MHH; Williams KM; Tian YC; Juan KC; Wu YJJ; Yang CH; Chang CJ; Lin YJ; Day RO; Hung SI, 2015, 'Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: The impact of renal insufficiency, high plasma levels of oxypurinol and granulysin', Annals of the Rheumatic Diseases, 74, pp. 2157 - 2164, http://dx.doi.org/10.1136/annrheumdis-2014-205577
    Journal articles | 2015
    Day R; Lipworth W; Ghinea N, 2015, 'The Ethics Around Drug Labels and Generic Medicines', Therapeutic Innovation and Regulatory Science, 49, pp. 348 - 351, http://dx.doi.org/10.1177/2168479015577867
    Journal articles | 2015
    Day RO, 2015, 'Prednisone for cardiac failure in patients with hypertension', Journal of Rheumatology, 42, pp. 739 - 740, http://dx.doi.org/10.3899/jrheum.150276
    Journal articles | 2015
    Diasinos N; Baysari M; Kumar S; Day RO, 2015, 'Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines?', Internal Medicine Journal, 45, pp. 55 - 62, http://dx.doi.org/10.1111/imj.12627
    Journal articles | 2015
    Duong JK; Kumar SS; Furlong TJ; Kirkpatrick CM; Graham GG; Greenfield JR; Williams KM; Day RO, 2015, 'The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitus', British Journal of Clinical Pharmacology, 79, pp. 617 - 623, http://dx.doi.org/10.1111/bcp.12525
    Journal articles | 2015
    Fransen M; Agaliotis M; Nairn L; Votrubec M; Bridgett L; Su S; Jan S; March L; Edmonds J; Norton R; Woodward M; Day R; Buckland-Wright C; Bridges-Webb C; Heritier S; Jones G; Sambrook P; Speechly C; Vignon E; Jovanovic G; Jeram S; Dowd M; Champion M; Grealy S; Watson D; Vrataric A; Johnson C; White R; O'Connell P; Milwraith F; Kennedy D; Faulkes C; Bulton O; Johnson K, 2015, 'Glucosamine and chondroitin for knee osteoarthritis: A double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens', Annals of the Rheumatic Diseases, 74, pp. 851 - 858, http://dx.doi.org/10.1136/annrheumdis-2013-203954
    Journal articles | 2015
    Gallego B; Walter SR; Day RO; Dunn AG; Sivaraman V; Shah N; Longhurst CA; Coiera E, 2015, 'Bringing cohort studies to the bedside: framework for a ‘green button’to support clinical decision-making', Journal of comparative effectiveness research, 4, pp. 191 - 197, http://dx.doi.org/10.2217/cer.15.12
    Journal articles | 2015
    Ghosh D; McGann PM; Furlong TJ; Day RO, 2015, 'Febuxostat-associated rhabdomyolysis in chronic renal failure', Medical Journal of Australia, 203, pp. 107 - 108, http://dx.doi.org/10.5694/mja14.01404
    Journal articles | 2015
    Hmar RC; Kannangara DRW; Ramasamy SN; Baysari MT; Williams KM; Day RO, 2015, 'Understanding and improving the use of allopurinol in a teaching hospital', Internal Medicine Journal, 45, pp. 383 - 390, http://dx.doi.org/10.1111/imj.12701
    Journal articles | 2015
    Lin CWC; Day RO; Harris I; Maher CG; McLachlan A, 2015, 'Comparative efficacy trials with no placebo group cannot determine efficacy', BMJ (Online), 350, http://dx.doi.org/10.1136/bmj.h3292
    Journal articles | 2015
    Machado GC; Maher CG; Ferreira PH; Pinheiro MB; Lin CWC; Day RO; McLachlan AJ; Ferreira ML, 2015, 'Efficacy and safety of paracetamol for spinal pain and osteoarthritis: Systematic review and meta-analysis of randomised placebo controlled trials', BMJ (Online), 350, http://dx.doi.org/10.1136/bmj.h1225
    Journal articles | 2015
    McKinney C; Stamp LK; Dalbeth N; Topless RK; Day RO; Kannangara DRW; Williams KM; Janssen M; Jansen TL; Joosten LA; Radstake TR; Riches PL; Tausche AK; Lioté F; So A; Merriman TR, 2015, 'Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout', Arthritis Research and Therapy, 17, http://dx.doi.org/10.1186/s13075-015-0802-3
    Journal articles | 2015
    Merriman TR; Stamp LK; Dalbeth N; Topless R; Day R; Kannangara D; Williams K; Janssen M; Jansen T; Joosten LA; Radstake T; Riches PL; Tausche A-K; Liote F; So A; McKinney C, 2015, 'Epistatic Interaction of Functional Inflammasome Genetic Variants in Determining the Risk of Gout', ARTHRITIS & RHEUMATOLOGY, 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370860204715&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2015
    Missiakos O; Baysari MT; Day RO, 2015, 'Identifying effective computerized strategies to prevent drug-drug interactions in hospital: A user-centered approach', International Journal of Medical Informatics, 84, pp. 595 - 600, http://dx.doi.org/10.1016/j.ijmedinf.2015.04.001
    Journal articles | 2015
    Wang LW; He EYJ; Ghosh D; Day RO; Jones GRD; Subbiah RN; Holloway CJ, 2015, 'Severe carbon monoxide poisoning from waterpipe smoking: A public health concern', Medical Journal of Australia, 202, pp. 446 - 448, http://dx.doi.org/10.5694/mja14.01264
    Journal articles | 2015
    Westbrook JI; Gospodarevskaya E; Li L; Richardson KL; Roffe D; Heywood M; Day RO; Graves N, 2015, 'Cost-effectiveness analysis of a hospital electronic medication management system', Journal of the American Medical Informatics Association, 22, pp. 784 - 793, http://dx.doi.org/10.1093/jamia/ocu014
    Journal articles | 2015
    Westbrook JI; Li L; Lehnbom EC; Baysari MT; Braithwaite J; Burke R; Conn C; Day RO, 2015, 'What are incident reports telling us? A comparative study at two Australian hospitals of medication errors identified at audit, detected by staff and reported to an incident system', International Journal for Quality in Health Care, 27, pp. 1 - 9, http://dx.doi.org/10.1093/intqhc/mzu098
    Journal articles | 2015
    Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2015, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, 18, pp. 1783 - 1796, http://dx.doi.org/10.1111/hex.12170
    Journal articles | 2015
    2015, 'Corrigendum to Does the availability of therapeutic drug monitoring, computerised dose recommendation and prescribing decision support services promote compliance with national gentamicin prescribing guidelines? [Intern Med J 45, (2015), 55-62], doi:10.1111/imj.12627', Internal Medicine Journal, 45, pp. 470 - 470, http://dx.doi.org/10.1111/imj.12751
    Journal articles | 2014
    Baysari MT; Adams K; Lehnbom EC; Westbrook JI; Day RO, 2014, 'iPad use at the bedside: A tool for engaging patients in care processes during ward rounds?', Internal Medicine Journal, 44, pp. 986 - 990, http://dx.doi.org/10.1111/imj.12518
    Journal articles | 2014
    Baysari MT; Westbrook JI; Richardson K; Day RO, 2014, 'Optimising computerised alerts within electronic medication management systems: A synthesis of four years of research', Studies in Health Technology and Informatics, 204, pp. 1 - 6, http://dx.doi.org/10.3233/978-1-61499-427-5-1
    Journal articles | 2014
    Fransen M; Day RO, 2014, 'Response to A. G. Helg's comments on the LEGS study', Annals of the Rheumatic Diseases, 73, http://dx.doi.org/10.1136/annrheumdis-2014-205569
    Journal articles | 2014
    Ghinea N; Lipworth W; Kerridge I; Little M; Day RO, 2014, 'Ethics & evidence in medical debates: The case of recombinant activated factor VII', Hastings Center Report, 44, pp. 38 - 45, http://dx.doi.org/10.1002/hast.287
    Journal articles | 2014
    Ghosh D; Williams KM; Graham GG; Nair P; Buscher H; Day RO, 2014, 'Multiple episodes of aspirin overdose in an individual patient: A case report', Journal of Medical Case Reports, 8, pp. 1 - 5, http://dx.doi.org/10.1186/1752-1947-8-374
    Journal articles | 2014
    Inam S; Lipworth W; Kerridge I; Day R, 2014, 'A review of strategies to improve rational prescribing in asthma', Journal of Pharmacy Practice and Research, 44, pp. 195 - 200, http://dx.doi.org/10.1002/jppr.1034
    Journal articles | 2014
    Kannangara DRW; Graham GG; Williams KM; Day RO, 2014, 'Hypouricemic effects of prednisone and allopurinol: An uneven playing field?', Canadian Journal of Cardiology, 30, pp. 376.e1, http://dx.doi.org/10.1016/j.cjca.2013.04.015
    Journal articles | 2014
    Lehnbom EC; Adams K; Day RO; Westbrook JI; Baysari MT, 2014, 'IPad use during ward rounds: An observational study', Studies in Health Technology and Informatics, 204, pp. 67 - 73, http://dx.doi.org/10.3233/978-1-61499-427-5-67
    Journal articles | 2014
    Lipworth W; Doran E; Kerridge I; Day R, 2014, 'Challenges to pharmaceutical policymaking: Lessons from Australia's national medicines policy', Australian Health Review, 38, pp. 160 - 168, http://dx.doi.org/10.1071/AH13240
    Journal articles | 2014
    Perera V; Bies RR; Mo G; Dolton MJ; Carr VJ; McLachlan AJ; Day RO; Polasek TM; Forrest A, 2014, 'Optimal sampling of antipsychotic medicines: A pharmacometric approach for clinical practice', British Journal of Clinical Pharmacology, 78, pp. 800 - 814, http://dx.doi.org/10.1111/bcp.12410
    Journal articles | 2014
    Perera V; Dolton MJ; McLachlan AJ; Carr VJ; Day RO, 2014, 'Pharmacometrics: An underused resource in Australian clinical research', Medical Journal of Australia, 200, pp. 82 - 83, http://dx.doi.org/10.5694/mja13.10663
    Journal articles | 2014
    Rasheed H; Topless R; Day R; Kannangara D; Williams K; Bradbury L; Brown M; Hill C; Lester S; Rischmueller M; Smith M; Andres M; Bardin T; Doherty M; Janssen M; Jansen T; Joosten L; Perez-Ruiz F; Radstake T; Riches PL; Roddy E; Tausche A-K; Stamp LK; Dalbeth N; Liote F; So A; McKinney C; Merriman TR, 2014, 'Association of the Toll-like Receptor 4 (TLR4) Gene with Gout.', ARTHRITIS & RHEUMATOLOGY, 66, pp. S1294 - S1295, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344384906196&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2014
    Wiley J; Westbrook M; Greenfield JR; Day RO; Braithwaite J, 2014, 'Shared decision-making: The perspectives of young adults with type I diabetes mellitus', Patient Preference and Adherence, 8, pp. 423 - 435, http://dx.doi.org/10.2147/PPA.S57707
    Journal articles | 2014
    Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2014, 'Diabetes Education: the Experiences of Young Adults with Type 1 Diabetes', Diabetes Therapy, 5, pp. 299 - 321, http://dx.doi.org/10.1007/s13300-014-0056-0
    Journal articles | 2014
    Williams CM; Maher CG; Latimer J; McLachlan AJ; Hancock MJ; Day RO; Lin C-WC, 2014, 'Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial', The Lancet, 384, pp. 1586 - 1596, http://dx.doi.org/10.1016/S0140-6736(14)60805-9
    Journal articles | 2013
    Arabadzhiyska PN; Baysari MT; Walter S; Day RO; Westbrook JI, 2013, 'Shedding light on junior doctors' work practices after hours', Internal Medicine Journal, 43, pp. 1321 - 1326, http://dx.doi.org/10.1111/imj.12223
    Journal articles | 2013
    Baysari M; Day R; Teo CK, 2013, 'Understanding compliance to an antibiotic prescribing policy: Perspectives of policymakers and prescribers', Journal of Pharmacy Practice and Research, 43, pp. 32 - 36, http://dx.doi.org/10.1002/j.2055-2335.2013.tb00212.x
    Journal articles | 2013
    Baysari MT; Oliver K; Egan B; Li L; Richardson K; Sandaradura I; Westbrook JI; Day RO, 2013, 'Audit and feedback of antibiotic use', Applied Clinical Informatics, 4, pp. 583 - 595, http://dx.doi.org/10.4338/ACI-2013-08-RA-0063
    Journal articles | 2013
    Brett J; Chong O; Graham GG; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Antifungal Use and Therapeutic Monitoring of Plasma Concentrations of Itraconazole in Heart and Lung Transplantation Patients.', Therapeutic Drug Monitoring, 35, pp. 133 - 136, http://dx.doi.org/10.1097/FTD.0b013e318275fe69
    Journal articles | 2013
    Carmichael SJ; Day RO; Tett S, 2013, 'A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus', Internal Medicine Journal, 43, pp. 547 - 553, http://dx.doi.org/10.1111/imj.12100
    Journal articles | 2013
    Day R; Lee H; Graham G; Williams K, 2013, 'Benzbromarone: Availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt on benzbromarone)', New Zealand Medical Journal, 126, pp. 124 - 126
    Journal articles | 2013
    Day R, 2013, 'Off-label prescribing', Australian Prescriber, 36, pp. 182 - 183, http://dx.doi.org/10.18773/austprescr.2013.075
    Journal articles | 2013
    Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs (NSAIDs)', BMJ, 346, pp. Article No. f3195, http://dx.doi.org/10.1136/bmj.f3195
    Journal articles | 2013
    Day RO; Graham GG, 2013, 'Republished research: Non-steroidal anti-inflammatory drugs (NSAIDs)', British Journal of Sports Medicine, 47, pp. 1127, http://dx.doi.org/10.1136/bjsports-2013-f3195rep
    Journal articles | 2013
    Duong JK; Kumar SS; Carl m kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO, 2013, 'Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes: Simulation of doses according to renal function', Clinical Pharmacokinetics, 52, pp. 373 - 384, http://dx.doi.org/10.1007/s40262-013-0046-9
    Journal articles | 2013
    Gallego B; Runciman WB; Perez-Concha O; Liaw S; Day RO; Dunn AG; Coiera E, 2013, 'The management of severe hypertension in Australian general practice', BMC health services research, 13, pp. 414, http://dx.doi.org/10.1186/1472-6963-13-414
    Journal articles | 2013
    Ghinea N; Lipworth W; Little M; Kerridge I; Day R, 2013, 'Overcoming Entrenched Disagreements: the Case of Misoprostol for Post-Partum Haemorrhage', Developing World Bioethics, 15, pp. n/a - n/a, http://dx.doi.org/10.1111/dewb.12040
    Journal articles | 2013
    Graham GG; Davies MJ; Day RO; Mohamudally A; Scott KF, 2013, 'The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.', Inflammopharmacology, 21, pp. 201 - 232, http://dx.doi.org/10.1007/s10787-013-0172-x
    Journal articles | 2013
    Harris IA; Day RO, 2013, 'PRECISE - pregabalin in addition to usual care for sciatica: study protocol for a randomised controlled trial', Trials, 14, pp. 213, http://dx.doi.org/10.1186/1745-6215-14-213
    Journal articles | 2013
    Kannangara DRW; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO, 2013, 'An audit of a therapeutic drug monitoring service for allopurinol therapy', Therapeutic Drug Monitoring, 35, pp. 863 - 866, http://dx.doi.org/10.1097/FTD.0b013e318299920a
    Journal articles | 2013
    Lee M-H; Stocker S; Williams KM; Day RO, 2013, 'HLA-B*5801 should be used to screen for risk of Stevens-Johnson Syndrome (SJS) in family members of Han-Chinese patients commencing allopurinol therapy', Journal of Rheumatology, 40, pp. 96 - 97, http://dx.doi.org/10.3899/jrheum.120803
    Journal articles | 2013
    Lee P; Day RO; Greenfield JR; Ho KK, 2013, 'Formoterol, a highly selective beta 2-selective agonist, increases energy expenditure and fat utilisation in men', International journal of obesity, 37, pp. 593 - 597, http://dx.doi.org/10.1038/ijo.2012.90
    Journal articles | 2013
    Lewis JRR; Lipworth WL; Kerridge IH; Day RO, 2013, 'The economic evaluation of personalised oncology medicines: Ethical challenges', Medical Journal of Australia, 199, pp. 471 - 473, http://dx.doi.org/10.5694/mja13.10046
    Journal articles | 2013
    Lipworth WL; Kerridge IH; Day RO, 2013, 'Formulating an ethics agenda for drug development, regulation, and utilization', Therapeutic Innovation & Regulatory Science, 47, pp. 46 - 49, http://dx.doi.org/10.1177/2168479012469949
    Journal articles | 2013
    Missiakos O; Baysari MT; Day RO, 2013, 'Identifying effective strategies to prevent drug-drug interactions in hospital: A user-centered approach', 49th Annual Human Factors and Ergonomics Society of Australia Conference 2013, HFESA 2013
    Journal articles | 2013
    Ramasamy SN; Korb-Wells CS; Kannangara DRW; Smith MWH; Wang N; Roberts DM; Graham GG; Williams KM; Day RO, 2013, 'Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012', Drug Safety, 36, pp. 953 - 980, http://dx.doi.org/10.1007/s40264-013-0084-0
    Journal articles | 2013
    Tea CK; Baysari MT; Day RO, 2013, 'Compliance with antibiotic prescribing policy: Perspectives of policymakers and prescribers', Australian Journal of Pharmacy, 94, pp. 74 - 77
    Journal articles | 2013
    Westbrook JI; Baysari MT; Li L; Burke R; Richardson KL; Day RO, 2013, 'The safety of electronic prescribing: Manifestations, mechanisms, and rates of system-related errors associated with two commercial systems in hospitals', Journal of the American Medical Informatics Association, 20, pp. 1159 - 1167, http://dx.doi.org/10.1136/amiajnl-2013-001745
    Journal articles | 2013
    Wiley J; Westbrook M; Long J; Greenfield JR; Day RO; Braithwaite J, 2013, 'Multidisciplinary diabetes team care: The experiences of young adults with Type 1 diabetes', Health Expectations, http://dx.doi.org/10.1111/hex.12170
    Journal articles | 2013
    Williams CM; Maher CG; Latimer J; McLachlan AJ; Hancock MJ; Day RO; Billot L; Lin CWC, 2013, 'PACE - the first placebo controlled trial of paracetamol for acute low back pain: Statistical analysis plan', Trials, 14, http://dx.doi.org/10.1186/1745-6215-14-248
    Journal articles | 2013
    Wong C; Kumar SS; Graham GG; Begg EJ; Chin P; Brett J; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Comparing dose prediction software used to manage gentamicin dosing', Internal Medicine Journal, 43, pp. 519 - 525, http://dx.doi.org/10.1111/imj.12067
    Journal articles | 2012
    Baysari MT; Day RO; Westbrook J, 2012, 'Consistency or efficiency? A dilemma for designers', Journal of the American Medical Informatics Association, 19, pp. 1119 - 1120, http://dx.doi.org/10.1136/amiajnl-2012-001254
    Journal articles | 2012
    Baysari MT; Reckmann M; Li L; Day RO; Westbrook J, 2012, 'Failure to utilize functions of an electronic prescribing system and the subsequent generation of 'technically preventable' computerized alerts', Journal of the American Medical Informatics Association, 19, pp. 1003 - 1010, http://dx.doi.org/10.1136/amiajnl-2011-000730
    Journal articles | 2012
    Baysari MT; Tang T; Brett J; Day RO, 2012, 'Implementation of revised aminoglycoside guidelines: Australian hospitals 'left in the lurch'', Journal of Pharmacy Practice and Research, 42, pp. 178 - 179, http://dx.doi.org/10.1002/j.2055-2335.2012.tb00163.x
    Journal articles | 2012
    Baysari MT; Westbrook J; Day RO, 2012, 'Understanding doctors perceptions of their prescribing competency and the value they ascribe to an electronic prescribing system', Studies in Health Technology and Informatics,Volume 178: Health Informatics: Building a Healthcare Future Through Trusted Information, 178, pp. 1 - 6, http://dx.doi.org/10.3233/978-1-61499-078-9-1
    Journal articles | 2012
    Day RO; Kannangara DRW; Hayes JM; Furlong TJ, 2012, 'Successful use of allopurinol in a patient on dialysis', BMJ Case Reports, 2012, pp. 1 - 3, http://dx.doi.org/10.1136/bcr.02.2012.5814
    Journal articles | 2012
    Day RO; Kannangara DRW; Hayes JM; Furlong TJ, 2012, 'Successful use of allopurinol in a patient on dialysis.', BMJ case reports, 2012
    Journal articles | 2012
    Dunn AG; Bourgeois F; Murthy S; Mandl K; Day RO; Coiera E, 2012, 'The role and impact of research agendas on the comparative effectiveness research amongst anti-hyperlipidemics', Clinical Pharmacology and Therapeutics, 91, pp. 685 - 691, http://dx.doi.org/10.1038/clpt.2011.279
    Journal articles | 2012
    Dunn AG; Braithwaite J; Gallego B; Day RO; Runciman W; Coiera E, 2012, 'Nation-scale adoption of new medicines by doctors: an application of the Bass diffusion model', BMC health services research, 12, pp. 248 - 248, http://dx.doi.org/10.1186/1472-6963-12-248
    Journal articles | 2012
    Dunn AG; Day RO; Mandl K; Coiera E, 2012, 'Learning from Hackers: Open-Source Clinical Trials', Science Translational Medicine, 4, pp. 132cm5, http://dx.doi.org/10.1126/scitranslmed.3003682
    Journal articles | 2012
    Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'Metformin therapy in patients with chronic kidney disease', Diabetes Obesity and Metabolism, 14, pp. 963 - 965, http://dx.doi.org/10.1111/j.1463-1326.2012.01617.x
    Journal articles | 2012
    Ghinea N; Lipworth WL; Kerridge IH; Day RO, 2012, 'No evidence or no alternative? Taking responsibility for off-label prescribing', Internal Medicine Journal, 42, pp. 247 - 251, http://dx.doi.org/10.1111/j.1445-5994.2012.02713.x
    Journal articles | 2012
    Hunt T; Ramanathan S; Hannaford N; Hibbert P; Braithwaite J; Coiera E; Day RO; Westbrook J; Runciman W, 2012, 'CareTrack Australia: assessing the appropriateness of adult healthcare: Protocol for a retrospective medical record review', BMJ Open, 2, pp. 665, http://dx.doi.org/10.1136/bmjopen-2011-000665
    Journal articles | 2012
    Kannangara D; Roberts DM; Furlong TJ; Graham GG; Williams K; Day RO, 2012, 'Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease', British Journal of Clinical Pharmacology, 73, pp. 828 - 829, http://dx.doi.org/10.1111/j.1365-2125.2011.04147.x
    Journal articles | 2012
    Kannangara DRW; Ramasamy SN; Indraratna P; Stocker S; Graham GG; Jones G; Portek I; Williams KM; Day RO, 2012, 'Fractional clearance of urate: Validation of measurement in spot urine samples in healthy subjects and gouty patients', Arthritis Research and Therapy, 14, pp. R189 - R197, http://dx.doi.org/10.1186/ar4020
    Journal articles | 2012
    Lee M-H; Stocker S; Anderson JM; Phillips EJ; Nolan DL; Williams KM; Graham GG; Sullivan JR; Day RO, 2012, 'Initiating allopurinol therapy: Do we need to know the patient's human leucocyte antigen status?', Internal Medicine Journal, 42, pp. 411 - 416, http://dx.doi.org/10.1111/j.1445-5994.2011.02567.x
    Journal articles | 2012
    Lipworth WL; Ho K; Kerridge IH; Day RO, 2012, 'Drug policy at the margins: The case of growth hormone replacement for adults with severe growth hormone deficiency', Medical Journal of Australia, 197, pp. 204 - 205, http://dx.doi.org/10.5694/mja11.11572
    Journal articles | 2012
    Lipworth WL; Kerridge IH; Day RO, 2012, 'Time for the Pharmaceutical Benefits Advisory Committee to set its own agenda', Medical Journal of Australia, 196, pp. 374 - 375, http://dx.doi.org/10.5694/mja12.10152
    Journal articles | 2012
    Lipworth WL; Kerridge IH; Day RO, 2012, 'Wrong questions, wrong answers? Are we getting the drugs we need?', Clinical Pharmacology and Therapeutics, 91, pp. 367 - 369, http://dx.doi.org/10.1038/clpt.2011.335
    Journal articles | 2012
    Lipworth WL; Kerridge IH; Little M; Day RO, 2012, 'Evidence and desperation in off-label prescribing: Recombinant factor VIIa', British Medical Journal: International, 344, pp. d7926, http://dx.doi.org/10.1136/bmj.d7926
    Journal articles | 2012
    Runciman W; Hunt T; Hannaford N; Hibbert P; Westbrook J; Coiera E; Hindmarsh D; Day RO; Mcglynn EA; Braithwaite J, 2012, 'CareTrack: Assessing the appropriateness of health care delivery in Australia', Medical Journal of Australia, 197, pp. 100 - 105, http://dx.doi.org/10.5694/mja12.10510
    Journal articles | 2012
    Runciman WB; Coiera E; Day RO; Hannaford NA; Hibbert PD; Hunt T; Westbrook JI; Braithwaite J, 2012, 'Towards the delivery appropriate healthcare in Australia', Medical Journal of Australia, 197, pp. 78 - 81, http://dx.doi.org/10.5694/mja12.10799
    Journal articles | 2012
    Runciman WB; Hunt TD; Hannaford NA; Hibbert PD; Westbrook JI; Coiera EW; Day RO; Hindmarsh DM; McGlynn EA; Braithwaite J, 2012, 'CareTrack: assessing the appropriateness of health care delivery in Australia REPLY', MEDICAL JOURNAL OF AUSTRALIA, 197, pp. 549 - 550, http://dx.doi.org/10.5694/mja12.11210
    Journal articles | 2012
    Stocker S; Mclachlan AJ; Savic RM; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'The pharmacokinetics of oxypurinol in people with gout', British Journal of Clinical Pharacology, 74, pp. 477 - 489, http://dx.doi.org/10.1111/j.1365-2125.2012.04207.x
    Journal articles | 2012
    Westbrook J; Reckmann M; Li L; Runciman W; Burke R; Lo C; Baysari MT; Braithwaite J; Day RO, 2012, 'Effects of two commercial electronic prescribing systems on prescribing error rates in hospital inpatients: a before and after study', PLOS Medicine, 9, pp. e1001164, http://dx.doi.org/10.1371/journal.pmed.1001164
    Journal articles | 2011
    Baysari MT; Westbrook J; Braithwaite J; Day R, 2011, 'The Role of Computerized Decision Support in Reducing Errors in Selecting Medicines for Prescription: Narrative Review', Drug Safety, 34, pp. 289 - 298, http://dx.doi.org/10.2165/11588200-000000000-00000
    Journal articles | 2011
    Baysari MT; Westbrook J; Richardson K; Day RO, 2011, 'The influence of computerized decision support on prescribing during ward rounds: are the decision-makers targeted?', Journal of the American Medical Informatics Association, 18, pp. 754 - 759, http://dx.doi.org/10.1136/amiajnl-2011-000135
    Journal articles | 2011
    Bell AJ; Mcd taylor D; Holdgate A; MacBean C; Huynh T; Thom O; Augello M; Millar R; Day RE; Williams AG; Ritchie P; Pasco J, 2011, 'Procedural sedation practices in Australian Emergency Departments', Emergency Medicine Australasia, 23, pp. 458 - 465, http://dx.doi.org/10.1111/j.1742-6723.2011.01418.x
    Journal articles | 2011
    Bombardier C; Laine L; Day RO; Hawkey CJ; Hochberg MC; Schnitzer TJ, 2011, 'Rofecoxib and clinically significant gastrointestinal events', American Journal of the Medical Sciences, 342, pp. 438 - 439, http://dx.doi.org/10.1097/MAJ.0b013e31822f3ff4
    Journal articles | 2011
    Brett J; Beresford R; Sevastos J; Day RO, 2011, 'Neem Extract Poisoning as a Cause of Renal Tubular Acidosis', Journal of Clinical Toxicology, 1, pp. 112, http://dx.doi.org/10.4172/2161-0495.1000112
    Journal articles | 2011
    Carney SL; Gazarian M; Denholm JT; Reith DM; Penhall RK; Jenkins CR; Wilhelm KA; Komesaroff P; Osborn MM; Day RO, 2011, 'What's in a name? Brand name confusion and generic medicines', Medical Journal of Australia, 195, pp. 650 - 651
    Journal articles | 2011
    Carney SL; Gazarian M; Denholm JT; Reith DM; Penhall RK; Jenkins CR; Wilhelm KA; Komesaroff PA; Osborn MM; Day RO, 2011, 'What's in a name? Brand name confusion and generic medicines', Medical Journal of Australia, 195, pp. 650 - 651, http://dx.doi.org/10.5694/mja10.10968
    Journal articles | 2011
    Day RO; Lipworth WL; Kerridge IH, 2011, 'Death of the ‘Blockbuster’ and ‘Pivotal’ Clinical Trial: Rethinking the Drug Development Process.', Journal of Pharmacy Practice and Research, 41, pp. 94 - 95, http://dx.doi.org/10.1002/j.2055-2335.2011.tb00671.x
    Journal articles | 2011
    Day RO; Roffe D; Richardson K; Baysari MT; Brennan NJ; Beveridge AH; Melocco T; Ainge J; Westbrook J, 2011, 'Implementing electronic medication management at an Australian teaching hospital', Medical Journal of Australia, 195, pp. 498 - 502, http://dx.doi.org/10.5694/mja11.10451
    Journal articles | 2011
    Graham GG; Punt J; Manit A; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup L; Carl m kirkpatrick CM; Ray J; Timmins P; Williams KM, 2011, 'Clinical pharmacokinetics of metforim', Clinical Pharmacokinetics, 50, pp. 81 - 98, http://dx.doi.org/10.2165/11534750-000000000-00000
    Journal articles | 2011
    Greenfield JR; Graham GG; Day RO, 2011, 'The Use of Metformin in Diabetic Patients with Renal Impairment', Geriatric Medicine in General Practice, 8, pp. 26 - 29, http://search.informit.com.au/documentSummary;dn=109054076198131;res=IELHEA
    Journal articles | 2011
    Harvey K; Day RO; Campbell W; Lipworth WL, 2011, 'Saving money on the PBS: Ranibizumab or Bevacizumab for Neovascular Macular Degeneration?', Medical Journal of Australia, 194, pp. 567 - 568
    Journal articles | 2011
    Henneicke H; Herrmann M; Kalak R; Brennan-Speranza TC; Heinevetter U; Bertollo N; Day RE; Huscher D; Buttgereit F; Dunstan CR; Seibel MJ; Zhou H, 2011, 'Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism', Bone, 49, pp. 733 - 742, http://dx.doi.org/10.1016/j.bone.2011.06.013
    Journal articles | 2011
    Inam S; Lipworth WL; Kerridge IH; Day RO, 2011, 'Rethinking the discordance between guidelines and practice in the treatment of rheumatoid arthritis: a failure of practice or failure of evidence?', Medical Journal of Australia, 195, pp. 446 - 447
    Journal articles | 2011
    Inam S; Lipworth WL; Kerridge IH; Day RO, 2011, 'Rethinking the discordance between guidelines and practice in rheumatoid arthritis treatment', Medical Journal of Australia, 195, pp. 446 - 447, http://dx.doi.org/10.5694/mja11.10068
    Journal articles | 2011
    Kannangara D; Datta I; Indraratna P; Stocker S; Portek I; Graham G; Williams K; Day R, 2011, 'INDIVIDUALISING ALLOPURINOL THERAPY IN GOUT', INTERNAL MEDICINE JOURNAL, 41, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2011
    Lee P; Kengne A; Greenfield JR; Day RO; Chalmers J; Ho KK, 2011, 'Metabolic sequelae of beta-blocker theraphy: weighing in on the obesity epidemic?', International journal of obesity, 35, pp. 1395 - 1403, http://dx.doi.org/10.1038/ijo.2010.284
    Journal articles | 2011
    Lipworth WL; Kerridge I; Brett J; Day R, 2011, 'How clinical and research failures lead to suboptimal prescribing: the example of chronic gout.', British Medical Journal, 343, pp. d7459, http://dx.doi.org/10.1136/bmj.d7459
    Journal articles | 2011
    Lipworth WL; Kerridge IH; Brett J; Day RO, 2011, 'How clinical and resaerch failures lead to suboptimal prescribing: the example of chronic gout', British Medical Journal, 343, pp. 1 - 3, http://dx.doi.org/10.1136/bmj.d7459
    Journal articles | 2011
    Lipworth WL; Wodak A; Haber P; Day RO, 2011, 'Why is Disulfiram not on the PBS?', Medical Journal of Australia, 195, pp. 371 - 372, http://dx.doi.org/10.5694/mja11.10708
    Journal articles | 2011
    Mcd taylor D; Bell AJ; Holdgate A; MacBean C; Huynh T; Thom O; Augello M; Millar R; Day RE; Williams AG; Ritchie P; Pasco J, 2011, 'Risk factors for sedation-related events during procedural sedation in the emergency departmentemm_1419 466..473', Emergency Medicine Australasia, 23, pp. 466 - 473, http://dx.doi.org/10.1111/j.1742-6723.2011.01419.x
    Journal articles | 2011
    Milder T; Lipworth W; Ritchie J; Williams K; Day R, 2011, 'WHAT DRIVES OSTEOARTHRITIS PATIENTS TO USE OR NOT USE NSAIDS, PARACETAMOL AND COMPLEMENTARY MEDICATIONS?', INTERNAL MEDICINE JOURNAL, 41, pp. 23 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2011
    Milder T; Lipworth WL; Williams KM; Ritchie JE; Day RO, 2011, '"It looks after me": how older patients make decisions about analgesics for osteoarthritis.', Arthritis Care and Research, 63, pp. 1280 - 1286, http://dx.doi.org/10.1002/acr.20514
    Journal articles | 2011
    Milder T; Williams K; Ritchie JE; Lipworth WL; Day RO, 2011, 'Use of NSAIDs for osteoarthritis amongst older-aged primary care patients: Engagement with information and perceptions of risk', Age and Ageing, 40, pp. 254 - 259, http://dx.doi.org/10.1093/ageing/afq160
    Journal articles | 2011
    Ng DY; Stocker SL; Graham GG; Williams KM; Day RO, 2011, 'Lack of effect of hydrochlorothiazide and low-dose aspirin on the renal clearance of urate and oxypurinol after a single dose of allopurinol in normal volunteers', European Journal of Clinical Pharmacology, 67, pp. 709 - 713, http://dx.doi.org/10.1007/s00228-010-0963-6
    Journal articles | 2011
    Ramasamy S; Kannangara D; Indraratna P; Stocker S; Jones G; Graham G; Williams K; Day R, 2011, 'ESTABLISHING THE USEFULNESS OF A SPOT URINE COLLECTION IN CALCULATING THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU)', INTERNAL MEDICINE JOURNAL, 41, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290489900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2011
    Roberts DM; Smith MA; Gopalakrishnan M; Whittaker G; Day RO, 2011, 'Extreme y-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis', Annals of Emergency Medicine, 58, pp. 83 - 85, http://dx.doi.org/10.1016/j.annemergmed.2011.01.017
    Journal articles | 2011
    Roberts DM; Smith MA; McMullan B; Sevastos J; Day RO, 2011, 'Acute kidney injury due to crystalluria following acute valacycolvir overdose', Kidney International, 79, pp. 574 - 575, http://dx.doi.org/10.1038/ki.2010.496
    Journal articles | 2011
    Roberts DM; Smith MA; Ritson R; Day RO, 2011, 'Death and morbidity from supratherapeutic dosing of colchicine: 3 cases over 2 weeks', Medical Journal of Australia, 194, pp. 612 - 613
    Journal articles | 2011
    Sklar P; Ripke S; Scott LJ; Andreassen OA; Cichon S; Craddock N; Edenberg HJ; Nurnberger JI; Rietschel M; Blackwood D; Corvin A; Flickinger M; Guan W; Mattingsdal M; McQuillan A; Kwan P; Wienker TF; Daly MJ; Dudbridge F; Holmans PA; Lin D; Burmeister M; Greenwood TA; Hamshere ML; Muglia P; Smith EN; Zandi PP; Nievergelt CM; McKinney R; Shilling PD; Schork NJ; Bloss CS; Foroud T; Koller DL; Gershon ES; Liu C; Badner JA; Scheftner WA; Lawson WB; Nwulia EA; Hipolito M; Coryell W; Rice J; Byerley W; McMahon FJ; Schulze TG; Berrettini W; Lohoff FW; Potash JB; Mahon AP; McInnis MG; Zollner S; Zhang P; Craig DW; Szelinger S; Barrett TB; Breuer R; Meier S; Strohmaier J; Witt SH; Tozzi F; Farmer A; McGuffin P; Strauss J; Xu W; Kennedy JL; Vincent JB; Matthews K; Day R; Ferreira MA; O'Dushlaine C; Perlis R; Raychaudhuri S; Ruderfer D; Hyoun PL; Smoller JW; Li J; Absher D; Thompson RC; Meng FG; Schatzberg A; Bunney WE; Barchas JD; Jones EG; Watson SJ; Myers RM; Akil H; Boehnke M; Chambert K; Moran J; Scolnick EM; Djurovic S; Melle I; Morken G; Gill M; Morris D; Quinn E; Muhleisen TW; Degenhardt FA; Mattheisen M; Schumacher J; Maier W; Steffens M; Propping P; Nothen MM; Anjorin A; Bass N; Gurling H; Kandaswamy R; Lawrence J; McGhee K; McIntosh A; McLean AW; Muir WJ; Pickard BS; Breen G; St Clair D; Caesar S; Gordon-Smith K; Jones L; Fraser C; Green EK; Grozeva D; Jones IR; Kirov G; Moskvina V; Nikolov I; O'Donovan MC; Owens MJ; Collier DA; Elkin A; Williamson R; Young AH; Ferrier IN; Stefansson K; Stefansson H; Porgeirsson P; Steinberg S; Gustafsson O; Bergen SE; Nimgaonkar V; Hultman C; Landen M; Lichtenstein P; Sullivan P; Schalling M; Osby U; Backlund L; Frisen L; Langstrom N; Jamain S; Leboyer M; Etain B; Bellivier F; Petursson H; Sigurgosson E; Muller-Mysok B; Lucae S; Schwarz M; Schofield PR; Martin N; Montgomery GW; Lathrop M; Oskarsson H; Bauer M; Wright A; Mitchell PB; Hautzinger M; Reif A; Kelsoe JR; Purcell SM, 2011, 'Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4', Nature Genetics, 43, pp. 977 - 985, http://dx.doi.org/10.1038/ng.943
    Journal articles | 2011
    Smith MWH; Roberts DM; Ritson SM; Day RO, 2011, 'Death and morbidity from supratherapeutic dosing of colchicine', Medical Journal of Australia, 194, pp. 612 - 613, http://dx.doi.org/10.5694/j.1326-5377.2011.tb03121.x
    Journal articles | 2011
    Stocker SL; Graham GG; McLachlan AJ; Williams K; Day RO, 2011, 'Pharmacokinetic and Pharmacodynamic interaction between allopurinol and probenecid in patients with gout', Journal of Rheumatology, 38, pp. 904 - 910, http://dx.doi.org/10.3899/jrheum.101160
    Journal articles | 2011
    Wang N; Lipworth WL; Ritchie JE; Williams K; Day RO, 2011, 'Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines', Internal Medicine Journal, 41, pp. 314 - 320, http://dx.doi.org/10.1111/j.1445-5994.2010.02239.x
    Journal articles | 2010
    Abdul M; Jiang XM; Williams KM; Day RO; Roufogalis B; Liauw WS; Xu H; Matthias A; Lehmann RP; McLachlan AJ, 2010, 'Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects', British Journal of Clinical Pharmacology, 69, pp. 508 - 515, http://dx.doi.org/10.1111/j.1365-2125.2010.03620.x
    Journal articles | 2010
    Carter SM; Samuel GN; Kerridge I; Day R; Ankeny RA; Jordens CFC; Komesaroff P, 2010, 'Beyond rhetoric in debates about the Ethics of marketing prescription medicines to consumers: The importance of Vulnerability in people, situations, and relationships', AJOB Primary Research, 1, pp. 11 - 21, http://dx.doi.org/10.1080/21507716.2010.482871
    Journal articles | 2010
    Day RO; Liauw WS; Tozer L; McElduff P; Beckett RJ; Williams K, 2010, 'A double-blind, placebo-controlled study of the short term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenpausal women', BMC Research Notes, 3, pp. 1 - 8, http://dx.doi.org/10.1186/1756-0500-3-180
    Journal articles | 2010
    Graham GG; Day RO; Graudins A; Mohamudally A, 2010, 'Erratum: FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): Are they reasonable? (Inflammopharmacol DOI: 10.1007/s10787-010-0036-6)', Inflammopharmacology, 18, pp. 57, http://dx.doi.org/10.1007/s10787-010-0039-3
    Journal articles | 2010
    Graham GG; Day RO; Graudins A; Mohamudally A, 2010, 'FDA proposals to limit the hepatoxicity of paracetamol (acetaminophen). Are they resonable?', Inflammopharmacology, 18, pp. 47 - 55, http://dx.doi.org/10.1007/s10787-010-0036-6
    Journal articles | 2010
    Indraratna P; Stocker SL; Williams KM; Graham GG; Jones G; Day RO, 2010, 'A proposal for identifying the low renal uric acid clearance phenotype', Arthritis Research and Therapy, 12, pp. 149 - 151, http://dx.doi.org/10.1186/ar3191
    Journal articles | 2010
    Lu CY; Lu VH; Goldberg I; Day RO, 2010, 'Towards integrated care: Australia's new model of care for patients with glaucoma', Medical Journal of Australia, 193, pp. 200 - 201, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03867.x
    Journal articles | 2010
    Magrabi F; Li S; Day RO; Coiera E, 2010, 'Errors and electronic prescribing: A controlled laboratory study to examine task complexity and interruption effects', American Medical Informatics Association Annual Symposium Proceedings, 17, pp. 575 - 583, http://dx.doi.org/10.1136/jamia.2009.001719
    Journal articles | 2010
    Standfield L; Norris S; Elliott L; Riordan J; Hall S; Day RO; Nash P; Thirunavukkarasu K; Robertson J; Palmer T, 2010, 'Relationship between rheumatoid arthritis disease severity, health related utility and resource use in Australian rheumatoid arthritis patients', Clinical Therapeutics, 32, pp. 1329 - 1342
    Journal articles | 2010
    Standfield L; Norris S; Harvey C; Elliot L; Riordan J; Hall S; Day R; Nash P; Thirunavukkarasu K; Robertson J; Palmer T, 2010, 'Relationship between rheumatoid arthritis disease severity, health-related utility, and resource use in australian patients: A cross-sectional, multicenter study', Clinical Therapeutics, 32, pp. 1329 - 1342, http://dx.doi.org/10.1016/j.clinthera.2010.07.006
    Journal articles | 2010
    Stocker S; Franklin M; Anderson JM; Pillans PI; Williams K; McLachlan AJ; Day RO; taylor P, 2010, 'Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry', Journal of Chromatography, 878, pp. 2363 - 2368, http://dx.doi.org/10.1016/j.jchromb.2010.07.017
    Journal articles | 2010
    Wallace H; Graham GG; Williams K; Day RO, 2010, 'A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeine', Pain Medicine, 11, pp. 951 - 965, http://dx.doi.org/10.1111/j.1526-4637.2010.00867.x
    Journal articles | 2010
    Westbrook JI; Woods A; Rob MI; Dunsmuir WTM; Day RO, 2010, 'Association of interruptions with an increased risk and severity of medication administration errors', Archives of Internal Medicine, 170, pp. 683 - 690, http://dx.doi.org/10.1001/archinternmed.2010.65
    Journal articles | 2010
    Williams CM; Latimer J; Maher C; McLachlan AJ; Cooper C; Hancock M; Day RO; McAuley J; Lin C, 2010, 'PACE-the first placebo controlled trail of paracetamol for acute low back pain:design of a randomised controlled trial', BMC Musculoskeletal Disorders, 11, pp. 1 - 11, http://dx.doi.org/10.1186/1471-2474-11-169
    Journal articles | 2009
    Day RO, 2009, 'Adherence to urate-lowering therapy', Southern Medical Journal, 102, pp. 114 - 115, http://dx.doi.org/10.1097/SMJ.0b013e31819042a0
    Journal articles | 2009
    Day RO, 2009, 'India: Emerging centre of drug develpment', Journal of Pharmacy Practice and Research, 39, pp. 262 - 263
    Journal articles | 2009
    Hancock M; Maher C; Latimer J; Mclachlan AJ; Day RO; Davies R, 2009, 'Can predictors of response to NSAIDs Be identified in patients with acute low back pain?', Clinical Journal of Pain, 25, pp. 659 - 665, http://dx.doi.org/10.1097/AJP.0b013e3181a7ee3a
    Journal articles | 2009
    Indraratna P; Williams KM; Graham GG; Day RO, 2009, 'Hyperuricemia, Cardiovascular Disease and the Metabolic Syndrome', The Journal of Rheumatology, 36, pp. 2842 - 2843, http://dx.doi.org/10.3899/jrheum.090500
    Journal articles | 2009
    Lee P; Greenfield JR; Day RO; Ho K, 2009, 'Weight maintenance in hospitalized geriatric patients treated with beta-blockers', Journal of the American Geriatrics Society, 57, pp. 1125 - 1126, http://dx.doi.org/10.1111/j.1532-5415.2009.02282.x
    Journal articles | 2009
    Osborn M; Day RO; Komesaroff P; Mant A, 2009, 'Do ethical guidelines make a difference to decision-making?', Internal Medicine Journal, 39, pp. 800 - 805, http://dx.doi.org/10.1111/j.1445-5994.2009.01954.x
    Journal articles | 2009
    Osborn M; Day RO; Westbrook JI, 2009, 'Are specialist physicians missing out on the e-Health boat?', Internal Medicine Journal, 39, pp. 655 - 661, http://dx.doi.org/10.1111/j.1445-5994.2009.02023.x
    Journal articles | 2009
    Reckmann M; Westbrook JI; Koh Y; Lo CM; Day RO, 2009, 'Does Computerized Provider Order Entry Reduce Prescribing Errors for Hospital Inpatients? A Systematic Review', American Medical Informatics Association Annual Symposium Proceedings, 16, pp. 613 - 623, http://dx.doi.org/10.1197/jamia.M3050
    Journal articles | 2008
    Abdul M; Jiang XM; Day RO; Roufogalis B; Liauw WS; Xu H; Mclachlan AJ, 2008, 'Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects', British Journal of Pharmacology, 154, pp. 1691 - 1700, http://dx.doi.org/10.1038/bjp.2008.210
    Journal articles | 2008
    Chung Y; Stocker S; Graham GG; Day RO, 2008, 'Optimizing therapy with allopurinol: Factors limiting hypouricemic efficacy', American Journal of the Medical Sciences, 335, pp. 219 - 226, http://dx.doi.org/10.1097/MAJ.0b013e31815acb10
    Journal articles | 2008
    Chung YW; Lu CY; Graham GG; Mant A; Day RO, 2008, 'Utilization of allopurinol in the Australian community', Internal Medicine Journal, 38, pp. 388 - 395, http://dx.doi.org/10.1111/j.1445-5994.2008.01641.x
    Journal articles | 2008
    Day RO; Fransen M; Zochling J; March L, 2008, 'Osteoarthritis: NSAIDs, paracetamol or other treatment approaches?', Medicine Today, 9, pp. 71 - 74
    Journal articles | 2008
    Lee M; Graham GG; Williams KM; Day RO, 2008, 'A benefit-risk assessment of benzbromarone in the treatment of gout - was its withdrawal from the market in the best interest of patients?', Drug Safety, 31, pp. 643 - 665, http://dx.doi.org/10.2165/00002018-200831080-00002
    Journal articles | 2008
    Lu CY; Macneill P; Williams K; Day R, 2008, 'Access to high cost medicines in Australia: Ethical perspectives', Australia and New Zealand Health Policy, 5, http://dx.doi.org/10.1186/1743-8462-5-4
    Journal articles | 2008
    Lu CY; Williams KM; Day RO, 2008, 'Access to biologic medicines for the treatment of rheumatic diseases: lessons from Australia', International Journal of Rheumatology, 11, pp. 11 - 14, http://dx.doi.org/10.1111/j.1756-185X.2008.00322.x
    Journal articles | 2008
    Magrabi F; Westbrook JI; Kidd MR; Day RO; Coiera E, 2008, 'Long-term patterns of online evidence retrieval use in general practice: A 12-month study', Journal of Medical Internet Research, 10, http://dx.doi.org/10.2196/jmir.974
    Journal articles | 2008
    McLachlan AJ; Day RO; Williams KM; Graham GG, 2008, 'Maximising gout therapy', Australian Journal of Pharmacy, 89, pp. 86 - 88
    Journal articles | 2008
    Stocker S; Williams KM; Mclachlan AJ; Graham GG; Day RO, 2008, 'Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects', Clinical Pharmacokinetics, 47, pp. 111 - 118, http://dx.doi.org/10.2165/00003088-200847020-00004
    Journal articles | 2008
    Xu H; Liauw WS; Murray M; Day RO; Mclachlan AJ, 2008, 'Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide', British Journal of Pharmacology, 153, pp. 1579 - 1586, http://dx.doi.org/10.1038/sj.bjp.0707685
    Journal articles | 2007
    Day R; Lu CY; Pearce G; Grainger D, 2007, 'Pharmaceutical benefits scheme: Rapid change and impetus towards achieving QUM', Journal of Pharmacy Practice and Research, 37, pp. 4 - 6, http://dx.doi.org/10.1002/j.2055-2335.2007.tb00644.x
    Journal articles | 2007
    Day RO; Graham G; Williams K, 2007, 'Fenofibratewarfarin interaction [1]', Australian Prescriber, 30, pp. 32, http://dx.doi.org/10.18773/austprescr.2007.014
    Journal articles | 2007
    Day RO; Graham GG; Hicks M; Mclachlan AJ; Stocker S; Williams KM, 2007, 'Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol', Clinical Pharmacokinetics, 46, pp. 623 - 644, http://dx.doi.org/10.2165/00003088-200746080-00001
    Journal articles | 2007
    Day RO; Williams KM, 2007, 'Open-label extension studies - Do they provide meaningful information on the safety of new drugs?', Drug Safety, 30, pp. 93 - 105, http://dx.doi.org/10.2165/00002018-200730020-00001
    Journal articles | 2007
    Graham GG; Day RO, 2007, 'Expert comment [6]', Australian Prescriber, 30, pp. 61 - 62
    Journal articles | 2007
    Granot R; Day RO; Cohen ML; Murnion B; Garrick R, 2007, 'Targeted pharmacotherapy of evoked phenomena in neuropathic pain: A review of the current evidence', Pain Medicine, 8, pp. 48 - 64, http://dx.doi.org/10.1111/j.1526-4637.2007.00156.x
    Journal articles | 2007
    Hancock M; Maher CG; Latimer J; Mclachlan AJ; Cooper C; Day RO; Spindler M; McAuley J, 2007, 'Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial', Lancet, 370, pp. 1638 - 1643, http://dx.doi.org/10.1016/S0140-6736(07)61686-9
    Journal articles | 2007
    Kaye K; Lu C; Day R, 2007, 'Can we deny patients expensive drugs? [2]', Australian Prescriber, 30, pp. 60
    Journal articles | 2007
    Kelman CW; Pearson S; Day RO; D Arcy C; Holman JW; Kliewer E; Henry D, 2007, 'Evaluating medicines: let`s use all the evidence', Medical Journal of Australia, 186, pp. 249 - 252
    Journal articles | 2007
    Lu C; Ritchie JE; Williams KM; Day RO, 2007, 'The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia', Australia and New Zealand Health Policy, 4, http://dx.doi.org/10.1186/1743-8462-4-26
    Journal articles | 2007
    Lu CY; Williams KM; Day RO, 2007, 'Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?', Internal Medicine Journal, 37, pp. 601 - 606, http://dx.doi.org/10.1111/j.1445-5994.2007.01396.x
    Journal articles | 2007
    Lu CY; Williams KM; Day RO, 2007, 'The funding and use of high-cost medicines in Australia: The example of anti-rheumatic biological medicines', Australia and New Zealand Health Policy, 4, http://dx.doi.org/10.1186/1743-8462-4-2
    Journal articles | 2007
    Mikhail S; Zwar NA; Vagholkar S; Dennis SM; Day RO, 2007, 'Non-steroidal anti-inflammatory drugs in general practice: a decision-making dilemma', Medical Journal of Australia, 187, pp. 160 - 163
    Journal articles | 2007
    Miners JO; Day RO, 2007, 'Relationships between the adverse effects of drugs and genetic polymorphism in genes encoding drug metabolizing enzymes', British Journal of Clinical Pharmacology, 63, pp. 380 - 381, http://dx.doi.org/10.1111/j.1365-2125.2006.02737.x
    Journal articles | 2007
    Murnion BP; Granot R; Day RO, 2007, 'Utility of urine drug screening: A clinical audit', EMA - Emergency Medicine Australasia, 19, pp. 246 - 252, http://dx.doi.org/10.1111/j.1742-6723.2007.00922.x
    Journal articles | 2007
    Pearson S; Ringland C; Kelman CW; Mant A; Lowinger J; Stark H; Nichol G; Day RO; Henry DA, 2007, 'Patterns of analgesic and anti-inflammatory medicine use by Australian veterans', Internal Medicine Journal, 37, pp. 798 - 805, http://dx.doi.org/10.1111/j.1445-5994.2007.01516.x
    Journal articles | 2007
    Tan E; Day RO; Brien JE, 2007, 'Prioritising drug and therapeutics committee (DTC) decisions: a national survey', Pharmacy World and Science, 29, pp. 90 - 96, http://dx.doi.org/10.1007/s11096-006-9074-y
    Journal articles | 2006
    Bombardier C; Laine L; Burgos-Vargas R; Davis BE; Day RO; Ferraz MB; Hawkey CJ; Hochberg MC; Kvien T; Schnitzer TJ; Weaver AJ; Reicin A; Shapiro D, 2006, 'Response to expression of concern regarding VIGOR study', New England Journal of Medicine, 354, pp. 1196 - 1198, http://dx.doi.org/10.1056/NEJMc066096
    Journal articles | 2006
    Coiera E; Magrabi F; Westbrook JI; Kidd MR; Day RO, 2006, 'Protocol for the Quick Clinical study - a randomised controlled trial to assess the impact of an online evidence retrieval system on decision-making in general practice', BMC Medical Informatics and Decision Making, 6, http://dx.doi.org/10.1186/1472-6947-6-33
    Journal articles | 2006
    Kaye KI; Lu CY; Day RO, 2006, 'Can we deny patients expensive drugs?', Australian Prescriber, 29, pp. 146 - 148, http://dx.doi.org/10.18773/austprescr.2006.087
    Journal articles | 2006
    Kaye KI; Welch SA; Graudins LV; Graudins A; Rotem T; Davis SR; Day RO, 2006, 'In reply [9]', Medical Journal of Australia, 184, pp. 44 - 45, http://dx.doi.org/10.5694/j.1326-5377.2006.tb00101.x
    Journal articles | 2006
    Kaye KI; Welch SA; Graudins LV; Graudins A; Rotem T; Davis SR; Day RO, 2006, 'Pethidine in emergency departments: promoting evidence-based prescribing - Reply', Medical Journal of Australia, 184, pp. 44 - 45, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235707000016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2006
    Loboz K; Gross AS; Williams KM; Liauw WS; Day RO; Blievernicht J; Zanger U; McLachlan AJ, 2006, 'Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: Effect of induction by rifampin and ethnicity', Clinical Pharmacology and Therapeutics, 80, pp. 75 - 84, http://dx.doi.org/10.1016/j.clpt.2006.03.010
    Journal articles | 2006
    Lu CY; Williams KM; Day RO, 2006, 'Access to high-cost medicines for the treatment of rheumatoid arthritis under Australia's pharmaceutical benefits scheme', Pharmacoepidemiology and Drug Safety, 15, pp. S213 - S213, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240281200458&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2006
    Lu CY; Williams KM; Day RO, 2006, 'Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target?', Internal Medicine Journal, 36, pp. 19 - 27, http://dx.doi.org/10.1111/j.1445-5994.2005.00992.x
    Journal articles | 2006
    Lu CY; Williams KM; Day RO, 2006, 'Accessing health outcome data on high-cost medicines in Australia', Medical Journal of Australia, 184, pp. 411 - 413
    Journal articles | 2006
    Lu CY; Williams KM; Day RO, 2006, 'Utilisation of anti-rheumatic drugs in Australia: Impact of introducing high-cost biologics under the pharmaceutical benefits scheme', Pharmacoepidemiology and Drug Safety, 15, pp. S213 - S213, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240281200457&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2006
    Mcneill PM; Kerridge IH; Henry DA; Stokes B; Hill SR; Newby D; Macdonald GJ; Day RO; Maguire J; Henderson KM, 2006, 'Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia', Internal Medicine Journal, 26, pp. 571 - 578, http://dx.doi.org/10.1111/j.1445-5994.2006.01151.x
    Journal articles | 2006
    Reicin A; Shapiro D, 2006, 'Response to expression of concern regarding VIGOR study.', N Engl J Med, 354, pp. 1196 - 1199, https://www.ncbi.nlm.nih.gov/pubmed/16544387
    Journal articles | 2006
    Strand V; Conaghan P; Lohmander L; Koutsoukos A; Hurley F; Bird H; Brooks PM; Day RO; Puhl W; Band P, 2006, 'An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the kneel', Osteoarthritis and Cartilage, 14, pp. 859 - 866, http://dx.doi.org/10.1016/j.joca.2006.02.012
    Journal articles | 2005
    Day R; Adams S, 2005, 'The birth of ibuprofen', Australian Journal of Pharmacy, 86, pp. 84 - 85
    Journal articles | 2005
    Day RO; Birkett DJ; Miners J; Shenfield GM; Henry DA; Seale JP, 2005, 'Access to medicines and high-quality therapeutics: Global responsibilities for clinical pharmacology', Medical Journal of Australia, 182, pp. 322 - 323, http://dx.doi.org/10.5694/j.1326-5377.2005.tb06728.x
    Journal articles | 2005
    Day RO; Graham GG, 2005, 'Paracetamol should be first-line therapy in osteoarthritis', Medical Journal of Australia, 182, pp. 198 - 199
    Journal articles | 2005
    Graham GG; Day RO, 2005, 'Tolerability of paracetamol', Drug Safety, 28, pp. 227 - 240, http://dx.doi.org/10.2165/00002018-200528030-00004
    Journal articles | 2005
    Hamama A; Ray J; Day RO; Brien JE, 2005, 'Simultaneous determination of rofecoxib and celecoxib in human plasma by high-performance liquid chromatography', Journal of Chromatographic Science, 43, pp. 351 - 354, http://dx.doi.org/10.1093/chromsci/43.7.351
    Journal articles | 2005
    Hancock M; Maher C; Latimer J; Mclachlan AJ; Cooper C; Day RO; Spindler M; McAuley J, 2005, 'Manipulative therapy and/or NSAIDs for acute low back pain: design of a randomized controlled trial [ACTRN012605000036617]', BMC Musculoskeletal Disorders, 6, http://dx.doi.org/10.1186/1471-2474-6-57
    Journal articles | 2005
    Henry D; Doran E; Kerridge IH; Hill SB; Mcneill PM; Day RO, 2005, 'Ties that bind - Multiple relationships between clinical researchers and the pharmaceutical industry', Archives of Internal Medicine, 165, pp. 2493 - 2496, http://dx.doi.org/10.1001/archinte.165.21.2493
    Journal articles | 2005
    Henry D; Kerridge IH; Hill S; Mcneill PM; Doran E; Newby D; Henderson K; Maguire J; Stokes B; Macdonald GJ; Day RO, 2005, 'Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience', Medical Journal of Australia, 182, pp. 557 - 560
    Journal articles | 2005
    Jiang X; Williams KM; Liauw WS; Ammit A; Roufogalis B; Duke C; Day RO; McLachlan AJ, 2005, 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59, pp. 425 - 432, http://dx.doi.org/10.1111/j.1365-2125.2005.02322.x
    Journal articles | 2005
    Kaye KI; Welch SA; Graudins LV; Graudins A; Rotem T; Davis S; Day RO, 2005, 'Pethidine in emergency departments: promoting evidence-based prescribing', Medical Journal of Australia, 183, pp. 129 - 133
    Journal articles | 2005
    Kerridge IH; Maguire J; Newby D; Mcneill PM; Henry D; Hill SB; Day RO; Macdonald GJ; Stokes B; Henderson K, 2005, 'Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations', Internal Medicine Journal, 35, pp. 206 - 210, http://dx.doi.org/10.1111/j.1444-0903.2004.00799.x
    Journal articles | 2005
    Lassere MN; Johnson KR; Boers M; Carlton KE; Day RO; Wit M; Edwards I; Fries J; Furst DE; Kirwan J; Tugwell P; Woodworth G; Brooks P, 2005, 'Standardized Assessment of adverse events in rheumatology clinical trials: Summary of the OMERACT 7 Drug Safety Module Update', Journal of Rheumatology, 32, pp. 2037 - 2041
    Journal articles | 2005
    Lassere MN; Johnson KR; Woodworth G; Furst DE; Fries J; Kirwan J; Tugwell P; Day RO; Brooks P, 2005, 'Challenges and Progress in adverse event ascertainment and reporting in clinical trials', Journal of Rheumatology, 32, pp. 2030 - 2032
    Journal articles | 2005
    Lu CY; Ritchie JE; Williams KJ; Day RE, 2005, 'Targeted access to high-cost medicines in Australia: Early analysis from a qualitative study', Value in Health, 8, pp. A28 - A28, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233021700089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2005
    Lu CY; Ritchie JE; Williams KM; Day RO, 2005, 'Recent developments in targeting access to high cost medicines in Australia', Australia and New Zealand Health Policy, 2, pp. 1 - 8, http://dx.doi.org/10.1186/1743-8462-2-28
    Journal articles | 2005
    Lu CY; Williams K; Day R, 2005, 'Evaluation of access to high-cost medicines in Australia using national claims data', VALUE IN HEALTH, 8, pp. A28 - A28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233021700088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2005
    Ritchie JE; Lu CY; Williams K; Day RO, 2005, 'Sample size is beside the point in policy development research', Australian and New Zealand Journal of Public Health, 29, pp. 583 - 583, http://dx.doi.org/10.1111/j.1467-842X.2005.tb00257.x
    Journal articles | 2005
    Tan EL; Day RO; Brien JAE, 2005, 'Perspectives on Drug and Therapeutics Committee policy implementation', Research in Social and Administrative Pharmacy, 1, pp. 526 - 545, http://dx.doi.org/10.1016/j.sapharm.2005.09.001
    Journal articles | 2004
    Day RO; Brooks P; Conaghan PG; Petersen M, 2004, 'A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee', Journal of Rheumatology, 31, pp. 775 - 782
    Journal articles | 2004
    Day RO; Graham GG, 2004, 'The vascular effects of COX-2 selective inhibitors', Australian Prescriber, 27, pp. 142 - 145, http://dx.doi.org/10.18773/austprescr.2004.119
    Journal articles | 2004
    Jiang X; Williams KM; Liauw WS; Ammit AJ; Roufogalis BD; Duke CC; Day RO; McLachlan AJ, 2004, 'Erratum: Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects (British Journal of Clinical Pharmacology (2004) 57 (592-599))', British Journal of Clinical Pharmacology, 58, pp. 102, http://dx.doi.org/10.1111/j.1365-2125.2004.02155.x
    Journal articles | 2004
    Jiang XM; Williams KM; Liauw WS; Ammit A; Roufogalis B; Duke C; Day RO; Mclachlan AJ, 2004, 'Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 57, pp. 592 - 599, http://dx.doi.org/10.1111/j.1365-2125.2003.02051.x
    Journal articles | 2004
    Jiang XM; Williams KM; Liauw WS; Ammit A; Roufogalis B; Duke C; Day RO; Mclachlan AJ, 2004, 'Pharmacokinetic-pharmacodynamic modelling to investigate herb-drug interactions with warfarin', Clinical and Experimental Pharmacology and Physiology, 31, pp. A227 - A227, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000225490400052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 2004
    Lee EJ; Williams KM; Day RO; Graham GG; Champion D, 2004, 'Stereoselective disposition of ibuprofen enantiomers in man (Reprintedfrom Br J Clin Pharmacol, vol 19, pg 669-674, 1985)', British Journal of Clinical Pharmacology, 58, pp. S759 - S764, http://dx.doi.org/10.1111/j.1365-2125.2004.02288.x
    Journal articles | 2004
    Liauw WS; Williams KM; Day RO, 2004, 'Protocol Appraisal: A Study Site's Viewpoint', Applied Clinical Trials, 13, pp. 34 - 42
    Journal articles | 2004
    Lu CY; Williams KM; Day RO; March LM; Sansom L; Bertouch JV, 2004, 'Access to high cost drugs in Australia', British Medical Journal: Clinical Research, 329, pp. 415 - 416
    Journal articles | 2004
    Lu CY; Williams KM; March LM; Bertouch JV; Day RO, 2004, 'Subsided access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible?', Medical Journal of Australia, 181, pp. 457 - 457
    Journal articles | 2004
    Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98, http://dx.doi.org/10.1310/1FLN-8KFC-5HEQ-K19J
    Journal articles | 2004
    Tan E; Day RO; Brien JE, 2004, 'Stakeholder Opinions on the Implementation of Drug and Therapeutics Committee Decisions', Journal of Pharmacy Practice and Research, 34, pp. 178 - 182, http://dx.doi.org/10.1002/jppr2004343178
    Journal articles | 2003
    Day R, 2003, 'COX-2: Where are we in 2003? Distinction from NSAIDs becoming blurred', Arthritis Research and Therapy, 5, pp. 116 - 119
    Journal articles | 2003
    Day RO, 2003, 'Hypertension in the patient with arthritis: Have we underestimated its significance?', Journal of Rheumatology, 30, pp. 642 - 644
    Journal articles | 2003
    Day RO, 2003, 'Pharmaceutical health and rational use of medicines committee', Journal of Pharmacy Practice and Research, 33, pp. 87 - 89, http://dx.doi.org/10.1002/jppr200333287
    Journal articles | 2003
    Day RO, 2003, 'Where are we in 2003? Distinction from NSAIDs becoming blurred', Arthritis Research and Therapy, 5, pp. 116 - 119
    Journal articles | 2003
    Graham GG; Scott KF; Day RO, 2003, 'Tolerability of Paracetamol', Drugs, 63, pp. 43 - 46, http://dx.doi.org/10.2165/00003495-200363992-00007
    Journal articles | 2003
    Graham GG; Scott KF, 2003, 'Alcohol and paracetamol', Australian Prescriber, 27, pp. 14 - 15
    Journal articles | 2003
    Liauw WS; Day RO, 2003, 'Adverse event reporting in clinical trials: room for improvement', Medical Journal of Australia, 179, pp. 426 - 428
    Journal articles | 2003
    Sasongko L; Williams KM; Day RO; Mclachlan AJ, 2003, 'Human subcutaneous tissue distribution of fluconazole: comparison of microdialysis and suction blister techniques', British Journal of Pharmacology, 56, pp. 551 - 561, http://dx.doi.org/10.1046/j.1365-2125.2003.01930.x
    Journal articles | 2003
    Tan E; Day RO; Brien JE, 2003, 'Drug and therapeutics committees - are they fulfilling their potential to improve the quality use of medicines?', International Journal of Pharmacy Practice, 11, pp. 175 - 181, http://dx.doi.org/10.1211/0022357022205
    Journal articles | 2003
    Wren BG; Day RO; Mclachlan AJ; Williams KM, 2003, 'Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women', Climacteric, 6, pp. 104 - 111, http://dx.doi.org/10.1080/cmt.6.2.104.111
    Journal articles | 2002
    Barraclough D; Bertouch J; Brooks P; Brown MA; Cleland L; Clemens LE; Crowley SJ; Day RO; DeJager JP; Edmonds JP; Fletcher P; Franks GR; Harris DC; Horowitz JD; Johnston MD; Kerr SJ; Littlejohn GO; Macdonald GJ; McColl GJ; Sambrook PN; Shakib S; Verso MW; Yeomans ND, 2002, 'Considerations for the safe prescribing and use of COX-2-specific inhibitors', Medical Journal of Australia, 176, pp. 328 - 331
    Journal articles | 2002
    Carmichael SJ; Beal J; Day RO; Tett SE, 2002, 'Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate', Journal of Rheumatology, 29, pp. 2077 - 2083
    Journal articles | 2002
    Day R, 2002, 'Adverse reactions to TNF-α inhibitors in rheumatoid arthritis', Lancet, 359, pp. 540 - 541, http://dx.doi.org/10.1016/S0140-6736(02)07718-8
    Journal articles | 2002
    Day R, 2002, 'Another selective COX-2 inhibitor: More questions than answers?', Journal of Rheumatology, 29, pp. 1581 - 1582
    Journal articles | 2002
    Day RE; Higgins VJ; Rogers PJ; Dawes IW, 2002, 'Characterisation of the putative maltose transporters encoded by YDL247w and YJR160c', Yeast, 19, pp. 1015 - 1027, http://dx.doi.org/10.1002/yea.894
    Journal articles | 2002
    Day RE; Rogers PJ; Dawes IW; Higgins VJ, 2002, 'Molecular Analysis of Maltotriose Transport and Utilisation by Saccharomyces cerevisiae', Applied and Environmental Microbiology, 68, pp. 5326 - 5335, http://dx.doi.org/10.1128/AEM.68.11.5326-5335.2002
    Journal articles | 2002
    Edmonds JP; Day RO; Bertouch JV, 2002, 'The road to consensus: considerations for the safe use and prescribing of COX-2 specific inhibitors', Medical Journal of Australia, 176, pp. 332 - 334
    Journal articles | 2002
    Edmonds JP; Day RO; Bertouch JV, 2002, 'The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors - Reply', MEDICAL JOURNAL OF AUSTRALIA, 177, pp. 573 - 573, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04961.x
    Journal articles | 2002
    Graham GG; Graham RM; Day RO, 2002, 'Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol)', Current Pharmaceutical Design, 8, pp. 1063 - 1075, http://dx.doi.org/10.2174/1381612023394917
    Journal articles | 2002
    Vitry AI; Hurley E; Gazarian M; Kaye KI; Edmonds JP; Day RO; Bertouch JV, 2002, 'The road to consensus: Considerations for the safe use and prescribing of COX-2-specific inhibitors (multiple letters)', Medical Journal of Australia, 177, pp. 572 - 573, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04959.x
    Journal articles | 2001
    Brooks PM; Day RO, 2001, 'COX-2 inhibitors - In reply', MEDICAL JOURNAL OF AUSTRALIA, 174, pp. 368 - 369, http://dx.doi.org/10.5694/j.1326-5377.2001.tb143324.x
    Journal articles | 2001
    Brooks PM; Day RO, 2001, 'Drug safety module: Summary and recommendations', Journal of Rheumatology, 28, pp. 1192 - 1193
    Journal articles | 2001
    Journal articles | 2001
    Day RO; Mashford ML, 2001, 'Pharmacotherapeutics: what a difference five decades makes!', Medical Journal of Australia, 174, pp. 48 - 51
    Journal articles | 2001
    Day RO, 2001, 'Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: A rheumatologists perspective', Clinical and Experimental Rheumatology, 19, pp. 59 - 62
    Journal articles | 2001
    Lawrie MM; McKeough GN; Jones DB; Brooks PM; Day RO, 2001, 'COX-2 inhibitors (multiple letters)', Medical Journal of Australia, 174, pp. 367 - 369, http://dx.doi.org/10.5694/j.1326-5377.2001.tb143321.x
    Journal articles | 2001
    Lipani JA; Strand V; Johnson KA; Woodworth T; Furst DE; Singh G; Day RO; Brooks PM, 2001, 'OMERACT Drug Safety Working Party. A proposal for developing a large ptient population cohort for longterm safety monitoring in rheumatoid arthritis.', Journal of Rheumatology, pp. 1170 - 1173
    Journal articles | 2001
    Welch V; Singh G; Strand V; Fries JW; Boers M; Ramey D; Day RO; Brooks PM; Tugwell P; Clinch J; Kristjansson B, 2001, 'Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index', Journal of Rheumatology, 28, pp. 1188 - 1191
    Journal articles | 2001
    Williams KM; Cooper S; Parisis K; Handel M; Day RO, 2001, 'The skin suction blister: A human model of inflammation', Clinical Pharmacology and Therapeutics, 69
    Journal articles | 2001
    Woodworth T; Furst DE; Strand V; Kempeni J; Fenner H; Lau CS; Miller F; Day RO; Lipani JA; Brooks PM, 2001, 'Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group march 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies', Journal of Rheumatology, 28, pp. 1163 - 1169
    Journal articles | 2000
    Bombardier C; Laine L; Reicin A; Shapiro D; Burgos-Vargas R; Davis BE; Day RO; Ferraz MB; Hawkey CJ; Hochberg MC; Kvien T; Schnitzer TJ, 2000, 'Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis', New England Journal of Medicine, 343, pp. 1520 - 1528, http://dx.doi.org/10.1056/NEJM200011233432103
    Journal articles | 2000
    Brooks PM; Day RO, 2000, 'COX-2 inhibitors', Medical Journal of Australia, 173, pp. 433 - 436
    Journal articles | 2000
    Davies NP; Mclachlan AJ; Day RO; Williams KM, 2000, 'Clinical pharmacokinetics and pharmacodynamics of celecoxib: A selective cyclo-oxygenase-2 inhibitor.', Clinical Pharmacokinetics, 38, pp. 225 - 242, http://dx.doi.org/10.2165/00003088-200038030-00003
    Journal articles | 2000
    Day R, 2000, 'COX-2 Specific Inhibitors: Should I Prescribe Them?', Current Therapeutics, 41, pp. 9 - 11
    Journal articles | 2000
    Day R, 2000, 'In Reply', The Australian Journal of Hospital Pharmacy, 30, pp. 120 - 120, http://dx.doi.org/10.1002/jppr2000303120a
    Journal articles | 2000
    Day RO; Graham GG; Whelton A, 2000, 'The position of paracetamol in the world of analgesics', American Journal of Therapeutics, 7, pp. 51 - 54, http://dx.doi.org/10.1097/00045391-200007020-00002
    Journal articles | 2000
    Day RO; Graham GG; Whelton A, 2000, 'The position of paracetamol in the world of analgesics.', American Journal of Therapeutics, pp. 51 - 54
    Journal articles | 2000
    Day RO; Morrison B; Luza A; Castaneda O; Strusberg A; Nahir M; Helgetveit KB; Kress B; Daniels BA; Bolognese J; Krupa D; Seidenberg B; Ehrich EW, 2000, 'A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis', Archives of Internal Medicine, 160, pp. 1781 - 1787, http://dx.doi.org/10.1001/archinte.160.12.1781
    Journal articles | 2000
    Day RO, 2000, 'COX-2 Specific inhibitors and the hospital pharmacist', Australian Journal of Hospital Pharmacy, 30, pp. 41 - 43, http://dx.doi.org/10.1002/jppr200030241
    Journal articles | 2000
    Day RO, 2000, 'COX-2 Specific inhibitors. Safer anti-inflammatory therapy?', Medicine Today, pp. 31 - 38
    Journal articles | 2000
    Day RO, 2000, 'COX-2 inhibitors: When should they be prescribed?', Current Therapeutics, pp. 9 - 11
    Journal articles | 2000
    Day RO, 2000, 'How to make the most of a visit from a pharmaceutical company representative', Australian Prescriber, 23, pp. 97 - 99, http://dx.doi.org/10.18773/austprescr.2000.114
    Journal articles | 2000
    Lipani JA; Strand V; Woodworth T; Furst DE; Singh G; Johnson KA; Day RO; Brooks PM, 2000, 'A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis', Journal of Rheumatology, 27, pp. 827 - 830, https://www.ncbi.nlm.nih.gov/pubmed/10782801
    Journal articles | 2000
    O Sullivan AJ; Kennedy M; Day RO; Case J; Corrigan B; Wodak AD, 2000, 'Medical assessment of anabolic-androgenic steroid users', Medical Journal of Australia, 173, pp. 323 - 327
    Journal articles | 2000
    Peterson G; Day R, 2000, 'COX-2 specific inhibitors and cancer (multiple letters)', Australian Journal of Hospital Pharmacy, 30, pp. 120, http://dx.doi.org/10.1002/jppr2000303120
    Journal articles | 2000
    Tett S; Cutler D; Beck C; Day RO, 2000, 'Concentration effect relationship of hydroxychloroquine in patients with rheumatoid arthritis - A prospective, dose-ranging study', Journal of Rheumatology, 27, pp. 1656 - 1660
    Journal articles | 2000
    Welch SA; Novy M; Preiz P; Quinn DI; Whicker SD; Brown S; Day RO, 2000, 'Promoting rational prescribing by emergency department junior medical officers', Australian Journal of Hospital Pharmacy, 30, pp. 262 - 270, http://dx.doi.org/10.1002/jppr2000306262
    Journal articles | 1999
    Brooks P; Emery P; Evans JF; Fenner H; Hawkey CJ; Patrono C; Smolen J; Breedveld F; Day R; Dougados M; Ehrich EW; Gijon-Baños J; Kvien TK; Van Rijswijk MH; Warner T; Zeidler H, 1999, 'The International Consensus Meeting on the Mode of Action of COX-2 Inhibition, 5-6 December 1997: Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2', Rheumatology, 38, pp. 779 - 788, http://dx.doi.org/10.1093/rheumatology/38.8.779
    Journal articles | 1999
    Brooks PM; Emery P; Evans JF; Fenner H; Hawkey CJ; Patrono C; Smolen J; Breedveld F; Day RO; Dougados M; Ehrich EW; Gijon-Banos J; Kvien T; Van Rijswijk MH; Warner T; Zeidler H, 1999, 'Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2', Rheumatology, 38, pp. 779 - 788, https://www.ncbi.nlm.nih.gov/pubmed/10501435
    Journal articles | 1999
    Browne GS; Nelson CJ; Nguyen TM; Ellis B; Day RO; Williams KM, 1999, 'Stereoselective and substrate-dependent inhibition of hepatic mitochondrial B-oxidation and oxidative phosphorylation by the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen and ketorolac', Biochemical Pharmacology, 57, pp. 837 - 844, http://dx.doi.org/10.1016/S0006-2952(98)00342-6
    Journal articles | 1999
    Day RO; Brooks PM; Petersen M; Conaghan P, 1999, 'Efficacy and safety of intraarticular hyaluronic acid in osteoarthritis', Clinical Pharmacology and Therapeutics, 65, pp. 172, http://dx.doi.org/10.1016/S0009-9236(99)80220-3
    Journal articles | 1999
    Day RO; Mclachlan AJ; Graham GG; Williams KM, 1999, 'Pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid', Clinical Pharmacokinetics, 36, pp. 191 - 210, http://dx.doi.org/10.2165/00003088-199936030-00002
    Journal articles | 1999
    Day RO; Rowett D; Roughead EE, 1999, 'Towards the safer use of non-steroidal anti-inflammatory drugs', Journal of Quality in Clinical Practice, 19, pp. 51 - 53, http://dx.doi.org/10.1046/j.1440-1762.1999.00287.x
    Journal articles | 1999
    Erb K; Brugger R; Williams KM; Geisslinger G, 1999, 'Stereoselective disposition of tiaprofenic acid enantiomers in rats', Chirality, 11, pp. 103 - 108
    Journal articles | 1999
    Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks PM; Day RO; Strand V; Wells G, 1999, 'Patient based methods for assessing adverse events in clinical trials in Rheumatology. Progress report for the Omeract Drug Toxicity Working Party', Journal of Rheumatology, 26, pp. 207 - 209
    Journal articles | 1999
    Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks PM; Day RO; Strand V; Wells G, 1999, 'Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress for the OMERACT drug toxicity working party', Journal of Rheumatology, pp. 207 - 209
    Journal articles | 1999
    Graham GG; Day RO; Milligan MK; Ziegler JB; Kettle AJ, 1999, 'Current Concepts of the actions of paracetamol (acetaminophen) and NSAIDS', Inflammopharmacology, 7, pp. 255 - 263, http://dx.doi.org/10.1007/s10787-999-0008-x
    Journal articles | 1999
    Ray JE; Marriott D; Day RO, 1999, 'MANAGING ANTI-TUBERCULOSIS DRUG THERAPY BY THERAPEUTIC DRUG MONITORING OF ISONIAZID AND RIFAMPICIN.', Therapeutic Drug Monitoring, 21, pp. 456 - 456, http://dx.doi.org/10.1097/00007691-199908000-00119
    Journal articles | 1999
    Williams KM; Day RO; Roberts LK; Harbin JA, 1999, 'A comparison of the efficacy of α-ketobutyric acid (KBA), nordihidro-guaiaretic acid (NDGA), salicylic acid (SA), and placebo (P) in the accelerated removal of corns', Clinical Pharmacology and Therapeutics, 65, pp. 122, http://dx.doi.org/10.1016/S0009-9236(99)80022-8
    Journal articles | 1998
    Bramley-Moore S; Wodak AD; Day RO; Lauchlan RL, 1998, 'Patterns of analgesic prescribing for patients with chronic non-malignant pain in NSW', Australian Journal of Hospital Pharmacy, pp. 83 - 88
    Journal articles | 1998
    Bramley-Moore S; Wodak AD; Day RO; Lauchlan RL, 1998, 'Patterns of analgesic prescribing patients with chronic non-malignant pain in NSW', Australian Journal of Hospital Pharmacy, 28, pp. 83 - 88
    Journal articles | 1998
    Brooks PM, 1998, 'Pharmaceutical company promotion: striking a balance', Australian and New Zealand Journal of Medicine, 28, pp. 291 - 293, http://dx.doi.org/10.1111/j.1445-5994.1998.tb01950.x
    Journal articles | 1998
    Carmody JJ; Walker JS; Sheather-Reid RB; Vial JH; Day RO, 1998, 'Non-steroidal anti-inflammatory drugs (NSAIDs): Support for the concept of 'responders' and 'non-responders', NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 358, pp. R450 - R450, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000075207800302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1998
    Day RO; Williams KM; Campbell TJ, 1998, 'The death of a normal healthy volunteer in a human research project: implications for Australian clinical research', Medical Journal of Australia, 168, pp. 449 - 451
    Journal articles | 1998
    Quinn DI; Day RO, 1998, 'A GP`s guide to clinically important drug interactions', Modern Medicine of Australia, 41, pp. 89 - 103
    Journal articles | 1998
    Quinn DI; Day RO, 1998, 'Drug Interactions Alert', First Ed., pp. 38
    Journal articles | 1998
    Quinn DI; Markus R; Day RO, 1998, 'Antiepileptic therapy', Current Therapeutics, 39, pp. 23 - 37
    Journal articles | 1998
    Scheuerer S; Williams KM; Brugger R; Mclachlan AJ; Brune K; Day RO; Geisslinger G, 1998, 'Effect of clofibrate on the chiral inversion of ibuprofen in rats', Journal of Pharmacology and Experimental Therapeutics, 284, pp. 1132 - 1138
    Journal articles | 1998
    Weekes LM; Brooks C; Day RO, 1998, 'Indicators for Drug and Therapeutics Committees', British Journal of Clinical Pharmacology, 45, pp. 393 - 398, http://dx.doi.org/10.1046/j.1365-2125.1998.00699.x
    Journal articles | 1998
    Weekes LM; Brooks C; Day RO, 1998, 'Indicators for Drug and Therapeutics Committees', British Journal of Clinical Pharmacology, 45, pp. 393 - 398, http://dx.doi.org/10.1046/j.1365-2125.1998.00699.x
    Journal articles | 1998
    Weekes LM; Day RO, 1998, 'The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees: an Australian perspective.', Drug Safety, 18, pp. 153 - 159, http://dx.doi.org/10.2165/00002018-199818030-00001
    Journal articles | 1997
    Bellamy N; Bachmeier C; Brooks PM; Browne CD; Cohen ML; March L; Conaghan PG; Day RO; Campbell J, 1997, 'Osteoarthritis antirheumatic drug trials: Effects of a standardized instructional videotape on the reliability of observer-dependent outcome measures', Inflammopharmacology, 5, pp. 285 - 295, http://dx.doi.org/10.1007/s10787-997-0006-9
    Journal articles | 1997
    Birkett DJ; Miners JO; Valente KJ; Lillywhite KJ; Day RO, 1997, '1-Methylxanthine Derived from Caffeine as a Pharmacodynamic Probe of', British Journal of Clinical Pharmacology, 43, pp. 197 - 200
    Journal articles | 1997
    Conaghan PG; Crotty M; Oh E; Day RO; Brooks PM, 1997, 'Anti-rheumatic drug-prescribing behaviour of australasian rheumatologists 1984-1994.', British Journal of Rheumatology, 36, pp. 487 - 490
    Journal articles | 1997
    Day R; Mant A; Whicker S; Primrose J, 1997, 'Quality assessment in therapeutics: Antibiotic use', Clinical Pharmacology and Therapeutics, 61, pp. 214
    Journal articles | 1997
    Day R; Mant A; Whicker S; Primrose J, 1997, 'Quality assessment in therapeutics: Antibiotic use.', CLINICAL PHARMACOLOGY & THERAPEUTICS, 61, pp. PII79 - PII79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WJ68400306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1997
    Day RE; Gero AM, 1997, 'Stimulated transport of hypoxanthine in Crithidia luciliae: Relationship to purine stress', Parasitology, 114, pp. 19 - 27, http://dx.doi.org/10.1017/S003118209600827X
    Journal articles | 1997
    Donnelly R; Williams KM; Baker A; Badcock CA; Day RO; Seale JP, 1997, 'Effects of budesonide and fluticasoue on 24-hour plasma cortisol: A dose-response study.', American Journal of Respiratory and Critical Care Medicine, 156, pp. 1746 - 1751, http://dx.doi.org/10.1164/ajrccm.156.6.9703003
    Journal articles | 1997
    Gero AM; Day RE; Hall ST, 1997, 'Stimulated transport of adenosine, guanosine and hypoxanthine in Crithidia luculiae: Metabolic machinery in which the parasite has a distinct advantage over the host', International Journal for Parasitology, 27, pp. 241 - 249, http://dx.doi.org/10.1016/S0020-7519(96)00153-1
    Journal articles | 1997
    Lehmann T; Day RO; Brooks PM, 1997, 'Rheumatology 12. Toxicity of antirheumatic', Medical Journal of Australia, 166, pp. 378 - 383, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WT68100013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Journal articles | 1997
    Lehmann T; Day RO; Brooks PM, 1997, 'Toxicity of antirheumatic drugs', Medical Journal of Australia, 166, pp. 378 - 383, http://dx.doi.org/10.5694/j.1326-5377.1997.tb123171.x
    Journal articles | 1997
    Quinn DE; Wodak AD; Day RO, 1997, 'Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.', Clinical Pharmacokinetics, pp. 344 - 400
    Journal articles | 1997
    Quinn DE; Wodak AD; Day RO, 1997, 'Pharmocokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users', Clinical Pharmacokinetics, pp. 344 - 400
    Journal articles | 1997
    Shackel NA; Day RO; Kellett B; Brooks PM, 1997, 'Copper-salicylate gel for pain relief in osteoarthritis - a randomised controlled trial.', Medical Journal of Australia, 167, pp. 134 - 136
    Journal articles | 1997
    Walker JS; Sheather-Reid RB; Carmody JJ; Vial JH; Day RO, 1997, 'Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis - support', Arthritis Care & Research, pp. 1944 - 1954
    Journal articles | 1997
    Walker JS; Sheather-Reid RB; Carmody JJ; Vial JH; Day RO, 1997, 'Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: Support for the concept of 'responders' and 'nonresponders'', Arthritis and Rheumatism, 40, pp. 1944 - 1954, http://dx.doi.org/10.1002/art.1780401105
    Journal articles | 1997
    Walker JS; Sheather-Reid RB; Carmody JJ; Vial JH; Day RO, 1997, 'Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders".', Arthritis Rheum, 40, pp. 1944 - 1954, http://dx.doi.org/10.1002/art.1780401105
    Journal articles | 1997
    Williams KM; Turner J; Geisslinger G; Day RO, 1997, 'The suction blister as an in vivo model of inflammation: Interblister variability and preliminary studies of the disposition of methotrexate', CLINICAL PHARMACOLOGY & THERAPEUTICS, 61, pp. PI93 - PI93, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WJ68400093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1997
    Williams KM; Turner J; Geisslinger G; Day RO, 1997, 'The suction blister as an in vivo model of inflammation: Interblister variability and preliminary studies of the disposition of methotrexate', Clinical Pharmacology and Therapeutics, 61, pp. 160
    Journal articles | 1997
    Wodak AD; Quinn DE; Day RO, 1997, 'Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users.', Clinical Pharmacokinetics, 33, pp. 344 - 400, http://dx.doi.org/10.2165/00003088-199733050-00003
    Journal articles | 1996
    Carey DL; Day RO; Bowden FJ, 1996, 'Common drug interactions in HIV medicine', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 605 - 606, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122205.x
    Journal articles | 1996
    Carey DL; Day RO; Bowden FJ, 1996, 'Managing HIV, Quick reference:drug interactions. Common drug interactions in HIV medicine', Medical Journal of Australia, 164, pp. 605 - 606
    Journal articles | 1996
    Carey DL; Day RO; Bowden FJ, 1996, 'Managing HIV. Common drug interactions in HIV medicine.', Med J Aust, 164, pp. 605 - 606, https://www.ncbi.nlm.nih.gov/pubmed/8637465
    Journal articles | 1996
    Day RO; Brown S; Weekes LM, 1996, 'Drug committees - the key to quality use of medicines?', Australian Journal of Hospital Pharmacy, pp. 622 - 623
    Journal articles | 1996
    Day RO; Williams KM; Geisslinger G, 1996, 'Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations - Reply', JOURNAL OF RHEUMATOLOGY, 23, pp. 1827 - 1828, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VL78300035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1996
    Graham GG; Day RO; Wong H; Mclachlan AJ; Bergendal L; Miners JO; Birkett DJ, 1996, 'Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects', British Journal of Clinical Pharmacology, 41, pp. 299 - 304
    Journal articles | 1996
    Handel ML; Watts CG; Silversten S; Day RO; Sutherland RL, 1996, 'D-Penicillamine causes free-radical-dependent inactivation of activator protein-1 DNA binding', Molecular Pharmacology, pp. 1 - 5
    Journal articles | 1996
    Handel ML; Watts CKW; Sivertsen S; Day RO; Sutherland RL, 1996, 'D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding', Molecular Pharmacology, 50, pp. 501 - 505
    Journal articles | 1996
    Johnson AG; Nguyen TM; Day RO, 1996, 'Evaluation of the Takeda TM-2420 in the Elderly', Journal of Hypertension, 10, pp. 61 - 61
    Journal articles | 1996
    Johnson AG; Nguyen TM; Owe-Young R; Williamson DJ; Day RO, 1996, 'Potential mechanisms by which nonsteroidal anti-inflammatory drugs elevate blood pressure: the role of endothelin-I', Journal of Hypertension, 10, pp. 257 - 261
    Journal articles | 1996
    Mcmanus PA; Primrose JG; Henry D; Birkett DJ; Lindner J; Day RO, 1996, 'Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994, A report from the Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory', Medical Journal of Australia, 164, pp. 589 - 592
    Journal articles | 1996
    Simkin PA; Bassett JE; Lapicque F; Bertin P; Netter P; Day RO; Williams KM; Geisslinger G, 1996, 'Naproxen concentration in plasma and synovial fluid and effects on prostanoid concentrations [1]', Journal of Rheumatology, 23, pp. 1826 - 1828
    Journal articles | 1996
    Tett S; Day RO; Cutler D, 1996, 'Hydroxychloroquine relative bioavailability: within subject reproducibility', British Journal of Clinical Pharmacology, 41, pp. 244 - 246, http://dx.doi.org/10.1111/j.1365-2125.1996.tb00190.x
    Journal articles | 1996
    Walker JS; Day RO; Moore UJ; Marsh VR; Ashton CH; Seymour RA, 1996, 'Experimental pain techniques [2]', British Journal of Clinical Pharmacology, 41, pp. 349 - 350
    Journal articles | 1996
    Walker JW; Chandler A; Wilson J; Binder W; Day RO, 1996, 'Effect of u-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats', Inflammation Research, 45, pp. 557 - 563, http://dx.doi.org/10.1007/BF02342227
    Journal articles | 1996
    Walker JW; Day RO, 1996, 'Experimental pain techniques', British Journal of Clinical Pharmacology, pp. 246 - 246
    Journal articles | 1996
    Walker JW; Lockton A; Nguyen L; Day RO, 1996, 'Effect of single and multiple doses of ibuprofen in chronic spinal pain patients', Analgesia, 2, pp. 93 - 101
    Journal articles | 1995
    BOERS M; BROOKS P; TUGWELL P; BAKER P; BOMBARDIER C; DAY R; DRUMMOND M; VANDERLINDEN S; OBRIEN B; SILMAN A; STRAND V; WELLS G, 1995, 'OUTCOME MEASURES IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - ACKNOWLEDGMENTS', JOURNAL OF RHEUMATOLOGY, 22, pp. 1433 - 1433, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995RG24600046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1995
    Brooks PM; Day R, 1995, 'Treatment issues', Bailliere's Clinical Rheumatology, 9, pp. 231 - 245, http://dx.doi.org/10.1016/S0950-3579(05)80158-X
    Journal articles | 1995
    Brooks PM; Day R, 1995, 'Tropical rheumatology. Treatment issues.', Baillieres Clin Rheumatol, 9, pp. 231 - 245, http://dx.doi.org/10.1016/s0950-3579(05)80158-x
    Journal articles | 1995
    Brooks PM; Day RO, 1995, 'Toxicity of antirheumatic drugs. Toxicity Workgroup Leaders.', J Rheumatol, 22, pp. 998 - 999, https://www.ncbi.nlm.nih.gov/pubmed/8587098
    Journal articles | 1995
    Brooks PM; Day RO, 1995, 'Workshop report - Part 1: Toxicity of antirheumatic drugs', Journal of Rheumatology, 22, pp. 998 - 999
    Journal articles | 1995
    Conaghan PG; Quinn DI; Brooks PM; Day RO, 1995, 'Hazards of low dose methotrexate', Australian and New Zealand Journal of Medicine, 25, pp. 670 - 673, http://dx.doi.org/10.1111/j.1445-5994.1995.tb02851.x
    Journal articles | 1995
    Day RO; Francis H; Vial J; Geisslinger G; Williams KM, 1995, 'Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations', Journal of Rheumatology, 22, pp. 2295 - 2303
    Journal articles | 1995
    Day RO; Francis H; Vial JH; Geisslinger G; Williams KM, 1995, 'Pharmacokinetics and pharmacodynamics of naproxen in synovial fluid and plasma', Journal of Rheumatology, pp. 2295 - 2303
    Journal articles | 1995
    Day RO; Geisslinger G; Paull P; Williams KM, 1995, 'The effect of tenoxicam on tolbutamide pharmacokinetics and glucose concentrations in healthy volunteers', International journal of clinical pharmacology, 33, pp. 308 - 310
    Journal articles | 1995
    Day RO; Quinn DE; Conaghan PG; Tett S, 1995, 'Adverse drug reactions and their measurement in the rheumatic diseases', Journal of Rheumatology, 22, pp. 983 - 988
    Journal articles | 1995
    Handel ML; Watts CKW; DeFazio A; Day RO; Sutherland RL, 1995, 'Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos', Proceedings of the National Academy of Sciences of the United States of America, 92, pp. 4497 - 4501, http://dx.doi.org/10.1073/pnas.92.10.4497
    Journal articles | 1995
    JOHNSON AG; NGUYEN TV; DAY RO, 1995, 'NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND HIGH BLOOD-PRESSURE - RESPONSE', ANNALS OF INTERNAL MEDICINE, 122, pp. 397 - 397, http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00028
    Journal articles | 1995
    Johnson AG; Quinn DE; Day RO, 1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 163, pp. 155 - 158, http://dx.doi.org/10.1136/bmj.f3195
    Journal articles | 1995
    Johnson AG; Quinn DI; Day RO, 1995, 'Non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 163, pp. 155 - 158, http://dx.doi.org/10.5694/j.1326-5377.1995.tb127972.x
    Journal articles | 1995
    Quinn DE; Day RO, 1995, 'Clinically Important Drug Interactions.', Drug Safety, 12, pp. 393 - 452
    Journal articles | 1995
    Quinn DE; Day RO, 1995, 'Drug interactions of clinical importance: an updated guide', Drug Safety, 12, pp. 393 - 452, http://dx.doi.org/10.2165/00002018-199512060-00005
    Journal articles | 1995
    Radack K; Johnson AG; Nguyen TV; Day RO, 1995, 'Nonsteroidal anti-inflammatory drugs and high blood pressure [8]', Annals of Internal Medicine, 122, pp. 397, http://dx.doi.org/10.7326/0003-4819-122-5-199503010-00027
    Journal articles | 1994
    Conaghan PG; Day RO, 1994, 'Risks and Benefits of Drugs Used in the Management and Prevention of Gout', Drug Safety, 11, pp. 252 - 258, http://dx.doi.org/10.2165/00002018-199411040-00004
    Journal articles | 1994
    Day R; Geisslinger G; Paull P; Williams K, 1994, 'Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.', British Journal of Clinical Pharmacology, 37, pp. 79 - 81, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04244.x
    Journal articles | 1994
    Day R; Quinn D, 1994, 'Adverse Interaction Between Warfarin and Indomethacin', Drug Safety, 11, pp. 213 - 214, http://dx.doi.org/10.2165/00002018-199411030-00006
    Journal articles | 1994
    Day R; Wodak A; Chesher G, 1994, 'Cannabis and suicide [3]', Medical Journal of Australia, 160, pp. 731, http://dx.doi.org/10.5694/j.1326-5377.1994.tb125924.x
    Journal articles | 1994
    Day R, 1994, 'Meeting report: Asian conference on clinical pharmacology and therapeutics', British Journal of Clinical Pharmacology, 38, pp. 197 - 198
    Journal articles | 1994
    Day RO; Birkett DJ; Hicks M; Miners JO; Graham GG; Brooks PM, 1994, 'New Uses for Allopurinol', Drugs, 48, pp. 339 - 344, http://dx.doi.org/10.2165/00003495-199448030-00002
    Journal articles | 1994
    Johnson AG; Nguyen TV; Day RO, 1994, 'Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis', Annals of Internal Medicine, 121, pp. 289 - 300, http://dx.doi.org/10.7326/0003-4819-121-4-199408150-00011
    Journal articles | 1994
    Johnson AG; Nuygen TV; Day RO, 1994, 'Evaluation of the accuracy and reproducibility of ambulatory blood pressure monitoring in the very elderly using the Takeda TM-2420', Journal of Human Hypertension, 8, pp. 433 - 439
    Journal articles | 1994
    Johnson AG; Seidemann P; Day RO, 1994, 'NSAID-related adverse drug interactions with clinical relevance. An update', International Journal of Clinical Pharmacology and Therapeutics, 32, pp. 509 - 532
    Journal articles | 1994
    LAU ATS; GRAHAM GG; DAY RO; PERRY MA, 1994, 'EFFECT OF HCL CONCENTRATION ON GASTRIC BLOOD-FLOW IN ACUTE ASPIRIN-INDUCED GASTRIC-ULCERS IN THE CAT', GASTROENTEROLOGY, 106, pp. A123 - A123, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994NH90900484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1994
    McLachlan AJ; Tett SE; Cutler DJ; Day RO, 1994, 'Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate', Chirality, 6, pp. 360 - 364, http://dx.doi.org/10.1002/chir.530060421
    Journal articles | 1994
    Mclachlan AJ; Tett SE; Cutler DJ; Day RO, 1994, 'Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis', Rheumatology, 33, pp. 235 - 239, http://dx.doi.org/10.1093/rheumatology/33.3.235
    Journal articles | 1994
    Parnham MJ; Day RO; van den Berg WB, 1994, 'Inflammation '93', Agents and Actions, 41, http://dx.doi.org/10.1007/BF01987616
    Journal articles | 1994
    Seideman P; Lohrer F; Graham G; Duncan M; Williams K; Day R, 1994, 'The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid.', British Journal of Clinical Pharmacology, 38, pp. 221 - 227, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04345.x
    Journal articles | 1994
    Tett SE; McLachlan AJ; Cutler DJ; Day RO, 1994, 'Pharmacokinetics and pharmacodynamics of hydroxychloroquine enantiomers in patients with rheumatoid arthritis receiving multiple doses of racemate', Chirality, 6, pp. 355 - 359, http://dx.doi.org/10.1002/chir.530060420
    Journal articles | 1994
    Walker J; Nguyen T; Day R, 1994, 'Clinical response to non‐steroidal anti‐inflammatory drugs in urate‐ crystal induced inflammation: a simultaneous study of intersubject and intrasubject variability.', British Journal of Clinical Pharmacology, 38, pp. 341 - 347, http://dx.doi.org/10.1111/j.1365-2125.1994.tb04364.x
    Journal articles | 1993
    Brooks PM; Day RO; Graham GG; Williams KM, 1993, 'Preface', Agents and Actions, 44
    Journal articles | 1993
    DAY RO; NGUYEN T; WILLIAMS KM, 1993, 'TENOXICAM DOSE CONCENTRATION RESPONSE RELATIONSHIP IN RHEUMATOID-ARTHRITIS (RA)', CLINICAL PHARMACOLOGY & THERAPEUTICS, 53, pp. 152 - 152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KP26900067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1993
    Day RO; Brooks PM; Williams KM; Graham GG, 1993, 'Meeting report: Third world conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992', Agents and Actions, 38
    Journal articles | 1993
    Day RO; Brooks PM; Williams KM; Graham GG, 1993, 'Third World conference on variability in response to anti-rheumatic drugs, Singapore, July 22-24, 1992.', Agents and actions, 38, http://dx.doi.org/10.1007/bf01976204
    Journal articles | 1993
    Day RO; Wacher T; Cairns D; Conners G; Mcgrath M, 1993, 'Nailfold capillary circulation in osteoarthritis', Rheumatology, 32, pp. 1062 - 1065, http://dx.doi.org/10.1093/rheumatology/32.12.1062
    Journal articles | 1993
    Day RO, 1993, 'Variability in response to NSAIDs: What progress?', Agents and Actions, 44, pp. 3 - 6
    Journal articles | 1993
    Diamond HS; Fitzgerald LL; Day R, 1993, 'An analysis of the cost and revenue of an expanded medical residency', Journal of General Internal Medicine, 8, pp. 614 - 618, http://dx.doi.org/10.1007/BF02599717
    Journal articles | 1993
    Handel ML; Sivertsen S; Watts CKW; Day RO; Sutherland RL, 1993, 'Comparative effects of gold on the interactions of transcription factors with DNA', Agents and Actions, 44, pp. 219 - 223
    Journal articles | 1993
    Hicks M; Wong LS; Day RO, 1993, 'Identification of products from oxidation of uric acid induced by hydroxyl radicals', Free Radical Research, 18, pp. 337 - 351, http://dx.doi.org/10.3109/10715769309147501
    Journal articles | 1993
    Hicks M; Wong LS; Day RO, 1993, 'Suitability of reverse-phase columns from different sources for separation of uric acid from its oxidation products', Analytical Biochemistry, 210, pp. 428 - 430, http://dx.doi.org/10.1006/abio.1993.1221
    Journal articles | 1993
    Johnson AG; Seideman P; Day RO, 1993, 'Adverse Drug Interactions with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Recognition, Management and Avoidance', Drug Safety, 8, pp. 99 - 127, http://dx.doi.org/10.2165/00002018-199308020-00002
    Journal articles | 1993
    Kot TV; Day RO; Brooks PM, 1993, 'Preventing acute gout when starting allopurinol therapy. Colchicine or NSAIDs?', Medical Journal of Australia, 159, pp. 182 - 184, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137784.x
    Journal articles | 1993
    McLACHLAN AJ; TETT SE; CUTLER DJ; DAY RO, 1993, 'Absorption and in vivo dissolution of hydroxycholoroquine in fed subjects assessed using deconvolution techniques', British Journal of Clinical Pharmacology, 36, pp. 405 - 411, http://dx.doi.org/10.1111/j.1365-2125.1993.tb00388.x
    Journal articles | 1993
    McLachlan A; Tett S; Cutler D; Day R, 1993, 'Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.', British Journal of Clinical Pharmacology, 36, pp. 78 - 81, http://dx.doi.org/10.1111/j.1365-2125.1993.tb05897.x
    Journal articles | 1993
    McLachlan A; Tett S; Day R; Cutler D, 1993, 'Interpretation of chloroquine pharmacokinetic data', European Journal of Clinical Pharmacology, 44, pp. 407 - 408, http://dx.doi.org/10.1007/BF00316484
    Journal articles | 1993
    Tett S; McLachlan A; Day R; Cutler D, 1993, 'Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine', Agents and Actions, 44, pp. 145 - 150
    Journal articles | 1993
    Tett SE; Day RO; Cutler DJ, 1993, 'Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis - A cross sectional study', Journal of Rheumatology, 20, pp. 1874 - 1879
    Journal articles | 1993
    Tett SE; Day RO; Lauchlan R, 1993, 'Clinical pharmacy and clinical pharmacology', Australian Journal of Hospital Pharmacy, 23, pp. 207 - 210
    Journal articles | 1993
    WALKER JS; ARROYO JF; NGUYEN T; DAY RO, 1993, 'Analgesic efficacy of non‐steroidal anti‐inflammatory drugs in experimental pain in humans', British Journal of Clinical Pharmacology, 36, pp. 417 - 425, http://dx.doi.org/10.1111/j.1365-2125.1993.tb00390.x
    Journal articles | 1993
    Walker JS; Knihinicki RD; Seideman P; Day RO, 1993, 'Pharmacokinetics of ibuprofen enantiomers in plasma and suction blister fluid in healthy volunteers', Journal of Pharmaceutical Sciences, 82, pp. 787 - 790, http://dx.doi.org/10.1002/jps.2600820806
    Journal articles | 1993
    Williams KM; Day RO; Breit SN, 1993, 'Biochemical actions and clinical pharmacology of anti-inflammatory drugs', Advances in Drug Research, 24, pp. 121 - 198
    Journal articles | 1992
    Carey DL; Day RO; Cairns DR; Pearce GA; Wodak AD; Lauchlan RL, 1992, 'An attempt to influence hypnotic and sedative drug use', Medical Journal of Australia, 156, pp. 389 - 392+396, http://dx.doi.org/10.5694/j.1326-5377.1992.tb139841.x
    Journal articles | 1992
    Day RO; Henry DA; Muirden KD; Yeomans ND; Brooks PM; Stiel D; Prichard PJ, 1992, 'Non-steroidal anti-inflammatory drug induced upper gastrointestinal haemorrhage and bleeding', Medical Journal of Australia, 157, pp. 810 - 812
    Journal articles | 1992
    EBRINGER R; AHERN M; THOMAS D; GRIFFITHS H; OCALLAGHAN J; LITTLEJOHN G; LEWIS D; HAZELTON R; BARRACLOUGH D; STOCKMAN A; TRAVERS R; GLASS J; MAJOR G; RATNARAJAH S; BROOKS P; CARR G; LAURENT R; MCNAUGHT P; NEEDS C; POTTER S; SCHRIEBER L; DEJAGER J; JOHNSON F; PORTEK I; BROWN C; DAY R; SAMBROOK P; BROOK A; TYMMS K; CAIRNS D, 1992, 'SULFASALAZINE IN EARLY RHEUMATOID-ARTHRITIS - THE AUSTRALIAN MULTICENTER CLINICAL-TRIAL GROUP', JOURNAL OF RHEUMATOLOGY, 19, pp. 1672 - 1677, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992JY69000005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1992
    Hicks M; Wong LS; Day RO, 1992, 'Antioxid ant activity of propylthiouracil', Biochemical Pharmacology, 43, pp. 439 - 444, http://dx.doi.org/10.1016/0006-2952(92)90561-V
    Journal articles | 1992
    LAU ATS; GRAHAM GG; DAY RO; PERRY MA, 1992, 'EFFECT OF ASPIRIN ON ULCER SITE BLOOD-FLOW IN CAT STOMACHS', AMERICAN JOURNAL OF PHYSIOLOGY, 263, pp. G155 - G160, http://dx.doi.org/10.1152/ajpgi.1992.263.2.G155
    Journal articles | 1992
    Lau AT; Graham GG; Day RO; Perry MA, 1992, 'Effect of aspirin on ulcer site blood flow in cat stomachs.', Am J Physiol, 263, pp. G155 - G160, http://dx.doi.org/10.1152/ajpgi.1992.263.2.G155
    Journal articles | 1992
    Lau ATS; Graham GG; Day RO; Perry MA, 1992, 'Effect of aspirin on ulcer site blood flow in cat stomachs', American Journal of Physiology - Gastrointestinal and Liver Physiology, 263, http://dx.doi.org/10.1152/ajpgi.1992.263.2.g155
    Journal articles | 1992
    Leibbrandt DM; Day RO; Armour C; Clowes C; Day R; Deans K; Eckert G; Gridneff G; Hampson J; Henry D; Higgins G; Hobbes J; Johnson G; Kaye K; Kelly M; Kirkwood L; Lauchlan R; Liebbrandt D; McDougall A, 1992, 'Cyclosporin and calcium channel blockers: An exploitable drug interaction?', Medical Journal of Australia, 157, pp. 296 - 297, http://dx.doi.org/10.5694/j.1326-5377.1992.tb137177.x
    Journal articles | 1992
    STUARTHARRIS RC; LAUCHLAN R; DAY R, 1992, 'THE CLINICAL-APPLICATION OF THE INTERFERONS - A REVIEW', MEDICAL JOURNAL OF AUSTRALIA, 156, pp. 869 - 872, http://dx.doi.org/10.5694/j.1326-5377.1992.tb137004.x
    Journal articles | 1992
    Sandhu GS; Day RO, 1992, 'Factors affecting prescribing in general practice - A role play', Medical Journal of Australia, 157, pp. 621 - 622, http://dx.doi.org/10.5694/j.1326-5377.1992.tb137406.x
    Journal articles | 1992
    Steadman CJ; Day RO; Henry DA; Muirden KD; Yeomans ND; Brooks PM; Stiel D; Prichard PJ, 1992, 'Prophylaxis against NSAID-induced ulcers', Medical Journal of Australia, 157, pp. 801 - 803
    Journal articles | 1992
    Tett SE; Cutler DJ; Day RO, 1992, 'Bioavailability of hydroxychloroquine tablets assessed with deconvolution techniques', Journal of Pharmaceutical Sciences, 81, pp. 155 - 159, http://dx.doi.org/10.1002/jps.2600810211
    Journal articles | 1992
    Zhao B; Geisslinger G; Hall I; Day RO; Williams KM, 1992, 'The effect of the enantiomers of ibuprofen and flurbiprofen on the β‐oxidation of palmitate in the rat', Chirality, 4, pp. 137 - 141, http://dx.doi.org/10.1002/chir.530040302
    Journal articles | 1991
    Birkett D; Miners J; Day R, 1991, '1‐Methylxanthine derived from theophylline as an in vivo biochemical probe of allopurinol effect.', British Journal of Clinical Pharmacology, 32, pp. 238 - 241, http://dx.doi.org/10.1111/j.1365-2125.1991.tb03888.x
    Journal articles | 1991
    Brooks PM; Day RO, 1991, 'Nonsteroidal Antiinflammatory Drugs — Differences and Similarities', New England Journal of Medicine, 324, pp. 1716 - 1725, http://dx.doi.org/10.1056/NEJM199106133242407
    Journal articles | 1991
    Day R; Seideman P, 1991, 'NSAIDs, musculoskeletal disorders and gastrointestinal adverse effects.', Australian family physician, 20, pp. 1735 - 1737
    Journal articles | 1991
    Day RO; Williams KM; Graham S; Handel M, 1991, 'The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma', Arthritis & Rheumatism, 34, pp. 751 - 760, http://dx.doi.org/10.1002/art.1780340617
    Journal articles | 1991
    FUGER KE; WIENBECK M; MANN J, 1991, 'NONSTEROIDAL ANTIINFLAMMATORY DRUGS - DIFFERENCES AND SIMILARITIES', NEW ENGLAND JOURNAL OF MEDICINE, 325, pp. 1653 - 1653, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991GR77000013&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1991
    Füger KE; Wienbeck M; Mann J; Kornowski R; Aderka D; Schwartz D; Levo Y; Djahanguiri B; Brooks P; Day RO, 1991, 'Nonsteroidal antiinflammatory drugs — differences and similarities', New England Journal of Medicine, 325, pp. 1653 - 1654, http://dx.doi.org/10.1056/NEJM199112053252314
    Journal articles | 1991
    Handel ML; deFazio A; Watts CKW; Day RO; Sutherland RL, 1991, 'Inhibition of DNA binding and transcriptional activity of a nuclear receptor transcription factor by aurothiomalate and other metal ions', Molecular Pharmacology, 40, pp. 613 - 618
    Journal articles | 1991
    Johnson AG; Day RO, 1991, 'The Problems and Pitfalls of NSAID Therapy in the Elderly (Part I)', Drugs & Aging, 1, pp. 130 - 143, http://dx.doi.org/10.2165/00002512-199101020-00005
    Journal articles | 1991
    Johnson AG; Day RO, 1991, 'The Problems and Pitfalls of NSAID Therapy in the Elderly (Part II)', Drugs & Aging, 1, pp. 212 - 227, http://dx.doi.org/10.2165/00002512-199101030-00005
    Journal articles | 1991
    Joyce DA; Day RO; Murphy BR, 1991, 'The pharmacokinetics of albumin conjugates of D-penicillamine in humans', Drug Metabolism and Disposition, 19, pp. 309 - 311
    Journal articles | 1991
    Kino R; Day RO; Pearce GA; Fulde GWO, 1991, 'Aminophylline in the emergency department: Maximizing safety and efficacy', Chest, 100, pp. 1572 - 1577, http://dx.doi.org/10.1378/chest.100.6.1572
    Journal articles | 1991
    Kino R; Day RO; Pearce GA; Fulde GWO, 1991, 'Bedside measurement of plasma theophylline concentration within the emergency department', Australian Journal of Hospital Pharmacy, 21, pp. 292 - 294
    Journal articles | 1991
    Knihinicki RD; Day RO; Williams KM, 1991, 'Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-II Racemization and hydrolysis of (R)- and (S)-ibuprofen-CoA thioesters', Biochemical Pharmacology, 42, pp. 1905 - 1911, http://dx.doi.org/10.1016/0006-2952(91)90588-V
    Journal articles | 1991
    Williams KM; Knihinicki RD; Day RO, 1991, 'Pharmacokinetics of the enantiomers of ibuprofen in the rabbit', Agents and Actions, 34, pp. 381 - 386, http://dx.doi.org/10.1007/BF01988732
    Journal articles | 1991
    Winn JS; Guille J; Gebicki JM; Day RO, 1991, 'Hydrogen peroxide modulation of the respiratory burst of human neutrophils', Biochemical Pharmacology, 41, pp. 31 - 36, http://dx.doi.org/10.1016/0006-2952(91)90007-R
    Journal articles | 1990
    Johnson AG; Day RO; Seldon WA, 1990, 'A functional psychosis precipitated by quinidine', Medical Journal of Australia, 153, pp. 47 - 49, http://dx.doi.org/10.5694/j.1326-5377.1990.tb125463.x
    Journal articles | 1990
    Joyce D; Day R, 1990, 'D‐penicillamine and D‐penicillamine‐protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.', British Journal of Clinical Pharmacology, 30, pp. 511 - 517, http://dx.doi.org/10.1111/j.1365-2125.1990.tb03808.x
    Journal articles | 1990
    Knihinicki RD; Day RO; Graham GG; Williams KM, 1990, 'Stereoselective disposition of ibuprofen and flurbiprofen in rats', Chirality, 2, pp. 134 - 140, http://dx.doi.org/10.1002/chir.530020303
    Journal articles | 1990
    Nuernberg B; Knihinicki R; Williams K; Freeman GE; Dalton C; Brooks PM; Day RO, 1990, 'Anti-inflammatory effects and disposition of S- and R-flurbiprofen in the rat', European Journal of Pharmacology, 183, pp. 1591 - 1592, http://dx.doi.org/10.1016/0014-2999(90)94757-O
    Journal articles | 1990
    Pearce GA; Day RO, 1990, 'Compliance with criteria necessary for effective drug concentration monitoring', Therapeutic Drug Monitoring, 12, pp. 250 - 257, http://dx.doi.org/10.1097/00007691-199005000-00007
    Journal articles | 1990
    Tett S; Cutler D; Day R, 1990, 'Antimalarials in rheumatic diseases', Bailliere's Clinical Rheumatology, 4, pp. 467 - 489, http://dx.doi.org/10.1016/S0950-3579(05)80004-4
    Journal articles | 1990
    Tett SE; Cutler DJ; Day RO, 1990, 'Hydroxychloroquine concentrations and clinical effects in rheumatoid arthritis patients', European Journal of Pharmacology, 183, pp. 1035, http://dx.doi.org/10.1016/0014-2999(90)92892-M
    Journal articles | 1989
    Day R; Graham G; Bieri D; Brown M; Cairns D; Harris G; Hounsell J; Platt‐ Hepworth S; Reeve R; Sambrook P; et al , 1989, 'Concentration‐response relationships for salicylate‐induced ototoxicity in normal volunteers.', British Journal of Clinical Pharmacology, 28, pp. 695 - 702, http://dx.doi.org/10.1111/j.1365-2125.1989.tb03562.x
    Journal articles | 1989
    Day R, 1989, 'Trends in the treatment of rheumatoid arthritis: Australia', Rheumatology SEAPAL 1988: proceedings of the 6th SEAPAL Congress of rheumatology. ICS809, pp. 159 - 161
    Journal articles | 1989
    Graham SR; Day RO; Hardy M, 1989, 'Captopril overdose', Medical Journal of Australia, 151, pp. 111, http://dx.doi.org/10.5694/j.1326-5377.1989.tb101174.x
    Journal articles | 1989
    HO KY; WEISSBERGER AJ; STUART MC; DAY RO; LAZARUS L, 1989, 'THE PHARMACOKINETICS, SAFETY AND ENDOCRINE EFFECTS OF AUTHENTIC BIOSYNTHETIC HUMAN GROWTH HORMONE IN NORMAL SUBJECTS', Clinical Endocrinology, 30, pp. 335 - 345, http://dx.doi.org/10.1111/j.1365-2265.1989.tb00431.x
    Journal articles | 1989
    Knihinicki RD; Williams KM; Day RO, 1989, 'Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-1. In vitro studies of ibuprofen and flurbiprofen', Biochemical Pharmacology, 38, pp. 4389 - 4395, http://dx.doi.org/10.1016/0006-2952(89)90647-3
    Journal articles | 1989
    Sambrook PN; Champion GD; Browne CD; Cairns D; Cohen ML; Day RO; Graham S; Handel M; Jaworski R; Kempler S; Wach er T, 1989, 'Corticosteroid injection for osteoarthritis of the knee: Peripatellar compared to intra-articular route', Clinical and Experimental Rheumatology, 7, pp. 609 - 613
    Journal articles | 1989
    Tett S; Cutler D; Day R; Brown K, 1989, 'Bioavailability of hydroxychloroquine tablets in healthy volunteers.', British Journal of Clinical Pharmacology, 27, pp. 771 - 779, http://dx.doi.org/10.1111/j.1365-2125.1989.tb03439.x
    Journal articles | 1988
    Bowden GJ; Cadogan JM; Day RK; Dunlop JB, 1988, '169Tm Mössbauer experiments in the paramagnetic phase of Tm2 Al', Hyperfine Interactions, 39, pp. 359 - 367, http://dx.doi.org/10.1007/BF02397645
    Journal articles | 1988
    Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; De Jager J; Sambrook PN, 1988, 'Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis', Journal of Rheumatology, 15, pp. 28 - 34
    Journal articles | 1988
    Day R; Harris G; Brown M; Graham G; Champion G, 1988, 'Interaction of salicylate and corticosteroids in man.', British Journal of Clinical Pharmacology, 26, pp. 334 - 337, http://dx.doi.org/10.1111/j.1365-2125.1988.tb05286.x
    Journal articles | 1988
    Day R; Miners J; Birkett D; Graham G; Whitehead A, 1988, 'Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol.', British Journal of Clinical Pharmacology, 26, pp. 429 - 434, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03402.x
    Journal articles | 1988
    Day R; Miners J; Birkett D; Whitehead A; Naidoo D; Hayes J; Savdie E, 1988, 'Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion.', British Journal of Clinical Pharmacology, 26, pp. 423 - 428, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03401.x
    Journal articles | 1988
    Day R; Paull P; Lam S; Swanson B; Williams K; Wade D, 1988, 'The effect of concurrent aspirin upon plasma concentrations of tenoxicam.', British Journal of Clinical Pharmacology, 26, pp. 455 - 462, http://dx.doi.org/10.1111/j.1365-2125.1988.tb03405.x
    Journal articles | 1988
    Day RO; Breit SN; Cairns D; Champion GD, 1988, 'Aspects of the clinical trials of slow-acting anti-rheumatic drugs.', Agents and actions. Supplements, 24, pp. 121 - 133, http://dx.doi.org/10.1007/978-3-0348-9160-8_11
    Journal articles | 1988
    Day RO; Furst DE; Dromgoole SH; Paulus HE, 1988, 'Changes in salicylate serum concentration and metabolism during chronic dosing in normal volunteers', Biopharmaceutics & Drug Disposition, 9, pp. 273 - 283, http://dx.doi.org/10.1002/bod.2510090306
    Journal articles | 1988
    Day RO; Graham GG; Willia KM; Brooks PM, 1988, 'Variability in Response to NSAIDs: Fact or Fiction?', Drugs, 36, pp. 643 - 651, http://dx.doi.org/10.2165/00003495-198836060-00001
    Journal articles | 1988
    Day RO; Graham GG; Williams KM, 1988, 'Pharmacokinetics of non-steroidal anti-inflammatory drugs', Bailliere's Clinical Rheumatology, 2, pp. 363 - 393, http://dx.doi.org/10.1016/S0950-3579(88)80019-0
    Journal articles | 1988
    Day RO; Williams KM; Graham GG; Lee EJ; Knihinicki RD; Champion GD, 1988, 'Stereoselective disposition of ibuprofen enantiomers in synovial fluid', Clinical Pharmacology and Therapeutics, 43, pp. 480 - 487, http://dx.doi.org/10.1038/clpt.1988.62
    Journal articles | 1988
    Day RO, 1988, 'Mode of action of non-steroidal anti-inflammatory drugs', Medical Journal of Australia, 148, pp. 195 - 199, http://dx.doi.org/10.5694/j.1326-5377.1988.tb112818.x
    Journal articles | 1988
    Graham SR; Day RO; Lee R; Fulde GWO, 1988, 'Overdose with chloral hydrate: A pharmacological and therapeutic review', Medical Journal of Australia, 149, pp. 686 - 688, http://dx.doi.org/10.5694/j.1326-5377.1988.tb120823.x
    Journal articles | 1988
    Keogh A; Day R; Critchley L; Duggin G; Baron D, 1988, 'The effect of food and cholestyramine on the absorption of cyclosporine in cardiac transplant recipients', Transplantation Proceedings, 20, pp. 27 - 30
    Journal articles | 1988
    Patapanian H; Graham S; Sambrook PN; Browne CD; Champion GD; Cohen ML; Day RO, 1988, 'The oncogenicity of chlorambucil in rheumatoid arthritis', Rheumatology, 27, pp. 44 - 47, http://dx.doi.org/10.1093/rheumatology/27.1.44
    Journal articles | 1988
    Stewart GA; Day RK; Dunlop JB; Price DC, 1988, 'A two-site analysis of169Tm Mössbauer measurements on thulium sesquioxide', Hyperfine Interactions, 40, pp. 339 - 342, http://dx.doi.org/10.1007/BF02049112
    Journal articles | 1988
    Tett S; Cutler D; Day R; Brown K, 1988, 'A dose‐ranging study of the pharmacokinetics of hydroxy‐chloroquine following intravenous administration to healthy volunteers.', British Journal of Clinical Pharmacology, 26, pp. 303 - 313, http://dx.doi.org/10.1111/j.1365-2125.1988.tb05281.x
    Journal articles | 1988
    Williams KM; Day RO, 1988, 'The contribution of enantiomers to variability in response to anti-inflammatory drugs.', Agents and actions. Supplements, 24, pp. 76 - 84, http://dx.doi.org/10.1007/978-3-0348-9160-8_7
    Journal articles | 1987
    Day R; Brooks P, 1987, 'Variations in response to non‐steroidal anti‐inflammatory drugs.', British Journal of Clinical Pharmacology, 23, pp. 655 - 658, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03098.x
    Journal articles | 1987
    Day R; Lam S; Paull P; Wade D, 1987, 'Effect of food and various antacids on the absorption of tenoxicam.', British Journal of Clinical Pharmacology, 24, pp. 323 - 328, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03176.x
    Journal articles | 1987
    Day RO; Graham GG; Williams KM; David Champion G; de Jager J, 1987, 'Clinical pharmacology of non-steroidal anti-inflammatory drugs', Pharmacology and Therapeutics, 33, pp. 383 - 433, http://dx.doi.org/10.1016/0163-7258(87)90072-6
    Journal articles | 1987
    MOULDS RFW; DAY RO, 1987, 'DRUG ADVERTISING', MEDICAL JOURNAL OF AUSTRALIA, 147, pp. 52 - 52, http://dx.doi.org/10.5694/j.1326-5377.1987.tb133252.x
    Journal articles | 1987
    Mant A; Wodak A; Day R, 1987, 'Benzodiazepine dependence. Strategies for prevention and withdrawal', Current Therapeutics, 28, pp. 59 - 79
    Journal articles | 1987
    PATAPANIAN H; SAMBROOK PN; BROWNE CD; CHAMPION GD; DAY RO; COHEN ML, 1987, 'ONCHOGENICITY OF CHLORAMBUCIL IN RHEUMATOID-ARTHRITIS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 17, pp. 124 - 124, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987G353300058&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1987
    Reilly DK; Ray JE; Day RO; Wodak A; Bsocstud DOC; Thompson J, 1987, 'Classification of overdose/self-poisoning presentations to an accident and emergency department', Substance Use and Misuse, 22, pp. 941 - 955, http://dx.doi.org/10.3109/10826088709109691
    Journal articles | 1987
    Reilly DK; Ray JE; Day RO; Wodak A; O'Connor D; Thompson J, 1987, 'Classification of overdose/self-poisoning presentations to an accident and emergency department', International Journal of the Addictions, 22, pp. 941 - 955
    Journal articles | 1987
    WING LMH; MOULDS RFW; SHENFIELD GM; DAY RO, 1987, 'DRUG ADVERTISING - REPLY', MEDICAL JOURNAL OF AUSTRALIA, 147, pp. 361 - 361, http://dx.doi.org/10.5694/j.1326-5377.1987.tb133532.x
    Journal articles | 1986
    Davis A; Day RO; Begg EJ, 1986, 'INTERACTIONS BETWEEN NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS AND ANTIHYPERTENSIVES AND DIURETICS', Australian and New Zealand Journal of Medicine, 16, pp. 537 - 546, http://dx.doi.org/10.1111/j.1445-5994.1986.tb02031.x
    Journal articles | 1986
    Goadsby PJ; Day RO; Kwan YL; Miners J; Birkett DJ, 1986, '6-MERCAPTOPURINE-RELATED LEUCOPENIA AND IN VIVO XANTHINE OXIDASE ACTIVITY', The Lancet, 328, pp. 869 - 870, http://dx.doi.org/10.1016/S0140-6736(86)92911-9
    Journal articles | 1986
    Ray JE; Reilly DK; Day RO, 1986, 'Drugs involved in self-poisoning: Verification by toxicological analysis', Medical Journal of Australia, 144, pp. 455 - 457, http://dx.doi.org/10.5694/j.1326-5377.1986.tb101047.x
    Journal articles | 1986
    SAMBROOK PN; CHAMPION GD; COMPTON PJ; BROWNE CD; COHEN M; DAY RO; DEJAGER JP, 1986, 'THERAPEUTIC OUTCOME WITH METHOTREXATE AND AZATHIOPRINE IN RHEUMATOID-ARTHRITIS - A LIFE TABLE ANALYSIS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16, pp. 144 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986A500500119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1986
    Sambrook PN; Champion GD; Browne CD; Cohen ML; Compton P; Day RO; Jager JD, 1986, 'Comparison of methotrexate with azathioprine or 6-mercaptopurine in refractory rheumatoid arthritis: A life-table analysis', Rheumatology, 25, pp. 372 - 375, http://dx.doi.org/10.1093/rheumatology/25.4.372
    Journal articles | 1986
    WILLIAMS KM; DAY RO; KNIHINICKI RD; DUFFIELD AM, 1986, 'STEREOSELECTIVE INCORPORATION OF IBUPROFEN ENANTIOMERS INTO ADIPOSE-TISSUE IN RATS AND MAN', ACTA PHARMACOLOGICA ET TOXICOLOGICA, 59, pp. 192 - 192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986D896000552&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1986
    Williams K; Day R; Knihinicki R; Duffield A, 1986, 'The stereoselective uptake of ibuprofen enantiomers into adipose tissue', Biochemical Pharmacology, 35, pp. 3403 - 3405, http://dx.doi.org/10.1016/0006-2952(86)90443-0
    Journal articles | 1985
    DAY RO; WILLIAMS KM; LEE EJ; KNIHINICKI R, 1985, 'DISPOSITION OF ENANTIOMERS OF IBUPROFEN IN PLASMA AND SYNOVIAL-FLUID IN ARTHRITIC DISEASE', CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 8, pp. A58 - A58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1985AQS8500134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1985
    Day RO, 1985, 'Variability in response to NSAID.', Agents and actions. Supplements, 17, pp. 15 - 19, http://dx.doi.org/10.1007/978-3-0348-7720-6_1
    Journal articles | 1985
    Lee E; Williams K; Day R; Graham G; Champion D, 1985, 'Stereoselective disposition of ibuprofen enantiomers in man.', British Journal of Clinical Pharmacology, 19, pp. 669 - 674, http://dx.doi.org/10.1111/j.1365-2125.1985.tb02694.x
    Journal articles | 1985
    Williams KM; Day RO, 1985, 'Stereoselective disposition--basis for variability in response to NSAID's.', Agents and actions. Supplements, 17, pp. 119 - 126, http://dx.doi.org/10.1007/978-3-0348-7720-6_14
    Journal articles | 1984
    Day RO; Graham GG; Champion GD; Lee E, 1984, 'Anti-rheumatic drug interactions', Clinics in Rheumatic Diseases, 10, pp. 251 - 275
    Journal articles | 1984
    Graham GG; Day RO; Champion GD; Lee E; Newton K, 1984, 'Aspects of the clinical pharmacology of non-steroidal anti- inflammatory drugs', Clinics in Rheumatic Diseases, 10, pp. 229 - 249
    Journal articles | 1984
    Lee EJD; Williams KM; Graham GG; Day RO; Champion GD, 1984, 'Liquid chromatographic determination and plasma concentration profile of optical isomers of ibuprofen in humans', Journal of Pharmaceutical Sciences, 73, pp. 1542 - 1544, http://dx.doi.org/10.1002/jps.2600731112
    Journal articles | 1984
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN, 1984, 'Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate', Medical Journal of Australia, 141, pp. 349 - 351, http://dx.doi.org/10.5694/j.1326-5377.1984.tb132803.x
    Journal articles | 1984
    Ray JD; Day RO, 1984, 'High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection', Journal of Chromatography B: Biomedical Sciences and Applications, 336, pp. 234 - 239, http://dx.doi.org/10.1016/S0378-4347(00)85146-4
    Journal articles | 1983
    BEGG EJ; CHINWAH PM; WEBB C; DAY RO; WADE DN, 1983, 'INTERACTION OF MEXILETINE WITH PHENYTOIN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 191 - 192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983QN17900029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1983
    DAY RO; HARRIS G; BROWN M; GRAHAM G, 1983, 'ASPIRIN GLUCOCORTICOSTEROID INTERACTION IN MAN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 717 - 717, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1983
    Day RO; Shen DD; Azarnoff DL, 1983, 'Induction of Salicyluric Acid Formation in Rheumatoid Arthritis Patients Treated with Salicylates', Clinical Pharmacokinetics, 8, pp. 263 - 271, http://dx.doi.org/10.2165/00003088-198308030-00005
    Journal articles | 1983
    RAY JE; REILLY DK; HAAVISTO T; PAULL PD; DAY RO, 1983, 'SURVEY OF DRUG-ABUSE PATTERNS IN A CASUALTY DEPARTMENT POPULATION', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 715 - 716, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1983
    Ray JE; Day RO, 1983, 'High‐performance liquid chromatographic analysis of diflunisal in plasma and urine: Application to pharmacokinetic studies in two normal volunteers', Journal of Pharmaceutical Sciences, 72, pp. 1403 - 1405, http://dx.doi.org/10.1002/jps.2600721209
    Journal articles | 1982
    Begg E; Chinwah P; Webb C; Day R; Wade D, 1982, 'Enhanced metabolism of mexiletine after phenytoin administration.', British Journal of Clinical Pharmacology, 14, pp. 219 - 223, http://dx.doi.org/10.1111/j.1365-2125.1982.tb01965.x
    Journal articles | 1982
    Journal articles | 1982
    DAY RO; FURST DE; DROMGOOLE SH; PAULUS HE, 1982, 'DECLINE OF STEADY-STATE SERUM SALICYLIC-ACID CONCENTRATIONS WITH TIME IN NORMAL VOLUNTEERS GIVEN HIGH-DOSE ASPIRIN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 557 - 558, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1982
    Day RO; Furst DE; Dromgoole SH; Kamm B; Roe R; Paulus HE, 1982, 'Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 31, pp. 733 - 740, http://dx.doi.org/10.1038/clpt.1982.103
    Journal articles | 1982
    Day RO; Sambrook P; Champion GD; Graham GG, 1982, 'Antimalarials in rheumatic diseases', Australian and New Zealand Journal of Medicine, 12, pp. 645 - 649, http://dx.doi.org/10.1111/j.1445-5994.1982.tb02658.x
    Journal articles | 1982
    HARRIS G; CAIRNS D; BIERI D; CHAMPION D; DAY R; GRAHAM G, 1982, 'RESPONSE OF RHEUMATOID-ARTHRITIS TO SLOWLY ACTING ANTI-RHEUMATIC DRUGS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 561 - 561, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1982
    RAY JE; DAY RO, 1982, 'DIFLUNISAL, A SPECIFIC ANALYTICAL PROCEDURE AND PRELIMINARY PHARMACOKINETICS IN MAN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 572 - 572, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1982
    Ray JE; Day RO, 1982, 'Diflunisal, a specific analytical procedure and preliminary pharmacokinetics in man', Clinical and Experimental Pharmacology and Physiology, 9, pp. 453
    Journal articles | 1982
    Sambrook PN; Browne CD; Champion GD; Day RO; Vallance JB; Warwick N, 1982, 'Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis', Journal of Rheumatology, 9, pp. 932 - 934
    Journal articles | 1981
    Day RO; Dromgoole SH; Furst DE; Hignite C; Paulus HE, 1981, 'Formation of methyl ester of salicyluric acid during quantitation of salicyluric acid in urine by high‐pressure liquid chromatography', Journal of Pharmaceutical Sciences, 70, pp. 1090 - 1092, http://dx.doi.org/10.1002/jps.2600700934
    Journal articles | 1981
    Day RO; Furst DE; Dromgoole SH, 1981, 'Decline in steady-state serum levels of salicylate in normal subjects: Preliminary results', Clinical and Experimental Pharmacology and Physiology, 8
    Journal articles | 1981
    Day RO; Furst DE; Dromgoole SH, 1981, 'Naproxen serum level response relationship in rheumatoid arthritis', Australian and New Zealand Journal of Medicine, 11, pp. 720
    Journal articles | 1981
    Day RO; Pearson CM, 1981, 'Primary inflammatory muscle diseases', Comprehensive Therapy, 7, pp. 22 - 30
    Journal articles | 1981
    Day RO, 1981, 'Effects of exercise performance on drugs used musculoskeletal disorders', Medicine and Science in Sports and Exercise, 13, pp. 272 - 275, http://dx.doi.org/10.1249/00005768-198104000-00013
    Journal articles | 1981
    Furst DE; Day RO; Dromgoole SH, 1981, 'Steady-state serum level vs response relationship for naproxen in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 29, pp. 247
    Journal articles | 1979
    Champion GD; Day RO; Paull PD, 1979, 'Clinical pharmacology and efficacy of benorylate in patients with rheumatoid arthritis', Current Therapeutics, 20, pp. 145
    Journal articles | 1979
    Day R; Shen D; Azarnoff D, 1979, 'Decline of steady-state serum salicylate in rheumatoid arthritics given high-dosage salicylate therapy', Clinical Pharmacology and Therapeutics, 25, pp. 220 - 221
    Journal articles | 1979
    Day RO; Lindsley HB, 1979, 'Rational use of aspirin and nonsteroidal anti-inflammatory drugs in inflammatory arthritis.', The Journal of the Kansas Medical Society, 80, pp. 155 - 159
    Journal articles | 1979
    Day RO; Shen DD; Azarnoff DL, 1979, 'Effect of high-dosage salicylate therapy on average steady-state serum salicylate and formation of salicylurate in patients with rheumatoid arthritis', Clinical Research, 27
    Journal articles | 1979
    Day RO, 1979, 'DEAFNESS DUE TO ASPIRIN', The Journal of Clinical Pharmacology, 19, pp. 328 - 328, http://dx.doi.org/10.1002/j.1552-4604.1979.tb02488.x
    Journal articles | 1979
    Graham G; Champion GD; Day RO, 1979, 'The pharmacokinetics of salicyclate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 6, pp. 194
    Journal articles | 1979
    RAY JE; WADE DN; GRAHAM GG; DAY RO, 1979, 'Pharmacokinetics of Carprofen in Plasma and Synovial Fluid', The Journal of Clinical Pharmacology, 19, pp. 635 - 643, http://dx.doi.org/10.1002/j.1552-4604.1979.tb01626.x
    Journal articles | 1978
    Champion GD; Day RO; Paull PD; Graham GG; Owen MS; Haski AL; Hills L, 1978, 'Clinical Pharmacology and Efficacy of Benorylate in Patients with Rheumatoid Arthritis', Australian and New Zealand Journal of Medicine, 8, pp. 22 - 28, http://dx.doi.org/10.1111/j.1445-5994.1978.tb02398.x
    Journal articles | 1978
    Day RO; Champion GD; Wade DN, 1978, 'The effect of various drugs on compound 48/80 and osmotic shock-induced histamine release from rat peritoneal cells', Clinical and Experimental Pharmacology and Physiology, 5, pp. 241 - 242
    Journal articles | 1978
    Day RO; Wade DN, 1978, 'EFFECTS OF VARIOUS DRUGS ON THE OSMOTIC LYSIS OF RAT MAST CELLS', Clinical and Experimental Pharmacology and Physiology, 5, pp. 477 - 485, http://dx.doi.org/10.1111/j.1440-1681.1978.tb00700.x
    Journal articles | 1978
    Day RO; Wade DN, 1978, 'Influence of flufenamic acid and calcium ion concentration on the histamine release from rat mast cells induced by compound 48/80 and the calcium ionophore A23187', Biochemical Pharmacology, 27, pp. 1385 - 1387, http://dx.doi.org/10.1016/0006-2952(78)90126-0
    Journal articles | 1978
    Day RO; Wade DN, 1978, 'THE EFFECT OF VARIOUS DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', Clinical and Experimental Pharmacology and Physiology, 5, pp. 223 - 227, http://dx.doi.org/10.1111/j.1440-1681.1978.tb00675.x
    Journal articles | 1977
    Bowden GJ; Day RK, 1977, 'A novel low temperature rearrangement of atoms in the rare earth intermetallic compound ErFe3', Journal of Physics F: Metal Physics, 7, pp. 181 - 190, http://dx.doi.org/10.1088/0305-4608/7/1/027
    Journal articles | 1977
    Bowden GJ; Day RK, 1977, 'On the magnetic anomaly in ErFe3 at 47K', Journal of Physics F: Metal Physics, 7, pp. 191 - 197, http://dx.doi.org/10.1088/0305-4608/7/1/028
    Journal articles | 1977
    CHAMPION GD; DAY RO; RAY JE; WADE DN, 1977, 'THE EFFECT OF NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', British Journal of Pharmacology, 59, pp. 29 - 33, http://dx.doi.org/10.1111/j.1476-5381.1977.tb06973.x
    Journal articles | 1977
    Champion GD; Corrigan AB; Day RO, 1977, 'The effect of enteric coating of aspirin tablets on occult gastrointestinal blood loss', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214 - 215
    Journal articles | 1977
    Champion GD; Day RO; Fagan N, 1977, 'Single dose comparison of analgesic action of acetylsalicylate and sodium salicylate in rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 213
    Journal articles | 1977
    Day RK; Bowden GJ, 1977, 'Magnetic anomalies in ErFe3', Physica B+C, 86-88, pp. 71 - 72, http://dx.doi.org/10.1016/0378-4363(77)90230-3
    Journal articles | 1977
    Day RO; Paull PD; Ray JE; Wade DN, 1977, 'The measurement of histamine release from suspensions of rat peritoneal cells rich in mast cells', Agents and Actions, 7, pp. 431 - 436, http://dx.doi.org/10.1007/BF01966848
    Journal articles | 1977
    Day RO; Ray JE; Champion GD; Wade DN, 1977, 'The effect of non steroidal anti inflammatory drugs on ATP levels and histamine release from rat peritoneal cell suspension rich in mast cells', Clinical and Experimental Pharmacology and Physiology, 4, pp. 212 - 213
    Journal articles | 1977
    Graham G; Champion GD; Day RO; Paull PD, 1977, 'The pharmacokinetics of salicylate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214
    Journal articles | 1977
    Graham GG; Champion GD; Day RO; Kaski AL; Hills LG; Paull PD, 1977, 'Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.', Agents and Actions Supplements, pp. 37 - 42
    Journal articles | 1977
    Graham GG; Champion GD; Day RO; Paull PD, 1977, 'Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 22, pp. 410 - 420, http://dx.doi.org/10.1002/cpt1977224410
    Journal articles | 1977
    Grahm GG; Champion GD; Day RO, 1977, 'Salicylates in rheumatoid arthritis: Pharmacokinetics and analgesic responses', Agents and Actions, 7, pp. 35 - 42
    Journal articles | 1977
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG, 1977, 'The Effects of Enteric Coating of Aspirin Tablets on Occult Gastrointestinal Blood Loss', Australian and New Zealand Journal of Medicine, 7, pp. 600 - 604, http://dx.doi.org/10.1111/j.1445-5994.1977.tb02315.x
    Journal articles | 1976
    Crozier RH; Day RW, 1976, 'Niche breadth in Bryozoans', Nature, 260, pp. 77 - 78, http://dx.doi.org/10.1038/260077c0
    Journal articles | 1976
    Day RO; Paull PD; Champion GD; Graham GG, 1976, 'Evaluation of an Enteric Coated Aspirin Preparation', Australian and New Zealand Journal of Medicine, 6, pp. 45 - 50, http://dx.doi.org/10.1111/j.1445-5994.1976.tb03290.x
    Journal articles | 1976
    Paull P; Day R; Graham G; Champion D, 1976, 'Single dose evaluation of a new enteric coated aspirin preparation', Medical Journal of Australia, 1, pp. 617 - 619, http://dx.doi.org/10.5694/j.1326-5377.1976.tb140908.x
    Journal articles | 1975
    CHAMPION GD; DAY RO; GRAHAM GG; PAULL PD, 1975, 'Salicylates in Rheumatoid Arthritis', Clinics in Rheumatic Diseases, 1, pp. 245 - 265, http://dx.doi.org/10.1016/s0307-742x(21)00120-x
    Journal articles | 1975
    Paull PD; Day RO; Graham GG; Champion GD, 1975, 'Bioavailability of enteric coated aspirin', Clinical and Experimental Pharmacology and Physiology, 2, pp. 442
    Journal articles | 1969
    Austin M; Singer G; Day RH, 1969, 'Visual orientation illusion following judgments with a tilted visual field', Nature, 221, pp. 583 - 584, http://dx.doi.org/10.1038/221583a0
  • Conference Abstracts | 2022
    Juhl CB; Simic M; Pihl K; Berthelsen DB; Day R; Koes B; Thorlund JB, 2022, 'COMPARISON OF EXERCISE THERAPY, NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, AND OPIOIDS FOR KNEE OSTEOARTHRITIS PAIN: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, GERMANY, Berlin, Vol. 30, pp. S65 - S66, presented at OARSI World Congress on Osteoarthritis, GERMANY, Berlin, 07 April 2022 - 10 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000775103700081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Knock E; Ezard N; Day R; Siefried KJ; Liknaitzky P; Ross M; Albert S; Brett J, 2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Milder T; Stocker S; Baysari M; Day R; Greenfield J, 2022, 'PRESCRIPTION OF SGLT2 INHIBITORS TO PATIENTS WITH CHRONIC KIDNEY DISEASE: A QUALITATIVE STUDY OF NEPHROLOGISTS AND CARDIOLOGISTS', in NEPHROLOGY, WILEY, Vol. 27, pp. 74 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000864433100145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Mao C; Coleshill M; Day RO; Aung E, 2021, 'ADHERENCE TO URATE LOWERING THERAPY AMONG PEOPLE WITH GOUT IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651518500135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Tiku A; Boudville N; Brown F; Cass A; Clarke P; Day R; de Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Pascoe E; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S; Dalbeth N, 2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1372 - 1373, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Aung E; Coleshill M; Schulz M; Kamel B; Stocker S; Day R, 2020, 'RECRUITING PEOPLE WITH GOUT INTO A CLINICAL TRIAL IN PRIMARY CARE: THE GAPP EXPERIENCE', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000553988700116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE SERUM URATE LEVEL: RESULTS FROM POST HOC ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day R; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO DIABETIC KIDNEY DISEASE AT BASELINE: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO ALBUMINURIA AT BASELINE: RESULTS FROM PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, Vol. 25, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Green EAE; Yee SW; Rashkin SR; Witte J; Shin JG; Klovins J; Stocker S; Day R; Giacomini KM, 2019, 'GENETIC DETERMINANTS OF METFORMIN PHARM-ACOKINETICS: A METFORMIN GENETIC CONSORTIUM COLLABORATION.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, DC, Washington, Vol. 105, pp. S36 - S36, presented at Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, DC, Washington, 13 March 2019 - 16 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000458561100109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Shingde R; Graham G; Reuter S; Carland J; Williams K; Day R; Stocker S, 2019, 'PREDICTIVE PERFORMANCE OF A COMMERCIAL BAYESIAN FORECASTING PROGRAM IN ESTIMATING VANCOMYCIN DRUG EXPOSURE.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, DC, Washington, Vol. 105, pp. S38 - S38, presented at Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics, DC, Washington, 13 March 2019 - 16 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000458561100115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Simic M; Harmer A; van der Esch M; Bennell K; Ferreira P; March L; Fransen M; Day R, 2019, 'DO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS CAUSE OSTEOARTHRITIS PROGRESSION, A SYSTEMATIC REVIEW AND META ANALYSIS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, CANADA, Toronto, pp. S280 - S282, presented at OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis, CANADA, Toronto, 02 May 2019 - 05 May 2019, http://dx.doi.org/10.1016/j.joca.2019.02.663
    Conference Abstracts | 2018
    Stocker SL; Carland JE; Moran MA; Tang S; Li CY; Alin JS; Gilbey T; Graham GG; Williams KM; Marriott DJ; Day RO, 2018, 'A CLINICAL EVALUATION OF VANCOMYCIN DOSING AND MONITORING.', in CLINICAL PHARMACOLOGY & THERAPEUTICS, WILEY, FL, Orlando, Vol. 103, pp. S88 - S88, presented at 119th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) - Breaking Down Barriers to Effective Patient Care, FL, Orlando, 21 March 2018 - 24 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424997100316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Kamel B; Stocker S; Graham G; Carland J; Parker M; Williams K; Pile K; Portek I; McGill N; Day R, 2017, 'A MULTICENTRE OPEN-LABEL PHARMACOKINETIC-PHARMACODYNAMIC (PKPD) STUDY OF FEBUXOSTAT IN PATIENTS WITH CHRONIC GOUT', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 47, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400304400034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Reports | 2017
    Kumar SS; Graham GG; Smith FC; Furlong TJ; Greenfield JR; Stocker SS; Carland JE; Day RO, 2017, Could metformin be used in patients with advanced chronic kidney disease?, http://dx.doi.org/10.1111/dom.12806
    Other | 2017
    Reports | 2016
    Butterfield RJ; Barratt MJ; Ezard N; Day RO, 2016, Drug checking to improve monitoring of new psychoactive substances in Australia, AUSTRALASIAN MED PUBL CO LTD, http://dx.doi.org/10.5694/mja15.01058
    Conference Abstracts | 2016
    Leopoldino AO; Machado GC; Ferreira PH; Pinheiro MB; Day RO; McLachlan AJ; Hunter DJ; Ferreira ML, 2016, 'EFFICACY AND SAFETY OF PARACETAMOL COMPARED TO PLACEBO FOR KNEE AND HIP OSTEOARTHRITIS: A COCHRANE SYSTEMATIC REVIEW', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, Vol. 24, pp. S44 - S44, presented at World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis, NETHERLANDS, Amsterdam, 31 March 2016 - 03 April 2016, http://dx.doi.org/10.1016/j.joca.2016.01.104
    Conference Papers | 2016
    Manollaras K; Nolan L; Day R; Norris R; Dear R, 2016, 'EFFICACY OF SCALP COOLING AND PHARMACOKINETICS AT THE KINGHORN CANCER CENTRE, ST VINCENT'S HOSPITAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 168 - 168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900313&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2016
    Martinello M; Schteinman A; Alavi M; Williams K; Dore GJ; Day R; Matthews GV, 2016, 'The impact of ribavirin plasma concentration on the eficacy of the interferon-sparing regimen, sofosbuvir and ribavirin', in Antiviral Therapy, pp. 127 - 132, http://dx.doi.org/10.3851/IMP2984
    Conference Abstracts | 2016
    Simic M; Harmer AR; Agaliotis M; Nairn L; Bridgett L; March L; Votrubec M; Edmonds J; Norton R; Woodward M; Day R; Fransen M, 2016, 'CLINICAL PREDICTORS OF MEDIAL KNEE OSTEOARTHRITIS PROGRESSION OVER 2 YEARS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, Amsterdam, NETHERLANDS, Vol. 24, pp. S220 - S220, presented at World Congress of the Osteoarthritis-Research-Society-International (OARSI) on Osteoarthritis, Amsterdam, NETHERLANDS, 31 March 2016 - 03 April 2016, http://dx.doi.org/10.1016/j.joca.2016.01.424
    Conference Posters | 2015
    Chroinin DN; Xiao D; Sandhu A; Brazel C; Farnham N; Neto HM; Perram J; Roach TS; Sutherland E; Day R; Beveridge A, 2015, 'Potentially inappropriate medications (PIMS) in older hospital in-patients: prevalence at admission and discharge, and contribution to hospital admission', Vol. 34, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354463000124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    Kannangara D; Day R; Williams K; Phipps-Green A; Dalbeth N; Stamp L; Merriman T, 2015, 'THE URATE TRANSPORTER ABCG2 AND THE FRACTIONAL RENAL CLEARANCE OF URATE (FCU): CHANGING THE WAY WE THINK ABOUT HYPERURICAEMIA', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    Kannangara D; Graham G; Wright D; Barclay M; Stamp L; Williams K; Day R, 2015, 'TREATING GOUT PATIENTS WITH ALLOPURINOL: A CONCENTRATION- OR DOSE-RESPONSE APPROACH?', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 45, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    Nguyen A; Baysari M; Kannangara D; Tariq A; Lau A; Westbrook J; Day R, 2015, 'MOBILE APPS TO ENHANCE SELF-MANAGEMENT OF GOUT: CONCORDANCE WITH MANAGEMENT GUIDELINES', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    Vaccher S; Kannangara D; Baysari M; Zwar N; Reath J; Williams K; Day R, 2015, 'IDENTIFYING BARRIERS TO TREATING GOUT EFFECTIVELY: A QUALITATIVE STUDY OF PATIENTS' AND GENERAL PRACTITIONERS' UNDERSTANDING AND MANAGEMENT OF GOUT', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354320700041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2014
    Fransen M; Agaliotis M; Nairn L; Votrubec M; Bridgett L; Su S; Jan S; March L; Edmonds J; Norton R; Woodward M; Day RO, 2014, 'GLUCOSAMINE AND CHONDROMN FOR KNEE OSTEOARTHRITIS: A DOUBLE BLIND RANDOMISED CONTROLLED CLINICAL TRIAL EVALUATING SINGLE AND COMBINATION REGIMENS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, FRANCE, Paris, Vol. 22, pp. S457 - S457, presented at World Congress of the Osteoarthritis-Research-Society-International (OARSI), FRANCE, Paris, 24 April 2014 - 27 April 2014, http://dx.doi.org/10.1016/j.joca.2014.02.868
    Conference Presentations | 2014
    Merriman T; Topless R; Day R; Kannangara D; Williams K; Bradbury L; Brown M; Harrison A; Hill C; Jones G; Lester S; Littlejohn G; Rischmueller M; Shenstone B; Smith M; Andres M; Bardin T; Doherty M; Janssen M; Jansen T; Joosten L; Perez-Ruiz F; Radstake T; Riches P; Roddy E; Tausche A-K; Stamp L; Dalbeth N; Liote F; So A; Rasheed H, 2014, 'ASSOCIATION OF THE TOLL-LIKE RECEPTOR 4 (TLR4) GENE WITH GOUT', Vol. 73, pp. 354 - 354, presented at 15th Annual European Congress of Rheumatology (EULAR), FRANCE, Paris, 11 June 2014 - 14 June 2014, http://dx.doi.org/10.1136/annrheumdis-2014-eular.4781
    Conference Posters | 2014
    Vaccher S; Kannangara D; Baysari M; Zwar N; Reath J; Williams K; Day R, 2014, 'Barriers to care in gout: A qualitative study of patients’ and prescribers’ understanding and management', Melbourne, Australia, presented at ASCEPT Scientific Meeting, Melbourne, Australia, 07 December 2014
    Conference Papers | 2013
    Baysari MT; Westbrook JI; Egan B; Day RO, 2013, 'Identification of strategies to reduce computerized alerts in an electronic prescribing system using a Delphi approach', in Lehmann CU; Ammenwerth E; Nøhr C (eds.), Studies in Health Technology and Informatics, IOS Press, Amsterdam, pp. 8 - 12, http://dx.doi.org/10.3233/978-1-61499-289-9-8
    Conference Presentations | 2013
    Conference Posters | 2013
    Matthews GV; Kaur A; Ray JE; Graham GG; Egan B; Williams KM; Day RO, 2013, 'USE OF A POPULATION PHARMACOKINETIC MODEL TO PREDICT WEEK 4 RIBAVIRIN LEVELS FROM EARLY CONCENTRATIONS', NETHERLANDS, Amsterdam, Vol. 58, pp. S357 - S357, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)60872-7
    Conference Papers | 2012
    Lipworth WL; Kerridge IH; Day RO, 2012, 'Evidence-based medicine, resource allocation, and the persisting problem of ethically contested outcomes', in Evidence-based medicine, resource allocation, and the persisting problem of ethically contested outcomes, New Zealand Bioethics Conference, Dunedin, New Zealand, presented at New Zealand Bioethics Conference, Dunedin, New Zealand
    Conference Papers | 2011
    Baysari MT; Westbrook J; Day RO, 2011, 'Ethnographic observation as a method of investigating alert fatigue', in Proceedings of the 5th International Symposium on Human Factors Engineering in Health Informatics, Tapir Academic Press, Trondheim, Norway, pp. 71 - 76, presented at 5th Human factors engineering, Trondheim, Norway, 26 August 2011 - 27 August 2011
    Reports | 2011
    Roberts DM; Chau A; Day RO; Nair P, 2011, Enhanced elimination of phenorbarbital using charcoal haemorperfusion in a patient with severe poisoning, Oxford Univ Press, http://dx.doi.org/10.1093/bja/aer317, http://dx.doi.org/10.1093/bja/aer317
    Conference Papers | 2011
    Westbrook J; Reckmann M; Li L; Day RO, 2011, 'The effectiveness of two commercial prescribing systems to reduce medication errors in hospital', in The effectiveness of two commercial prescribing systems to reduce medication errors in hospital, Annual Conference of the Australasian Association for Quality in Health Care (AAQHC), Melbourne, Australia, presented at Annual Conference of the Australasian Association for Quality in Health Care (AAQHC), Melbourne, Australia, 12 October 2011 - 14 October 2011
    Conference Papers | 2010
    Baysari MT; Westbrook J; Day RO, 2010, 'THE IMPACT OF COMPUTERISED DECISION SUPPORT ON SELECTING MEDICINES FOR PRESCRIPTION', in THE IMPACT OF COMPUTERISED DECISION SUPPORT ON SELECTING MEDICINES FOR PRESCRIPTION, ASCEPT Annual Scientific meeting, Melbourne, Australia, presented at ASCEPT Annual Scientific meeting, Melbourne, Australia, 28 November 2010 - 01 December 2010
    Conference Papers | 2010
    Westbrook J; Lo C; Reckmann M; Runciman W; Braithwaite J; Day RO, 2010, 'The effectiveness of an electronic medication management system to reduce prescribing errors in hospital', in 18th Annual Health Informatics Conference, Health Informatics Society of Australia, Mebourne, pp. 1 - 8, presented at HIC 2010, 18th National Health Informatics Conference, Melbourne, Australia, 24 August 2010 - 26 August 2010, http://search.informit.com.au/documentSummary;dn=430012692310760;res=IELHEA
    Conference Papers | 2009
    Franklin ME; Anderson JM; Stocker SL; Pillans PI; Williams KM; Day RO; Taylor PJ, 2009, 'Measurement of Oxypurinol Concentrations in Urine by HPLC-Tandem Mass Spectrometry', in THERAPEUTIC DRUG MONITORING, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Montreal, pp. 640 - 640, presented at 11th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, CANADA, Montreal, 03 October 2009 - 08 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270484600142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2005
    Botch B; Day RO; Vining WJ; Hixson S; Samal P; Hart D; Peterfreund A; Rath KA, 2005, 'ChemPrep: Self-paced owl preparation for general chemistry and organic chemistry', in ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, AMER CHEMICAL SOC, CA, San Diego, pp. U346 - U346, presented at 229th National Meeting of the American-Chemical-Society, CA, San Diego, 13 March 2005 - 17 March 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000228177702047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2005
    Day RO; Lamont GB, 2005, 'Extended multi-objective fast messy genetic algorithm solving deception problems', in Coello CAC; Aguirre AH; Zitzler E (eds.), EVOLUTIONARY MULTI-CRITERION OPTIMIZATION, SPRINGER-VERLAG BERLIN, MEXICO, Guanajuato, pp. 296 - 310, presented at 3rd International Conference on Evolutionary Multi-Criterion Optimization (EMO 2005), MEXICO, Guanajuato, 09 March 2005 - 11 March 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229021300021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2001
    Lipani JA; Strand V; Johnson K; Woodworth T; Furst D; Singh G; Day R; Brooks P, 2001, 'A proposal for developing a large patient population cohort for longterm safety monitoring in rheumatoid arthritis', in Journal of Rheumatology, pp. 1170 - 1173
    Conference Papers | 2000
    Day RO; Bombardier C; Laine L; Reicin A; Ramey D; Brett C, 2000, 'Fewer Gastrointestinal Protective Agents, Procedures & Hospitalisations with Rofecoxib vs. Naproxen in the Vigor (VIOXXX GI Outcomes Research) Study', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, ASCEPT: 34th Annual Scientific Meeting, Newcastle, pp. 6.35, presented at ASCEPT: 34th Annual Scientific Meeting, Newcastle
    Conference Papers | 2000
    Day RO, 2000, 'Cox 2 Inhibitors and safety', in Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, ASCEPT: 34th Annual Scientific Meeting, Newcastle, pp. 1.12, presented at ASCEPT: 34th Annual Scientific Meeting, Newcastle
    Conference Papers | 1999
    Day RO, 1999, 'Drug interactions with methadone: Pharmacokinetics', in Workshop on the Induction and Stabilisation of patients onto methadone, Workshop on the Induction and Stabilisation of patients onto methadone, Adelaide, Sth Aust, presented at Workshop on the Induction and Stabilisation of patients onto methadone, Adelaide, Sth Aust, 28 January 1999 - 29 January 1999
    Conference Papers | 1998
    Carmody JJ; Walker JS; Sheather-Reid R; Vial JH; Day RO, 1998, 'Non steroidal anti-inflammatory drugs (NSAIDS) in rheumatoid and osteoarthritis: support for the concept of `responders` and `non-responders`', in Naunyn - Schmiedebergs Archives of Pharmacology, Springer, New York, NY, USA, pp. 15, presented at Archives of Pharmacology 358, Munich, Germany
    Conference Papers | 1998
    Day RO; Mclachlan AJ; Williams KM, 1998, 'Population pharmacokinetics (PK) and pharmacodynamics (PD) of tenoxicam (TN) in patients with rheumatoid arthritis (RA)', in Clinical Pharmacology and Therapeutics, Mosby, St Louis, MO, USA, pp. 168, presented at Clinical and Pharmacology Therapeutics, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072420300125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Papers | 1998
    Weekes LM; Brooks C; Day RO, 1998, 'Describing the performance of pharmacy and therapeutics committees', in Clinical Pharmacology and Therapeutics, Mosby, St Louis, MO, USA, pp. 179, presented at Clinical and Pharmacology Therapeutics
    Conference Papers | 1998
    Williams KM; Mclachlan AJ; Day RO; Pritchard A, 1998, 'Comparative pharmacokinetics of hepatitis B immuno-globulin after intramuscular administration in healthy subjects', in Naunyn - Schmiedebergs Archives of Pharmacology, Springer, New York, NY, USA, pp. 285, presented at Archives of Pharmacology 358, Munich, Germany, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000075207701061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Papers | 1997
    Ziegler JB; Graham GG; Day RO; Williams KM; Milligan MK, 1997, 'THERAPEUTIC CONSIDERATIONS FROM PHARMACOKINETICS AND METABOLISM: IBUPROFEN AND PARACETAMOL.', in Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, presented at Safety and Efficacy of non-prescription analgesics and NSAIDS, San Francisco, California USA, 17 March 1997 -
    Conference Posters | 1990
    Day RO; Walker JS; Seideman P; Knihinicki RD; Williams K, 1990, 'A human model for evaluation of non-steroidal anti-inflammatory drug (NSAID) distribution into extracellular fluid', Vol. 183, pp. 1034, http://dx.doi.org/10.1016/0014-2999(90)92891-L
    Conference Posters | 1990
    Walker JS; Day RO; Wessell H; Arroyo J, 1990, 'Validation of a human model of experimental pain for testing pharmacodynamics of non-steroidal anti-inflammatory drugs', Vol. 183, pp. 1036, http://dx.doi.org/10.1016/0014-2999(90)92893-N
    Conference Presentations | 1983
    CHAMPION GD; BIERI D; BROWNE CD; CAIRNS D; DAY RO; GRAHAM GG; HARRIS G; SAMBROOK PN, 1983, 'DETERMINATION OF RESPONSE OF INDIVIDUAL PATIENTS WITH RHEUMATOID-ARTHRITIS TO AURANOFIN', Vol. 10, pp. 674 - 674, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 1982
    Conference Presentations | 1977
    BIERI D; CHAMPION GD; DAY RO; GRAHAM GG; HASKI AL, 1977, 'MEASUREMENT OF SUBJECTIVE PARAMETERS OF RHEUMATOID-ARTHRITIS - DEVELOPMENT OF AN INDEX OF FUNCTION', Vol. 7, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DH49400031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 1977
    Bieri D; Champion GD; Corrigan AB, 1977, 'Bioavailability, gastrointestinal microbleeding and side effects of four aspirin formulations in subjects with rheumatoid arthritis', Vol. 7, pp. 458 - 458, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DS42200077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 1977
    Conference Presentations | 1977
    GRAHAM GG; CHAMPION GD; DAY RO, 1977, 'INFLUENCE OF CORTICOSTEROIDS ON METABOLISM AND PLASMA CONCENTRATIONS OF SALICYLATE', Vol. 7, pp. 91 - 91, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DH49400028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 1977
    HILLS LJ; BIERI D; CHAMPION GD; DAY RO; GRAHAM GG; HASKI A; PAULL PD, 1977, 'STATISTICAL PROCEDURES IN ANALYSIS OF AN ANALGESIC STUDY', Vol. 7, pp. 458 - 459, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1977DS42200078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 1975
    CHAMPION GD; DAY RO; PAULL PD; GRAHAM GG; OWEN MS; HASKI AL, 1975, 'CLINICAL PHARMACOLOGY AND EFFICACY OF BENORYLATE IN PATIENTS WITH RHEUMATOID-ARTHRITIS', Vol. 5, pp. 501 - 501, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1975AU07300093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 1975
    Champion GD; Day RO; Paull PD, 1975, 'Clinical pharmacology and efficacy of benorylate in patients with rheumatoid arthritis', Vol. 2, pp. 416 - 417
    Conference Presentations | 1975
    DAY RO; RAY JE; CHAMPION GD; WADE DN, 1975, 'ACTION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON RAT MAST-CELLS', Vol. 5, pp. 500 - 500, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1975AU07300091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 1975
    GRAHAM G; CHAMPION GD; DAY RO; PAULL PD, 1975, 'PHARMACOKINETICS OF SALICYLATE IN SUBJECTS WITH RHEUMATOID-ARTHRITIS', Vol. 5, pp. 500 - 500, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1975AU07300090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

NHMRC RESEARCH FUNDING

Postgraduate Medical Scholarship; NHMRC Postgraduate Medical Scholar; Recipient; 1975; 3 years    

Travelling Fellowship Scholarship; NHMRC Travelling Fellowship in Clinical Pharmacology; Recipient; 1977; 3 years    

Pharmacokinetics and Pharmacodynamics of Allopurinol (with Birkett DJ & Miners J; Flinders University, SA); 1983; 3 years; $36,493.00
        
Relationship between Plasma Salicylate Concentrations and Ototoxicity (with Graham GG; University of New South Wales); 1984; 1 year; $15,159.00
        
Disposition of the Enantiomers of Ibuprofen in Man (with Williams K; St Vincent's Hospital, Sydney); 1984; 2 years; $56,000.00
        
Disposition and Interconversion of the Enantiomers of Ibuprofen (with Williams K; St Vincent's Hospital, Sydney); 1986; 3 years; $90,939.00

APP890731; Lipid peroxidation of human polymorph membranes (with Gebicki J; Macquarie University; Guille J; St Vincent's Hospital, Sydney); 1989; 3 years; $66,000.00

APP890677; Enantioselective metabolism of 2 arylpropionic acid antiinflammatory drugs (with Williams K, St Vincent's Hospital, Sydney); 1989; 3 years; $115,908.00

APP900242; Determinants of the variability in clinical response to nonsteroidal anti-inflammatory drugs (with Walker J; St Vincent's Hospital, Sydney); 1990; 3 years; $143,571.00

APP910550; Indices of free radical activity in acute and chronic alcohol exposure (with Hicks M, Gebicki J, Wodak A; UNSW, Macquarie University & St Vincent's Hospital, Sydney); 1991; 3 years; $77,582.00

APP920932; Rational therapy of rheumatic diseases with hydroxychloroquine (with Tett S, Cutler D; St Vincent's Hospital & Sydney University); 1992; 3 years; $81,378.00

APP920221; Allopurinol dose-response in man (with Birkett D, Miners J, Graham G; St Vincent's, UNSW & Flinders); 1992; 3 years; $112,458.70
                        
Stereoselective disposition of 2 arylpropionic acid antiinflammatory drugs (with Williams K; St Vincent's Hospital, Sydney); 1993; 3 years; $183,000.00

APP970946; Investigation of the skin suction blister as a model of inflammation and its treatment; 1997; 3 years; $159,867.00

APP971087; Quality use of medication; pharmacokinetics, pharmacodynamics and optimal dose prediction (With Tett S; University of Queensland); 1997; 3 years; $246,075.59

APP141772 Project Grant; An investigation of the relationship between the pharma industry and medical practitioner (Associate-investigator with Kerridge I, McNeill P, Hill S, Henry D); 2001; 2 years;    $185,000.00

APP300435 Project Grant; Changing decision-making behaviour in primary care by providing access to online evidence (EW Coiera, JI Westbrook, MR Kidd, R. Day); CID; 2004; 2 years; $202,625.00

APP352576 Project Grant; A clinical trial of manipulative therapy and/or NSAIDs for significant acute low back pain (Maher C, Latimer J, McLachlan A, Day R, Cooper C); CID; 2005; 3 years; $521,625.00

APP400929 Project Grant; The safety and effectiveness of hospital e-prescribing systems: a controlled time series study (Westbrook J, Runciman W, Day R, Dunsmuir W, Braithwaite J, Williamson M); CIC; 2006; 3 years; $583,000.00

APP401020 Project Grant; Measuring adverse events: Development of a Patient-Centred Adverse Event Reporting Tool (PAET) (Lassere M, Bellamy N, Day R, Iedema R, Johnson K, Tugwell P); CIC; 2006; 3 years; $438,500.00

APP402511 Project Grant; The effect of glucosamine sulphate on structural disease progression in knee osteoarthritis (Fransen M, Day R, Edmonds J, Bridges-Webb C, Norton R, Woodward M); CIB; 2006; 5 years; $1,174,955.00

APP455270 Project Grant; The impact of electronic medication administration records (e-MAR) on medication administration safety and nurses' work (Westbrook J, Dean-Franklin B, Day R, Duffield C, Coiera E, Williamson M); CIC; 2007; 3 years; $678,475.00

APP568612 Program Grant; Patient Safety: enabling and supporting change for a safer and more effective health system. (Braithwaite J, Coiera E, Westbrook J, Runciman W, Day R) CIE; 2009; 5years; $8,400,000

                        
APP1045065 Project Grant; Using collaboration networks to measure bias and inefficiency in the production and translation of evidence about cardiovascular risk. (Dunn A) AI; 2013; 2 years; $214,181.18

APP1042073 Project Grant; Pregabalin in addition to usual care for sciatica (PRECISE): a randomised, placebo-controlled trial. (Lin C, Maher C, McLachlan A, Latimer J, Koes B, Hancock M, Harris I) AI; 2013; 3 years; $618,589.00

APP1054146 Program Grant; Creating safe, effective systems of care: the translational challenge. (Braithwaite J, Westbrook J, Coiera E, Runciman W, Day R, Hillman K) CIE; 2014; 5 years; $10,855,710

APP1059732 Project Grant; Addressing conflicts of interest in public health and biomedicine: enhancing professional integrity and safeguarding the public’s health. (Lipworth W, Kerridge I, Komersaroff P, Stewart C, Olver I) AI; 2014; 3 years; $564,553

APP1082480 Project Grant; The first placebo-controlled trial of opioid analgesics for acute spinal pain. (Lin C, Maher C, McLachlan A, Latimer J, Billot L, Koes B) AI; 2015; 3 years; $996,237

APP1080673 Project Grant; Improving decisions about the funding of high cost cancer medicines in Australia. (Lipworth W, Kerridge I, Salkeld G, Olver I, Isaacs D, Pearson S) AI; 2015; 3 years; $549,492

APP1094708 Partnership Project Grant; Patient-centred eHealth approach to improving outcomes for gout sufferers. (Day R, Zwar N, Reath J, Westbrook J, Lau A, Baysari M, Laba T, McLachlan A, Runciman W); CIA;    2015; 5 years;    NHMRC $660,656.85, Partners $661,000, Total: $1,321,656.80

APP1094878 Partnership Project Grant; Delivering safe and effective care for children in hospital with eHealth systems. (Westbrook J, Georgiou A, Day R, O’Brien T, Karnon J, Dalla-Pozza L, Cowell C, Li L, Baysari M, Ambler G); CIC; 2015; 5    years; NHMRC $632,806, Partners $450,000, Total: $1,082,806

APP1122332 Partnership Project Grant; How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in Australia, Canada the European Union and the United States. (Mintzes B, Roughead EE, Lexchin J, Bero L, Dormuth C, Kesselheim A, Lipworth W, De Bruin ML, Gnjidic D, Puil L)    AI; 2017; 3 years; $1,002,283.40

APP1125414 Project Grant; Enabling personalised cohort studies from large repositories of clinical practice data. (Gallego Luxan B, Shah N, Verspoor K, Liaw ST) AI; 2017; 3 years; $520,967.50

APP1134459 Partnership Project Grant; Creating a culture of safety and respect: a controlled, mixed methods study of the effectiveness of a behavioural accountability intervention to reduce unprofessional behaviours. (Westbrook J, Braithwaite J, Day R, Middleton S, Scott D, Rapport F, Mitchell R, Baysari M, Li L, Taylor N) CIC; 2017;    4 years; $875,978.40

APP1134824 Partnership Project Grant; Optimising computerised decision support to transform medication safety and reduce prescriber burden. (Baysari M, Li L, Westbrook J, Day R, Hilmer S) CID; 2017; 4 years; NHMRC $325,545.96, Partners: $505,000, Total: $830,545.96

APP1134856 Centres of Research Excellence; Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network (Buchbinder R, Maher C, March L, Day R, Hinman R, Harris I, Ferreira M, Glasziou P, Green S, Billot L); CID; 2017; 5 years; $2,497,653.50

 

OTHER RESEARCH FUNDING


Federal Department of Health through the National Campaign against Drug Abuse; Study of hypnotic-sedative use. CI; 1985;    2 years; $30,000.00

Rayner fellowship. CI;    1987; 3 years;    $90,000.00

Rheumatology Unit Research Fund (Fellowship Clinical Pharmacology in Rheumatic Diseases). 1987; 3 years; $45,000.00

Arthritis Foundation of Australia; Allopurinol pharmacokinetics and pharmacodynamics. 1989; 1 year; $3,000.00

Arthritis Foundation of Australia; Pharmacodynamic studies with nonsteroidal antiinflammatory drugs in arthritis (with Dr J. Walker, St Vincent's Hospital, Sydney). 1989; 1 year; $3,000.00

Department of Veterans Affairs; NSW Therapeutic Assessment Group sponsored study of patterns of NSAID use in NSW.    1989; 2 years; $112,000.00

Rheumatology Unit Research Fund (Fellowship Clinical Pharmacology in Rheumatic Diseases). 1990; 2 years; $40,000.00

Ramaciotti Foundation (with Dr J Walker, St Vincent's Hospital, Sydney). 1990; 1 year; $10,000.00

Ramaciotti Foundation; The use of allantoin/urate ratios as indices of free radical activity in acute and chronic alcohol exposure (with Dr M Hicks, St Vincent's Hospital, Sydney). 1990; 1 year; $23,000.00

Arthritis Foundation of Australia; Concentration analgesic effect relationships for NSAIDs in patients with rheumatoid arthritis (with Dr J Walker, St Vincent's Hospital, Sydney). 1990; 1 year; $5,000.00

Arthritis Foundation of Australia; Antirheumatic activities of the enantiomers of thalidomide (with Dr K Williams, St. Vincent's Hospital, Sydney). 1990; 1 year; $6,000.00

Committee on Residents Continuing Education, NSW; Computer assisted learning for House Staff (with Dr G Connors). CI; 1991; 1 year; $25,000.00

Therapeutics in General Practice Project (with A/Prof A Mant) RACGP via Commonwealth Department of Health. 1993; 3 years; $750,000.00

Arthritis Foundation of Australia. Free radicals in inflammation (With Dr M Hicks, St. Vincent's Hospital, Sydney). 1994; 1 year; $5,000.00

Commonwealth Department of Health: Investigation of the Interaction between the Pharmaceutical Industry and Prescribers: Co-director. 1995; 2 years; $150,000.00

Faculty Medicine Quality Funds; Metabolism of antiinflammatory drugs, lipids and prostaglandins (K.M. Williams & R.O. Day). 1996; 1 year; $11,900.00

Faculty Medicine Quality Funds; Metabolism of antiinflammatory drugs, lipids and prostaglandins (K.M. Williams & R.O. Day). 1997; 1 year; $26,250.00

Arthritis Foundation of Australia. First Stage Adverse Events Instrument (AEI) Project (with A/Prof M.Lassere, Dr Kent Johnson, St George Hospital). 2001; 3 years; $15,000.00

Quintiles  Pty Ltd (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 02/034. CIA; 2002; 1 year; $20,000.00

GSK, PO Box 168, Boronia VIC 3155 (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 02/128. CIA; 2002; 1 year; $253,200.00

GSK Medicines Research Unit, Prince of Wales Hospital, Parkes 10 East High Street Randwick  2031 (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 03/028. CIA;    2003; 1 year; $40,500.00

GSK Medicines Research Unit, Prince of Wales Hospital, Parkes 10 East High Street Randwick 2031 (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 03/046. CIA;    2003; 1 year; $187,602.53

GSK, PO Box 168, Boronia VIC 3155 (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 03/047. CIA; 2003; 1 year; $27,530.00

GSK, PO Box 168, Boronia VIC 3155 (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 03/049. CIA; 2003; 1 year; $170,000.00

Bone Medical Ltd, Unit 2 Sarich Way, Bentley Technology Park, Perth WA (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 04/111.    CIA; 2004; 1 year; $165,325.71

Unique Global Possibilities Medical Pty Ltd, PO Box 4314, Kingston ACT 2604 (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 05/045. CIA; 2005; 1 year; $204,965.10

Sanofi Pasteur, 2 Avenue Pont Pasteur, F-69367 Lyon cedex 07 France (via Directorship of St Vincent’s Clinical Trials Centre); (HREC# 05/034). CIA; 2005; 1 year; $152,600.00

GlaxoSmithKline, PO Box 168, Boronia VIC 3155 (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 05/030. CIA; 2005; 1 year; $65,138.00

Arthritis Australia, (with Lassare M, Bellamy N, Iedema R, Johnson K, Tugwell P). CIC; 2006; 1 year; $15,000.00

University of New South Wales; Goldstar Star Award, (with Westbrook J, Dean-Franklin B, Coiera E, Duffield C, Williamson M). CID; 2006;    1 year;    $40,000.00

Hemisperx Biopharma Inc, Philadelphia PA (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 06/069.    CIA; 2006; 1 year; $130,683.58

Jupitar Pty, 8/11 Bungan St MONA VALE NSW 2103 (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 07/038. CIA; 2007; 1 year; $262,082.25

Peptech Limited, (via Directorship of St Vincent’s Clinical Trials Centre); HREC# 07/003. CIA; 2007; 1 year; $235,506.00

Commonwealth of Australia: Dept. of Education & Science Training: Collaboration and Structural Reform (CASR) Fund. CIA; 2007; 2 years; $230,000.00

University of Queensland/NICM Collaborative Centre for Nutraceuticals & Herbal Medicine Shared Grant/Subcontract. CIF; 2008; 3 years; $20,000.00

UNSW Goldstar near miss funding (McLachlan A, Williams K, Graham G) (relinquished on receipt of Arthritis Australia Grant). CIA;    2008; 1 year; $40,000.00

Arthritis Australia: Better management of gout through better use of allopurinol (with McLachlan A, Williams K, Graham G). CIA; 2008; 1 year; $40,000.00

St Vincent's Hospital/ARC Linkage Project (LP0990670) Industry Partner Contribution; Development of computer-based decision support tools using population-based PK-PD modeling (Day RO, Kirkpatrick CM, Williams KM, Greenfield J, Giacomini K).    CIA; 2009; 4 years; $63,734.00

Australian Research Council/Linkage Projects LP0990670; Development of computer-based decision support tools using population-based PK-PD modeling (Day RO, Kirkpatrick CM, Williams KM, Greenfield J, Giacomini K). CIA;    2009; 4 years; $318,668.00

St Vincent’s Clinic Foundation; Disposition of metformin in renal impairment (RO Day, J Greenfield, KM Williams, GG Graham, JE Ray). CIC; 2009;    1 year;    $100,000.00

St Vincent's Hospital Sydney, Lexy Davies Estate Trust Fund (T/Fund 869753). PI; 2010; 2 years; $100,000.00

St Vincent's Clinic Foundation: ‘Reducing hospital prescribing errors by enhancing the effectiveness of computerized decision support’ (with M Baysari). AI; 2012; 1 year; $30,000.00

St Vincent's Hospital Sydney, Lexy Davies Estate Trust Fund (T/Fund 869753). PI; 2012; 2 years; $100,000.00

St Vincent’s Curran Foundation’s 2012 Annual Grants: funding support for ten iPads. PI; 2012; 1 year; $7,300.00

St Vincent’s Clinic Foundation. Annual Research Grant 2014. Exploiting new opportunities with an electronic prescribing system to identify prescribers at risk of making prescribing errors. (Baysari MT, Day RO, Richardson K)    PI; 2014; 1 year; $30,000

Diabetes Australia Research Trust (DART) Research Grant. 2014. Safety of metformin in dialysis. (Day RO, Williams KM, Furlong TJ, Greenfield JR, Graham GG, Kumar SK) PI; 2014; 1 year; $60,000

St Vincent's Health Network (SVHN) Sydney, Lexy Davies Estate Trust Fund (T/Fund 869753). PI; 2014/15;    5 years; $450,000

St Vincent’s Clinic Foundation. Annual Research Grant 2016. Implementation of drug-drug interaction alerts: An investigation of burden of prescribers. (Baysari M, Sandhu A, Richardson K, Li L, Day R) AI; 2016;    1 year;    $30,000

St Vincent’s Clinic Foundation Research Grant 2017. The safety and pharmacokinetics of metformin in heart failure. (Day R, Macdonald P, Greenfield J, Graham G, Stocker S, Carland J) PI;    2017;1 year; $30,000

UNSW Research Infrastructure Scheme 2017: Supporting Collaborative Research. Installation of a Shimadzu Nexera X2 UHPLC into the Department of Clinical Pharmacology and Toxicology. (Day R, Carland JE, Stocker SL, Norris RLG, Greenfield JR) PI; 2017; 1 year; $78,431

St Vincent's Clinical School Funding 2018. UNSW Medicine, UNSW Sydney. Identifying predictors of response to sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with newly-diagnosed type 2 diabetes. (Day R, Greenfield JR, Milder T)     PI; 2018; 1year; $10,000

St Vincent’s Clinic Foundation, SVPHS Ladies’ Committee Sister Mary Bernice Research Grant 2019: Vascular effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin in people with type 2 diabetes and chronic kidney disease. (Day RO, Greenfield JR, Sevastos J, Stocker S, Samocha-Bonet D, Milder T); CI; 2019; 1 year; $120,000

St Vincent’s Centre for Applied Medical Research (AMR) Translational Research Grant 2019, St Vincent’s Health Australia Inclusive Health Innovation Fund (SVHA IHIF). Examining the feasibility and acceptability of intranasal take home naloxone in the Emergency Department in patient presenting with opioid related overdose. (Short title: The ONE Study (Overdose and take home Naloxone in Emergency settings). (Brett J, Ezard N, Day R, Leung J, Welch S.); AI; 2019; 1 year; $39,427

Heart Foundation 2018 Vanguard Grant (Award ID 102279). Vascular effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin in people with type 2 diabetes and chronic kidney disease (Stage 3B/4). (Short title: Vascular effects of empagliflozin in chronic kidney disease) (CIs: Day R, Greenfield J, Stocker S, Samocha Bonet D; AIs: Milder T, Sevastos J, Macdonald P); PI 2019; 1 year; $74,087

Awards

Honorary Membership, The Society of Hospital Pharmacists of Australia, 1991. 
Member of the Order of Australia (AM), 2000.
Inaugural QUM (Quality of Use of Medicines) Life Member of the National Prescribing Service, 2011. 
Excellence in Mentoring Award 2012, Royal Australasian College of Physicians, 2012. 
Quality Award ‘Exceptional care: A culture of no harm’ for application ‘Transforming medication safety with information technology’. St Vincent’s Health Australia, 2012.
Inaugural Honorary Fellow of the DIA (Drug Information Association), 2013.
Certificate awarded for being a member in good standing since 1995 and has fulfilled the Objectives of the Association and abided by its Code of Ethics, Australian Medical Association (NSW), 2016.
Awarded Life Membership by the Board and Fellows of The Royal Australasian College of Physicians (RACP), 2016.
St Vincent’s Clinical School 2016 Researcher of the Year Award, UNSW Medicine, University of New South Wales, 2016.
2016 SoMS (School of Medical Sciences) Higher Degree Research Supervisor Award, School of Medical Sciences, UNSW Medicine, University of New South Wales, 2016.
St Vincent’s Clinical School 2017 Researcher of the Year Award, UNSW Medicine, UNSW Sydney, 2017.
St Vincent’s Clinical School 2018 Researcher of the Year Award, UNSW Medicine, UNSW Sydney, 2018.

Fellow of ASCEPT (Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists) 2022

Prizes

Distinguished Mentor Award, International Association of Inflammation Societies (IAIS), 2005.
ASCEPT Lecture & Plaque, ASCEPT, 2006.
DIA Outstanding Service Award, Drug Information Association (DIA), 2008.
John Sands Medal (“Recognition of outstanding contribution…to College affairs”), The Royal Australasian College of Physicians (RACP), 2008. 
AMA Distinguished Service Award, Australian Medical Association (AMA), 2009.
 

Research Interests:
Rheumatic disorders and diabetes are prevalent chronic illnesses that demand high quality pharmacotherapy. We are researching powerful techniques for individualising pharmacotherapy using pharmacokinetic/pharmacodynamic models. Our aim is safe yet effective therapy. Allopurinol used in gout and metformin used in diabetes in patients with kidney, liver or heart failure are currently being studied. We are using therapeutics drug monitoring to optimise outcomes in patients treated with antibiotics and antifungal drugs and those treated with immunosuppressants (transplantation patients) and immunological disorders. We are examining genetic factors that predict serious adverse drug reactions and also explain variation in response to medicines, especially transporter molecules and their controlling genes. The effects of electronic medication management and decision support tools in a teaching hospital on the rate of adverse events occurring is a new and exciting research interest.

Broad Research Areas:
Pharmacology, Preventive Medicine, Arthritis / Rheumatology, Diabetes, Anti-infectives, Dosage Prediction, Electronic Medication Management, Decision Support.

Specific Research Keywords:
Drug Safety, Clinical Pharmacology, Rheumatology, Gout, Diabetes and Endocrinology, Anti-infectives, Decision Support, Therapeutic Drug Monitoring.

Research Study:
Gout Self-Management App: mygoutapp.com -large prospective, 1 year, Double Blind RCT with over 500 patients from across Australia;  Data-locked - numerous sub-studies available to examine outcome, features of Apps that influence adherence

Gout Medication Adherence studies

SGLT2i uptake in collaboration with Profs Jerry Greenfield & Sallie Pearson

Therapeutic Drug Monitoring Studies across transplantation, infectious diseases, endocrinology

 

 

Society Memberships & Professional Activities:
Fellow Royal Australian College of Physicians, Past Chair Federal PHARM Committee (Pharmaceutical Health and Rational Use of Medicines Committee) , Member of Australian Rheumatology Association and Australasian Society of Clinical & Experimental Pharmacologists and Toxicologists (Past President), Practising Clinical Pharmacologist & Rheumatologist at St Vincent's Hospital Sydney and St Vincent's Medical Centre, Darlinghurst, Director of Clinical Pharmacology & Toxicology, St Vincent's Hospital, President Drug Information Association 2010/11 (http://www.diahome.org/DIAHome/Home.aspx)

 

Community Engagement

Opinion

1.    Day, R. O.; Graham, G. G. Curious Kids: How does pain medicine work in the body? 2018; Available from The Conversation

2.    Danta, M.; Ma, C.; Day, R.; Ma, D. Dealing with the spiraling price of medicines: how “low” can it go? 2018; Available from John Menadue – Pearls and Irritations

3.    Day, R.; McLachlan, A. I can’t sleep. What drugs can I (safely) take? 2018; Available from The Conversation

4.    Day, R. Pharmacy Guild Out Muscles Government Again. 7th May 2019. Available from John Menadue – Pearls and Irritations 

5.    Day, R.; McLachlan, A. Health check: why do we get motion sickness and what’s the best way to treat it? 7th May 2019. Available from The Conversation

6.    Day, R. While talking about medicines during the election campaign, here are some critical questions…. [Opinion] 10th May 2019; Available from Croakey

 

DIA Global Forum

1.    Day, R. Changing Times Down Under. DIA Global Forum. 2016;8(1):31.

2.    Day, R. Eradicating Hepatitis C in Australia; “Choosing Wisely” to Spend Wisely. DIA Global Forum. 2016;8(2):19.

3.    Day, R. Policy, Practice, Evidence & Future Trends: 8th National Medicines Symposium. DIA Global Forum. 2016;8(3):49.

4.    Day, R. TGA Head: Australia Moves to Improve Medicines Labeling & Nomenclature. DIA Global Forum. 2016;8(5):18.

5.    Day, R. Accelerated Reviews and Adaptive Licensing are Coming to Australia. DIA Global Forum. 2016;8(6):54.

6.    Day, R. What Price for Medicines in Australia? DIA Global Forum. 2017;9(1):27.

7.    Day, R. PBAC CHAIR: Listening to Patients, Assessing Technology, Weighing Expedited and Conditional Approvals. DIA Global Forum. 2017;9(3):22.

8.    Day, R. Priority Review and Provisional Approval: More Work and More Challenges for Government as Payer. DIA Global Forum. 2017;9(5):16-7.

9.    Day, R. Medicinal Cannabis Prospects in Australia. DIA Global Forum. 2017;9(7):16-7.

10.    Day, R. New ACTA’s Unexpectedly Positive Global Impact. DIA Global Forum. February 2018.

11.    Day, R. Delivering ‘Quality Use of Medicines’ to Australia: NPS MedicineWise celebrates 20 years and large healthcare budget savings. DIA Global Forrum. May 2018.

12.    Day, R. Down Under, Changes at the Top: Perspective on the Fast-Tracking of Drug Approvals. DIA Global Forum. October 2018.

13.    Day, R. Medicines Shortages Down Under. DIA Global Forum. January 2019.

14.    Day, R. A National, Personally Controlled Health Record. Australia Getting Privacy Right? DIA Global Forum. February 2019.

15.    Day, R. Change of Government and a Health Reform Commission for Australia? DIA Global Forum. May 2019.

 

Radio

1.    Prof Ric Day speaks about Gout and the Gout App Study on SBS Hmong. Listen here.

 

Podcast

1.    Joint Action: What anti-inflammatory should I take for my osteoarthritis? with Ric Day. Listen here.

My Research Supervision

​​​​​2018 Projects

  • Optimisation of metformin therapy by personalising dosage based on individuals' relevant characteristics
  • Safety and Pharmacokinetics of Metformin in Heart Failure
  • Determining the overall cost of healthcare to Australian gout patients
  • Vancomycin - Implementation of an electronic monitoring program
  • Development and evaluation of educational resources for vancomycin
  • A Time and Motion Study of Phlebotomists' work
  • Therapeutic Drug Monitoring (TDM) of voriconazole
  • Evaluation of Drug-Drug Interaction Alerts in Electronic Systems
  • Treat-to-target investigations of febuxostat in gouty and hyperuricaemic patients including those with renal and hepatic impairment as well as in patients intolerant of allopurinol